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Preamble 
Common carp (Cyprinus carpio) is cultivated for human consumption worldwide. It is one of 
the most important freshwater species in aquaculture with a world production of 3.4 million metric 
tons per year (estimation from the FAO for 2010). While the common carp represents a cheap source 
of animal proteins, its coloured subspecies koi (Cyprinus carpio koi) is cultivated as an expensive pet 
fish for personal pleasure or worldwide competitive exhibitions. The price of individual collectable 
subjects fluctuates between 1 to 30 K euros, but can reach much higher prices. In the late 1990s, a 
highly contagious and virulent disease began to cause severe economic losses in these two carps 
industries worldwide. The causative agent of the disease was initially called koi herpesvirus (KHV). It 
has been renamed as cyprinid herpesvirus 3 (CyHV-3) in 2005 and classified in the Alloherpesviridae 
family of the Herpesvirales order. 
In addition to its economic importance, CyHV-3 has several qualities as a fundamental model 
of infection: (i) It is phylogenically distant from the vast majority of herpesviruses that have been 
studied so far. (ii) It can be studied in laboratories by infection of its natural host (homologous 
virus-host model). (iii) The sequence of its genome published in 2007 revealed a fascinating virus with 
unique properties in the Herpesvirales, such as an extremely large genome (295 Kb), a high number of 
genes which are not homologous to known viral sequences, and genes that are normally found 
exclusively in the Poxviridae. (iv) Interestingly, the sequencing of the CyHV-3 genome revealed 
several genes potentially encoding proteins involved in immune evasion mechanisms. Among these 
genes, ORF134 encodes a homologue of carp Interleukin 10 (IL-10). The identification of this ORF in 
the CyHV-3 genome represents an opportunity to study in vitro and in vivo the roles of a viral IL-10 
(vIL-10) homologue using a homologue virus-host model. The present thesis was devoted to the study 
of this viral gene. 
The structure of this manuscript is as follows. It starts with an introduction on the 
Herpesvirales order, on CyHV-3 and on the viral Interleukin-10 homologues encoded by viruses. 
While the first section is brief and general, the second and the third represent review manuscripts that 
have been published (in Veterinary research) or accepted for publication (in Journal of General 
Virology), respectively. After the introduction, the objectives of the thesis are briefly exposed. The 
results obtained during this thesis are then presented in two chapters. The first chapter has been 
published in Veterinary Research, while a manuscript including the results of the second chapter is 
under preparation for publication. In the last section of this manuscript, the main results are discussed 
and potential perspectives are presented. 
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Preamble 
 The introduction of this thesis is structured in three chapters. The first chapter presents a brief 
description of the order Herpesvirales. The general properties of the viruses belonging to this order 
and the families it contains are described. This section of the manuscript is an update and adapted 
version of a text used in most theses of the host lab on herpesviruses. The second chapter of this 
introduction summarized the knowledge on Cyprinid herpesvirus 3 (CyHV-3) available in the 
literature when this thesis was printed. It represents a review has been published in Veterinary research. 
Ping Ouyang is second author of this review. The third and last chapter of the introduction represents a 
review on viral homologues of Interleukin-10 encoded by viruses (vIL-10). Ping Ouyang is co-first 
author of this manuscript. 
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1. Introduction 
At the border of living and non-living, viruses are submicroscopic biological agents consisting 
of nucleic acid and protein shell which may be multilayered. They cannot replicate in the extracellular 
medium and reproduce as obligate intracellular parasites in the host organism. Since the description of 
the tobacco mosaic virus at the end of the 19th century, thousands of viruses were described in every 
ecosystem. They infect bacteria, plants and animals (Dimmock et al., 2007). The International 
Committee on Taxonomy of viruses (ICTV) developed universal systems for classifying viruses. In 
the current ICTV taxonomy, six orders have been established, the Caudovirales, the Herpesvirales, the 
Mononegavirales, the Nidovirales, the Picornavirales and the Tymovirales (King et al., 2012). 
Members of the order Herpesvirales are enveloped viruses with a linear double-stranded DNA 
(dsDNA) genome. They share an identical structure. A densely packed DNA core is contained in an 
icosahedral capsid. The capsid is embedded in a complex proteinaceous layer called the tegument. A 
lipid envelope containing numerous viral glycoproteins forms the outermost structure of the viral 
particle (McGeoch et al., 2008). Most of the members of the order Herpesvirales have been shown to 
realize two distinct phases in their life cycle: lytic replication characterized by a transcription program 
where immediate-early (IE), early (E), and late (L) genes are expressed successively; and latency, 
consisting of the maintenance of the viral genome as a non-integrated episome and the expression of a 
limited number of viral genes and microRNAs (Roizman & Pellet, 2007). Upon reactivation, latency 
reverses to a lytic replication. 
The origin of the order Herpesvirales has been estimated at several hundred million years ago 
(Davison, 2002). So far, approximately 135 members have been isolated from oyster, fish, amphibian, 
reptile, bird and mammal species, including human (Davison et al., 2009). Herpesviruses have mainly 
co-evolved with their host and in most cases are well adapted to them. This adaption is demonstrate 
that the ability of most herpesviruses to persist in the host species without inducing lethal infection. 
The order Herpesvirales contains three families, the Herpesviridae (comprising viruses 
infecting mammals, birds and reptiles), the Alloherpesviridae (comprising viruses infecting fish and 
amphibians) and the Malacoherpesviridae (comprising viruses infecting mollusks) families. Below, 
we will first provide a general and brief description of the structure, the genome, the common 
biological properties and the replication cycle of the members of the order Herpesvirales. Next, we 
will discribe briefly the biological specificities of the three families. 
2. Virus structure 
Every virus classified in the order Herpesvirales possesses an identical structure (Ackermann, 
2004). Their genome is protected by an icosahedral capsid with diameter of approximately 100 nm. 
The capsid is composed of 162 capsomers (150 hexons and 12 pentons) (Figure 1). This nucleocapsid 
is surrounded by an amorphous layer of proteins termed tegument, which contains proteins mainly 
Glycoproteins
Envelope
Genome
Capsid
Tegument
Isomers Examples
Figure 1. Herpesvirus structure. Schematic representation and electron microscopy picture of a viral
particle.
A
LTR RTR
B
C
R4 R3 R2 R1
1
1
1
HHV-6
AlHV-1
BoHV-4
HHV-4
CyHV-3
F
D
IR ERUSUL
E
2
4
1
UL USb’       c’ can b ana’n
BoHV-1
HHV-1
MuHV-1
Figure 2. The order Herpesvirales regroups 6 classes of genome. Horizontal lines represent unique
regions. Rectangles represent left and right terminal repeats (LTR and RTR, respectively) for A group;
internal repeats R1 to R4 of the C group and internal and external repeats (IR and ER) for the D group.
Terminal repeats of the E group are constituted by two parts. One is composed by n copies of the a sequence
near the larger b sequence. The other one is composed by the repeated a sequences followed by a c
sequence. Terminal sequences anb and can are inversed and are separated by long (UL) and short (US) unique
sequences. In the B group, terminal sequences are repeated a variable number of times at each extremity. In
the D group, US can be inverted compared to the UL giving two different isomers. In the E group, UL and US
regions can also be inverted generating four different isomers. Terminal repeats were not described in the F
group. Human herpesvirus 1 (HHV-1), 4 (HHV-4) and 6 (HHV-6), Alcelaphin herpesvirus 1 (AlHV-1),
Bovin herpesvirus 1 (BoHV-1) and 4 (BoHV-4), Murin herpesvirus 1 (MuHV-1) and Cyprinid herpesvirus 3
(CyHV-3) were chosen as examples (adapted from Roizman et al., 2007).
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involved in gene expression regulation. Finally, a lipid envelope bearing viral glycoproteins is 
covering the elements listed above to form a spherical particle of approximately 150 to 300 nm in 
diameter (Figure 1). 
3. Genomic features 
Herpesvirus genome is a long dsDNA molecule, linear in the capsid, but circular once it 
penetrates the nucleus of the host cell (Roizman & Pellet, 2007). Depending of the virus species, the 
guanine plus cytosine (G+C) percentage varies from 31 to 75% while the genome length varies from 
120 to 295 kilo base pairs (kbp) (Aoki et al., 2007; Roizman & Pellet, 2007). The genome contains 
variable internal and terminal repeated sequences. Based on the arrangement of these sequences, 
herpesvirus genomes have been classified in 6 different groups (Figure 2) (Roizman & Pellet, 2007). 
All herpesvirus genomes contain at their termini conserved signals for packaging of the DNA into 
capsids (Roizman & Pellet, 2007). 
4. Common biological properties 
Herpesviruses seem to share 4 important biological properties (Ackermann, 2004). Firstly, 
they encode their own enzymes for nucleic acid synthesis. Secondly, both viral DNA replication and 
assembly of the nucleocapsid take place in the nucleus of the infected cell. Thirdly, production of 
progeny viral particles leads to the lysis of the infected cell. Finally, even if this not firmly 
demonstrated for the Alloherpesviridae and Malacoherpesviridae families, all studied herpesviruses 
are able to establish a latent infection in their natural host. 
5. Biological cycle 
Herpesviruses have two distinct phases in their life cycle: lytic and latent infection. The 
characterization of these two phases is based on the study of members of the Herpesviridae family. 
5.1 Lytic infection 
The herpesvirus multiplication cycle is illustrated in Figure 3. It starts with the virion 
attachment on the host cell surface mediated by the interaction of viral glycoproteins with their 
cellular receptors. For example, human herpesvirus 1 (HHV-1) first binds to the cells through 
interaction of glycoproteins gC and gB with some cellular proteoglycans such as heparan sulfate 
(Spear, 2004). A stronger attachment is then mediated by the interaction of gD to its specific cellular 
receptor (Spear, 2004). 
After fusion of the viral envelope with the plasma membrane (or eventually endocytic 
vesicles), the nucleocapsid and tegument proteins are delivered in the cytoplasm where microtubules 
bring the nucleocapsid surrounded by the tegument close to the nucleus (Figure 3) (Sodeik et al., 
Attachment of the virion on the cell
surface and fusion of the envelope
with the plasma membrane
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Viral protein 
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Figure 3. Schematic representation of the lytic infection of herpesviruses (adapted from Flint et al.,
2000).
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1997). The genome is then released and enters the nucleus through a pore of the nuclear membrane. 
As soon as the genome enters in the nucleus, the viral DNA circularizes prior to viral protein synthesis 
(Garber et al., 1993). This circularization is realized by direct ligation of single unpaired 3’ end 
nucleotides present at both ends of the genome (Davison, 1984). Tegument proteins migrate with 
genome into the nucleus where they regulate virus and cellular gene expression. 
Herpesvirus gene expression is characterized by a transcription program where 
immediate-early (IE or α), early (E or β), and late (L or γ) genes are expressed successively (Figures 3 
and 4) (Honess & Roizman, 1974; 1975; Jones & Roizman, 1979). IE gene expression is initiated by 
tegument proteins which interact with cellular transcriptional proteins, such as RNA polymerase II, to 
activate the transcription. IE genes encode mainly for transcription factors which inhibit IE gene 
expression and promote E gene expression. The maximum of E gene expression is usually observed 
between 4 and 8 hours post-infection (Figure 4). They are mainly coding for enzymes involved in 
nucleotide metabolism and viral DNA replication (Figure 3). Similarly as IE genes, E genes down 
regulate their own expression while stimulating the expression of L genes. Maximum L gene 
expression occurs after virus DNA replication (Figures 3 and 4). L genes are further divided in L1 (or 
γ1) and L2 (or γ2) subclasses. L1 gene expression is increased by viral DNA synthesis genes while L2 
gene expression starts only after the synthesis of the viral genome (Figure 4) (Wagner et al., 1998). 
Most of the L genes code for the proteins incorporated in mature virions; these proteins are called 
structural proteins. The structural proteome of a virus is defined as all the proteins which enter in the 
virion composition. Produced capsid proteins encoded by L genes are assembled in the nucleus to 
form the nucleocapsid containing newly synthesized viral DNA (Figure 3). 
The replication of the viral genome is initiated from one or several origins of replication. 
Specific viral proteins are involved in viral DNA synthesis through a rolling-circle mechanism 
(Ackermann, 2004; Jacob et al., 1979). This process generates concatemers consisting of complexe 
structure of high molecular weight made of several genomic units linked head-to-tail (Figure 3). A 
viral protein complex brings concatemers close to the portal complex of a capsid through which a 
single genomic unit is internalized and cleaved from the concatemer (Mettenleiter et al., 2009). 
Different models were proposed for the egress of the nucleocapsid from the nucleus to the 
extracellular space (Granzow et al., 2001; Johnson & Spear, 1982; Wild et al., 2005). In the 
envelopment-deenvelopment model (Figure 3), the temporary enveloped virus in the peri-nuclear 
space fuses with the external nuclear membrane to deliver the naked capsid in the cytoplasm. 
Tegument proteins are associated with the capsid before it buds into trans-golgi vesicles to form the 
envelope (Browne et al., 1996; Granzow et al., 2001; Masse et al., 1999; Smith, 1980). The virion is 
finally released from the cell by exocytosis or cell lysis (Figure 3) (Flint et al., 2000; Mettenleiter, 
2004; Mettenleiter et al., 2009). In the luminal model, the capsids bud in the internal nuclear 
membrane then migrate in the endoplasmic reticulum (ER). The enveloped virions are then (i) 
incorporated in a transport vesicle and delivered in the golgi apparatus (vesicular model) or  
Figure 5. Acquisition process of herpesvirus envelope. (A) Primary enveloped virions in the perinuclear
space. The electron-dense sharply bordered layer of tegument underlying the envelope and the absence of
envelope glycoprotein spikes is noteworthy. (B) After translocation into the cytosol, capsids of HSV-1, PrV
and BoHV-4 appear “naked”, whereas those of HCMV and KHV are covered with a visible layer of “inner”
tegument. (C) Secondary envelopment and (D) presence of enveloped virions within a cellular vesicle during
transport to the plasma membrane. The same stages can be observed for members of the Herpesviridae
family and KHV, a member of the Alloherpesviridae family. HSV-1: Herpes simplex type 1; PrV:
Pseudorabies virus; HCMV: Human cytomegalovirus; BHV-4: Bovin herpesvirus 4; KHV: Koi herpesvirus.
Bars represent 100 nm. Reproduced from Mettenleiter et al. (2009).
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(ii) reach the golgi apparatus through connexions between the latter and the ER (intra-cisternal model). 
Independently of these models, enveloped virions are released by exocytosis (Darlington & Moss, 
1968; Johnson & Spear, 1982). Recently, a new model was described for BoHV-1 where capsids 
present in the nucleus are able to reach the cytoplasm trough enlarged nuclear pore (Wild et al., 2005). 
The capsids, once in the cytoplasm, bud with golgi-derived vesicles before egress from the host cell by 
exocytosis.  
A recent study by electron microscopy on the morphogenesis of different herpesviruses 
belonging to the Herpesviridae and Alloherpesviridae families, concludes that the nucleocapsids 
follow the envelopment-deenvelopment model before being released in the extracellular space by 
exocytosis (Figure 5) (Mettenleiter et al., 2009). 
5.2 Latent infection 
Latency is observed in all members of the family Herpesviridae. It consists in the virus 
maintenance in the host cell without production of viral particles. The mechanisms that induce latency 
are still poorly understood (Roizman & Pellet, 2007). Latency is supposed to occur when the virus 
infected specific cell types. The virus can then persist in the host even after the onset of an adaptive 
immune response able to clear cells supporting a replicative infection. Only few viral genes are 
expressed during latency. During latency, the genome is maintained as a non integrated episome in the 
nucleus. When the latent infected cells divide (if they do so), the viral episome is replicated with the 
cellular genomic DNA. Copies of this episome are then distributed between daughter cells. The latent 
infection can be interrupted by exogenous stimuli and switched to lytic infection. Latency has been 
studied mainly in the family Herpesviridae. Regulation of latency seems to be mediated mainly by 
transcripts (LATs for latency associated transcripts) in alphaherpesviruses (Jones, 2003) while in beta- 
and gammaherpesviruses latency proteins are expressed (Ballestas & Kaye, 2001; Cardin et al., 2009; 
Lee et al., 1999). 
Recent studies described the presence of microRNAs (miRNA) in the genome of different 
herpesviruses of the Herpesviridae family (Pfeffer et al., 2005). Ever since, several studies 
demonstrated miRNA productions amongst the latency transcripts (alphaherpesvirus LATs). They 
seem to play an important role in cooperation with the beta- and gammaherpesvirus proteins during 
the viral biological cycle and essentially during the latency where they can modulate cell apoptosis 
and immune pathways, as well as the viral lytic cycle (Burnside et al., 2006; Cai et al., 2005; Lu et al., 
2008; Umbach et al., 2008; Wang et al., 2008). 
6. Classification of the order Herpesvirales 
The ICTV has classified under the order Herpesvirales viruses encoding the putative ATPase 
subunit of the terminase (a complex that is responsible for packaging virus DNA into progeny capsids) 
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(Davison, 1992; 2002; Waltzek et al., 2009). This protein is specific to herpesviruses; however, it is 
also conserved to a lesser degree in the T4-like bacteriophages of the family Myoviridae (Davison et 
al., 2009). The Herpesvirales order is subdivided in three families: the Herpesviridae, the 
Alloherpesviridae and the Malacoherpesviridae (Davison et al., 2009; Roizmann et al., 1992). 
6.1 The Herpesviridae family 
The family Herpesviridae is highly studied and is divided into three sub-families: Alpha-, 
Beta-, and Gammaherpesvirinae (Davison et al., 2009; Roizman & Pellet, 2007). It regroups 
herpesviruses infecting reptiles, birds and mammals, including humans. 
The alphaherpesviruses have a variable host range, a relatively short reproduction cycle, a 
rapid spread in culture, an efficient destruction of infected cells, and a capacity to establish latent 
infection in sensory neurons. As example, this subfamily contains the human herpesvirus 1 (HHV-1 or 
HSV-1) and 3 (HHV-3 or VZV), belonging to the genera Simplexvirus and Varicellovirus, 
respectively.  
In contrast to alphaherpesviruses, betaherpesviruses have a restricted host range. The 
reproductive cycle is relatively long, and the infection progresses slowly in cell culture. Infected cells 
frequently become enlarged (cytomegalia). Their latency is established mainly in secretory glands. As 
example, this subfamily contains the human herpesvirus 5 (HHV-5 or HCMV) and the murid 
herpesvirus 1 (MuHV-1 or MCHV), belonging to the genera Cytomegalovirus and the 
Muromegalovirus, respectively. 
Gammaherpesviruses have usually a host range restricted to the family or the order of their 
natural host. In vitro, all members replicate in lymphoblastic cells, and some also cause lytic infections 
in some types of epithelioid and fibroblastic cells. Viruses in this group are usually specific for either 
T or B lymphocytes. Latent virus is frequently demonstrated in lymphoid tissue.  
As example, this subfamily contains the human herpesvirus 4 (HHV-4 or EBV) and 8 (HHV-8 or 
KSHV), belonging to the genera Lymphocryptovirus and Rhadinovirus, respectively. 
6.2 The Malacoherpesviridae family 
Until recently, this family consisted in a single virus (Davison et al., 2005): the Ostreid 
herpesvirus 1 (OsHV-1) infecting the Japanese oyster (Crassostrea gigas). Its genome contains 207 kb 
and is composed of two unique regions (UL and US; 168 kb and 3 kb, respectively), each flanked by 
an inverted repeat (TRL/IRL and TRS/IRS of 7 kb and 10 kb, respectively). The presence of 124 ORFs 
are described whose 12 are duplicated in inverted repeats. Interestingly, among all these genes, 38 
belong to 12 families of related genes (Davison et al., 2005). Recently, a neurotropic herpesvirus 
infecting the gastropod abalone (Haliotis spp) was described (Savin et al., 2010). Based on the 
homology existing between Abalone Herpesvirus (AbHV) and OsHV-1, it has been proposed to 
Table 1. Herpesviruses of fish and amphibians (adapted from Hallon et al. 2011). 
Virus name 
(abbreviation) 
Clade 
Common name 
(abbreviation) 
Host(s) Disease 
Anguillid HV 1 
(AngHV-1) 
1 
HV anguillae 
(HVA) 
Japanese eel Anguilla japonica  
and European eel A. Anguilla 
Haemorrhages of skin, fins, gills, liver 
Cyprinid HV 1 
(CyHV-1) 
1 
HV cyprini, carp pox 
HV, carp HV(CHV) 
Common carp  
Cyprinus carpio 
High losses in fry- exophthalmia 
haemorrhages, survivors have papilloma 
Cyprinid HV 2 
(CyHV-2) 
1 
Goldfish 
hematopoietic 
necrosis virus  
(GFHNV) 
Goldfish  
Carassius auratus 
High mortality at all ages. Necrosis of 
hematopoietic tissue, spleen, pancreas, 
intestine 
Cyprinid HV 3 
(CyHV-3) 
1 
Koi HV (KHV),  
carp nephritis and gill 
necrosis virus 
(CNGV) 
Common carp 
Gill inflammation, hyperplasia, and 
necrosis, hematopoietic tissue necrosis. 
High mortality at all ages 
Ictalurid HV 1 
(IcHV-1) 
2 
Channel catfish virus 
(CCV), Channel 
catfish herpesvirus 
Channel catfish  
Ictalurus punctatus 
Kidney, liver and intestinal necrosis, 
haemorrhages, high mortality in young 
subjects  
Ictalurid HV 2 
(IcHV-2) 
2 
Ictalurus melas HV 
(IcmHV) 
Black bullhead  
Ameiurus melas 
Kidney necrosis, haemorrhages, high 
mortality at all ages 
Acipenserid HV 
1 (AciHV-1) 
2 White sturgeon HV 1 
White sturgeon  
Acipenser transmontanus 
diffuse dermatitis, high losses in juveniles 
Acipenserid HV 
2 (AciHV-2) 
2 White sturgeon HV 2 White sturgeon Epithelial hyperplasia 
Salmonid HV 1 
(SalHV-1) 
2 
HV salmonis (HPV) 
Steelhead herpesvirus 
(SHV) 
Rainbow trout  
Oncorhynchus mykiss 
Mild disease associated with low losses at 
10 °C. Adults: female shed virus in ovarian 
fluid. Asymptomatic infection 
Salmonid HV 2 
(SalHV-2) 
2 
Oncorhynchus masou 
virus (OMV) 
Cherry salmon O. masou, coho 
salmon O. kisutch, sockeye 
salmon O. nerka, coho salmon 
O. keta, rainbow trout, 
Viremia, external haemorrhages 
exophthalmia, hepatic necrosis. High 
mortality in young subjects. Survivors have 
oral papilloma. Infected female shed virus in 
ovarian fluid 
Salmonid HV 3 
(SalHV3-) 
2 
Epizootic 
epitheliotropic disease 
virus (EEDV) 
Lake trout Salvelinus 
namaycush, lake trout × brook 
trout S. fontinalis hybrids 
Epithelial hyperplasia, hypertrophy, 
haemorrhages on eye and jaw. High 
mortality in juveniles at 6–15 °C 
Gadid 
herpesvirus 1 
(GaHV-1) 
2 
Atlantic cod 
herpesvirus (ACHV) 
Atlantic cod  
Gadus morhua 
Hypertrophy of cells in gills. High mortality 
in adults. 
Ranid HV 1 
(RaHV-1) 
2 
Lucké tumor HV 
(LTHV) 
Leopard frog  
Rana pipiens 
Renal adenocarcinoma 
Ranid HV 2 
(RaHV-2) 
2 
Frog virus 4  
(FV-4) 
Leopard frog No known disease 
Pilchard HV 2  
Australian pilchard  
Sardinops sagax 
Gill inflammation associated with epithelial 
hyperplasia and hypertrophy. High mortality 
Tilapia HV 
Possible 
Herpesviridae 
Tilapia larvae 
encephalitis virus 
(TLEV) 
Blue tilapia  
Oreochromis aureus 
Encephalitis in larvae. High mortality 
Percid HV 1 
(PeHV-1) 
 
HV vitreum,  
walleye HV 
Walleye  
Stizostedion vitreum 
Diffuse epidermal hyperplasia 
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include the AbHV-1 in the Malacoherpesviridae family (Savin et al., 2010). Despite the lack of 
similarity with the capsid proteins encoded by other herpesviruses, electron microscopy analysis 
demonstrates that OsHV-1 and AbHV-1 have a capsid morphology comparable to that of HHV-1 and 
IcHV-1 (Davison et al., 2005; Savin et al., 2010). 
6.3 The Alloherpesviridae family 
The Alloherpesviridae encompasses viruses infecting fish and amphibians. So far, this family 
regroups 13 viruses infecting teleost fish, 2 viruses of chondrostean fish and 2 viruses infecting 
amphibians (Hanson et al., 2011) (Table 1). Phylogenetic studies öbased on the DNA polymerase and 
the terminase genes led the subdivision of the Alloherpesviridae family into two clades: the first clade 
comprises large linear dsDNA viruses (245-295 kb) as Anguillid and Cyprinid herpesviruses; the 
second clade comprises viruses with smaller genome (134-235 kb) as Ictalurid, Salmonid, Acipenserid 
and Ranid herpesviruses (Davison & Stow, 2005; Waltzek et al., 2009). The genomes of several 
Alloherpesviridae have been sequenced: Ictalurid herpesvirus 1 (IcHV-1), Cyprinid herpesvirus 3 
(CyHV-3), Anguillid herpesvirus 1 (AngHV-1); the Ranid herpesvirus 1 (RaHV-1) and 2 (RaHV-2). 
Based on these sequences, 12 conserved genes have been identified in the Alloherpesviridae family 
(Aoki et al., 2007; van Beurden et al., 2010). 
Even though Alloherpesviridae are distantly related to Herpesviridae, there are similarities in 
the way they infect, replicate and persist in the host (Table 1). (i) They display a high level of host 
specificity, causing disease in only one species or in closely related members of the same genus. (ii) 
Some alloherpesviruses have been evaluated for long-term latent infections (persistence of viral DNA 
in survivors without production of infectious particles). Latency has been suggested in CyHV-1, 
CyHV-3, SalHV-2 and IcHV-1 (Hanson et al., 2011). Much of our knowledge on the biology of 
Alloherpesviridae is derived from research on two models of infection: IcHV-1 for clade 2 and 
CyHV-3 for clade 1. CyHV-3 being the subject of this thesis, the remaining part of this introduction 
has been devoted to this virus. 
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Abstract 
Cyprinid herpesvirus 3 (CyHV-3), a member of the family Alloherpesviridae is the causative 
agent of a lethal, highly contagious and notifiable disease in common and koi carp. The economic 
importance of common and koi carp industries together with the rapid spread of CyHV-3 worldwide, 
explain why this virus became soon after its isolation in the 1990s a subject of applied research. In 
addition to its economic importance, an increasing number of fundamental studies demonstrated that 
CyHV-3 is an original and interesting subject for fundamental research. In this review, we summarized 
recent advances in CyHV-3 research with a special interest for studies related to host-virus interactions. 
 
Key words: Cyprinid herpesvirus 3, CyHV-3, koi herpesvirus, KHV, Alloherpesviridae, Common 
carp, host-virus interactions 
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1. Introduction 
The common carp (Cyprinus carpio) is one of the oldest cultivated fish species. In China, 
culture of carp dates back to at least the 5th century BC, whereas in Europe, carp farming began during 
the Roman Empire [1]. Nowadays, common carp is one of the most economically valuable species in 
aquaculture: (i) it is one of the main cultivated fish for human consumption with a world production of 
3.4 million tons per year [2]; (ii) it is produced and stocked into fishing areas for angling purpose; and 
(iii) its colorful, ornamental varieties (koi carp) grown for personal pleasure and competitive 
exhibitions represent probably the most expensive market of individual freshwater fish with some 
prize-winners sold for 104-106 US dollars [3]. 
Herpesviruses infect a wide range of vertebrates and invertebrates [4]. However, the 
host-range of individual herpesvirus species is generally restricted revealing host-virus co-evolution. 
In aquaculture, herpesvirus infections have been associated with mass mortality of different fish 
species causing severe economic losses [5-7]. In the late 1990s, a new highly contagious and virulent 
disease began to cause severe economic losses in both koi and common carp industries. Soon after its 
first known occurrences reported in Israel, USA, and Germany [8, 9], the disease was described in 
various countries worldwide. The rapid spread of the disease was attributed to international fish trade 
and to koi shows around the world [10]. The causative agent of the disease was initially called koi 
herpesvirus (KHV) because of its morphological resemblance to viruses of the order Herpesvirales [9]. 
The virus was subsequently called carp interstitial nephritis and gill necrosis virus (CNGV) because of 
the associated lesions [11]. Finally, on the basis of genome homology with previously described 
cyprinid herpesviruses the virus was renamed cyprinid herpesvirus 3 (CyHV-3) [12]. 
Because of its worldwide spread and the economic losses it caused, CyHV-3 became rapidly a 
notifiable disease and a subject of application oriented research. However, an increasing number of 
recent studies have demonstrated that it is also an interesting subject for fundamental research. In this 
review, we summarized recent advances in CyHV-3 research with a special interest for those related to 
host-virus interactions. 
2. Characterization of CyHV-3 
2.1 General description 
2.1.1 Classification 
CyHV-3 is a member of genus Cyprinivirus, family Alloherpesviridae, order Herpesvirales 
(Figure 1a) [13]. The Alloherpesviridae is a newly designated family which regroups herpesviruses 
infecting fish and amphibians [14]. It is divided into four genera: Cyprinivirus, Ictalurivirus, 
Salmonivirus, and Batrachovirus [13]. The genus Cyprinivirus contains viruses that infect common 
carp (Cyprinid herpesvirus 1 and 3; CyHV-1 and CyHV-3), goldfish (Cyprinid herpesvirus 2; CyHV-2) 
A 
B 
Figure 1. Phylogeny of the order Herpesvirales and the Alloherpesviridae family. (A) Cladogram 
depicting relationships among viruses in the order Herpesvirales, based on the conserved regions of the 
terminase gene. The Bayesian maximum likelihood tree was rooted using bacteriophages T4 and RB69. 
Numbers at each node represent the posterior probabilities (values > 90 are shown) of the Bayesian analysis. 
(B) Phylogenetic tree depicting the evolution of fish and amphibian herpesviruses, based on sequences of the 
DNA polymerase and terminase genes. The maximum likelihood tree was rooted with two mammalian 
herpesviruses (HHV-1 and HHV-8). Maximum likelihood values (> 80 are shown) and Bayesian values (> 90 
are shown) are indicated above and below each node, respectively. Branch lengths are based on the number 
of inferred substitutions, as indicated by the scale bar. AlHV-1: alcelaphine herpesvirus 1; AtHV-3: ateline 
herpesvirus 3; BoHV-1, -4, -5: bovine herpesvirus 1, 4, 5; CeHV-2, -9: cercopithecine herpesvirus 2, 9; 
CyHV-1, -2: cyprinid herpesvirus 1, 2; EHV-1, -4: equid herpesvirus 1, 4; GaHV-1, -2, -3: gallid herpesvirus 
1, 2, 3; HHV-1, -2, -3, -4, -5, -6, -7, -8: human herpesvirus 1, 2, 3, 4, 5, 6, 7, 8; IcHV-1: ictalurid herpesvirus 
1; McHV-1, -4, -8: macacine herpesvirus 1, 4, 8; MeHV-1: meleagrid herpesvirus 1; MuHV - 2, - 4: murid 
herpesvirus 2, 4; OsHV-1: ostreid herpesvirus 1; OvHV-2: ovine herpesvirus 2; PaHV-1: panine herpesvirus 
1; PsHV-1: psittacid herpesvirus 1; RaHV-1, -2: ranid herpesvirus 1, 2; SaHV - 2: saimiriine herpesvirus 2; 
SuHV-1: suid herpesvirus 1; TuHV-1: tupaiid herpesvirus 1. Reproduced with permission from Waltzek et al. 
[14]. 
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and freshwater eel (Anguillid herpesvirus 1; AngHV-1). Phylogenetic analyses revealed that the genus 
Cyprinivirus forms a clade distinct from the three other genera listed above (Figure 1b). Viruses of the 
Cyprinivirus genus possess the largest genomes (248–295 kb) in the order Herpesvirales. 
2.1.2 Morphology 
Like all members of the order Herpesvirales, CyHV-3 virions are composed of an icosahedral 
capsid containing the genome, a lipid envelope bearing viral glycoproteins and an amorphous layer of 
proteins termed tegument, which resides between the capsid and the envelope [15]. The diameter of 
CyHV-3 virions is 167–200 nm according to the infected cell type (Figure 2) [15]. Morphogenesis of 
CyHV-3 is also characteristic of the order Herpesvirales, with assembly of the nucleocapsid and 
acquisition of the lipid envelope (derived from host cell trans-golgi membrane) that take place in the 
nucleus and the cytosol of the host cell, respectively [9,15,16]. 
2.1.3 Genome 
The genome of CyHV-3 is a 295 kb, linear, double stranded DNA molecule consisting of a 
large central portion flanked by two 22 kb repeat regions, called the left and right repeats [18]. To date, 
this is the largest genome among all sequenced herpesviruses. The CyHV-3 genome has been cloned 
as a stable and infectious bacterial artificial chromosome (BAC), which can be used to produce 
CyHV-3 recombinants [19]. 
The CyHV-3 genome is predicted to contain 155 potential protein-coding open reading frames 
(ORFs), among which eight (ORF1-ORF8) are duplicated in terminal repeats [13]. Nine ORFs are 
characterized by the presence of introns [13]. CyHV-3 genome encodes five gene families: ORF2, 
tumor necrosis factor receptor (TNFR), ORF22, ORF25, and RING gene families [18]. The ORF25 
family consists of 6 paralogous sequences (ORF25, ORF26, ORF27, ORF65, ORF148 and ORF149) 
encoding potential type 1 membrane glycoproteins. Independently of the viral strain sequences, 
ORF26 is described as a pseudogene; while ORF27 has been characterized as pseudogene in 2 out of 3 
sequenced laboratory strains [18]. All non-fragmented members of this family (ORF25, ORF65, 
ORF148 and ORF149) are incorporated in mature virions, presumably in the envelope [20]. 
Interestingly, CyHV-3 genome encodes proteins potentially involved in immune evasion 
mechanisms such as, for example, G-protein coupled receptor (encoded by ORF16), TNFR 
homologues (encoded by ORF4 and ORF12) and an interleukine-10 (IL-10) homologue (encoded by 
ORF134) [18]. 
Among the family Alloherpesviridae, twelve ORFs (named core ORFs) are conserved in all 
sequenced viruses and were presumably inherited from a common ancestor [13]. The Cypriniviruses  
(CyHV-1, CyHV-2, and CyHV-3) possess 120 orthologous ORFs. Twenty one ORFs are unique to 
CyHV-3, including ORF134 encoding an IL-10 homolog [13]. The recently described second IL-10 
Figure 2. Electron microscopy examination of CyHV-3 virion. Bar represents 100 nm. Adapted with 
permission from Mettenleiter et al. [17]. 
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Figure 3. Schematic representation of CyHV-3 virion proteome. The viral composition of the envelope 
(circle), capsid (hexagon) and tegument is indicated. Membrane proteins of type 1, 2 and 3 are represented by 
triangles pointed inside, triangles pointed outside and rectangles, respectively. Other proteins are shown as 
squares. The different fillings indicate the relative abundance of proteins based on their emPAI (< 0.25, < 
0.50, < 1, < 3 and > 3). p: protein, gp: glycoprotein, ND: no data. Reproduced with permission from Michel et 
al. [20]. 
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homolog in the family Alloherpesviridae encoded by AngHV-1 does not seem to be an orthologue of 
the CyHV-3 ORF134 [21]. CyHV-3 shares 40 orthologous ORFs with AngHV-1 although the total 
number of ORFs shared by all CyHVs with AngHV-1 is estimated to be 55 [13]. This supports the 
phylogenetic conclusion that among the genus Cyprinivirus, CyHVs are more closely related to each 
other than to other members of the family Alloherpesviridae [14]. Interestingly, CyHV-3 also encodes 
genes with closest relatives in viral families such as Poxviridae and Iridoviridae [18, 22]. 
2.1.4 Genotypes 
Whole genome analysis of three CyHV-3 strains isolated in Israel (CyHV-3 I), Japan 
(CyHV-3 J) and United States (CyHV-3 U) revealed high sequence identity between the strains [18]. 
The relationships between these strains revealed that U and I strains are more closely related to each 
other and form one lineage (U/I), whereas J strain is more distinct and forms a second lineage (J) [18]. 
The existence of genetic differences between European lineage (including U and I genotypes) and 
Asian lineage (including J genotype) were later confirmed and suggests independent CyHV-3 
introductions in various geographical locations [23, 24]. Furthermore, Kurita et al. demonstrated that 
the Asian lineage contains only two variants (A1 and A2) while the European lineage has seven 
variants (E1–E7) [24]. Recently, a new intermediate genetic lineage of CyHV-3 including isolates 
from Indonesia has been suggested [25]. This hypothesis was later supported by analyses of 
multi-locus variable number of tandem repeats (VNTR). These analyses also suggested that 
genetically distinct viral strains can coexist in a same location following various introduction events 
[26]. Although previous study described presence of both CyHV-3 lineages in Europe [23], an 
European genotype of CyHV-3 has only been revealed recently in East and Southeast Asia [27]. 
Recently, Han et al. described polymorphism in DNA sequences encoding three envelope glycoprotein 
genes (ORF25, ORF65, and ORF116) among CyHV-3 strains from different geographical origins [28]. 
2.1.5 Proteome 
Different groups used mass spectrometry to identify CyHV-3 proteins and to study their 
interactions with cellular and viral proteins. The structural proteome of CyHV-3 was recently 
characterized by using liquid chromatography tandem mass spectrometry [20]. A total of 40 structural 
proteins, comprising 3 capsid, 13 envelope, 2 tegument, and 22 unclassified proteins, were described 
(Figure 3). The genome of CyHV-3 possesses 30 potential transmembrane-coding ORFs [18]. With 
the exception of ORF81, which encodes a type 3 membrane protein expressed on the CyHV-3 
envelope, no CyHV-3 structural proteins have been studied [20, 29]. ORF81 is thought to be one of 
the most immunogenic (major) membrane proteins of CyHV-3 [29]. Recently, Gotesman et al. using 
anti-CyHV-3 antibody-based purification coupled with mass spectrometry, identified 78 host proteins 
and five potential immunogenic viral proteins [30]. In another study, concentrated supernatant was 
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produced from CyHV-3 infected CCB cultures and analyzed by 2D-LC MS/MS in order to identify 
CyHV-3 secretome. Five viral and 46 cellular proteins were detected [31]. CyHV-3 ORF12 and 
ORF134 encoding respectively a soluble TNFR homologue and an IL-10 homologue, were among the 
most abundant secreted viral proteins [31]. 
2.2 In vitro replication 
CyHV-3 is widely cultivated in cell lines derived from common carp brain (CCB), gills (CCG) 
and fin (CaF-2) [32, 33]. Permissive cell lines have also been derived from koi fin: KF-1 [9], KFC 
[11], KCF-1 [34], NGF-2 and NGF-3 [16]. Non-carp cell lines, such as silver carp fin (Tol/FL) and 
goldfish fin (Au) were also described as permissive to CyHV-3 [35]. Oh et al. reported the expression 
of cytopathic effect (CPE) in cell line from fathead minnow (FHM) after inoculation with CyHV-3 
[36], but this observation was not confirmed by other studies [9, 35]. 
In vitro study showed that all annotated CyHV-3 ORFs are transcribed during CyHV-3 
replication [37]. Transcription of CyHV-3 genes starts as early as 1 h post-infection and viral DNA 
synthesis initiates as early as 4–8 h post-infection [37]. Similar to all other herpesviruses, most of 
CyHV-3 ORF transcripts can be classified into three temporal kinetic classes: immediate early (IE;     
n = 15 ORFs), early (E; n = 111 ORFs) and late (L; n = 22 ORFs). Seven ORFs are unclassified [37]. 
Fuchs et al. demonstrated that CyHV-3 ORFs that encode for three enzymes implicated in nucleotide 
metabolisms: thymidine kinase (ORF55), dUTPase (ORF123) and ribonucleotide reductase (ORF141) 
are nonessential for virus replication in vitro [38]. 
2.3 Temperature restriction 
Water temperature is one of the major environmental factors that influences the onset and 
severity of viral infection in fish [39]. This statement certainly applies to CyHV-3 as temperature was 
shown to affect drastically both viral replication in vitro and CyHV-3 disease in vivo. 
2.3.1 In vitro 
CyHV-3 replication in cell culture is restricted by temperature. Optimal viral growth in KF-1 
cell line was observed at temperatures between 15°C and 25°C. Virus propagation and virus gene 
transcription are gradually turned off when cells are moved from permissive temperature to the 
non-permissive temperature of 30°C [40, 41]. However, infected cells maintained for 30 days at 30°C 
preserve infectious virus, as demonstrated by viral replication when the cells are returned to 
permissive temperatures [40]. 
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2.3.2 In vivo 
CyHV-3 disease occurs naturally when water temperature is between 18°C and 28°C. Several 
studies demonstrated that transfer of recently infected fish (between 1 and 5 days post-infection (dpi)) 
to non-permissive low (≤ 13°C) or high temperatures (> 30°C) significantly reduces the mortality [11, 
42-44]. Water temperature was also shown to affect the onset of mortality: the first mortalities 
occurred between 5–8 and 14–21 dpi when the fish were kept between 23-28°C and 16-18°C, 
respectively [42,45]. 
2.4 Geographical distribution 
CyHV-3 was first isolated from infected koi originating from Israel and USA in 2000 [9]. 
Soon after, outbreaks of CyHV-3 occurred in many countries in Europe, Asia and Africa [10, 22]. 
Currently, only South America, Australia and northern Africa seem to be free of CyHV-3. The global 
and rapid spread of the virus is thought to be mainly due to the international trading of common and 
koi carp, but also to koi shows. 
2.5 Presence of CyHV-3 in natural environment 
In addition to its economic impact on common and koi carp industries, CyHV-3 has also a 
negative environmental impact by affecting wild populations of carp. In 2003, the first outbreak of 
CyHV-3 disease among wild carp occurred in the Yoshi river in Japan [46]. The virus then spread 
among several freshwater systems and caused mass mortalities in wild carp populations. In Lake Biwa, 
about 70% of carp population (more than 100 000 fish) died due to CyHV-3 infection in 2004 [46]. 
Mass mortalities of wild carp have been also described in angling waters in UK in 2003 [47], in New 
York and South Carolina, USA in 2004 [48, 49] and in Kawartha Lakes region, Ontario, Canada in 
2007 [50]. The monitoring of the distribution of CyHV-3 in rivers and lakes in Japan demonstrated 
that it can persist in the wild carp populations and can be subsequently transmitted to naïve fish [46, 
51, 52]. Studies performed in habitats with CyHV-3 history suggested that sediments [53] and aquatic 
invertebrates feeding by water filtration could represent potential reservoirs of CyHV-3 [54]. 
Moreover the viral DNA could be detected in water not only during the outbreak of the disease but 
also for at least 3 months after the end of mass mortality [51]. However, it has to be noted that these 
studies relied on the detection of viral genome and not CyHV-3 infectivity. Consequently further 
studies are required to determine whether these potential reservoirs of infectious virus could play a 
role in CyHV-3 epidemiology. 
A B
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Figure 4. Some of the clinical signs observed during CyHV-3 infection. (A) Severe gill necrosis. (B) 
Hyperemia at the base of the caudal fin. (C) Herpetic skin lesions on the body (arrows) and fin erosion 
(arrowheads). Reproduced with permission from Michel et al. [22]. 
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3. Disease 
3.1 Disease characteristics 
CyHV-3 disease is seasonal, occurring when water temperature is between 18°C and 28°C. It 
is restricted to common and koi carp and their hybrids with other species [55]. It is highly contagious 
and extremely virulent with mortality rate that can reach 80 to 100%. Fish infected with CyHV-3 by 
immersion, injection or oral route and kept at 23-28°C die between 5 and 22 dpi with a peak of 
mortality between 8 and 12 dpi [9, 56, 57]. Gilad et al. suggested that loss of osmoregulation of the 
gills, gut and kidney contributes to mortality during acute infection with CyHV-3 [42]. Furthermore, 
CyHV-3 infected fish are more susceptible to secondary infections by bacterial, parasitic or fungal 
pathogens which may cause further mortality within the population. 
3.1.1 Clinical signs 
The first clinical signs appear at 2–3 dpi. Fish become lethargic, lie at the bottom of the tank 
with the dorsal fin folded and exhibit loss of appetite. In ponds, infected fish are usually gathering 
close to the water inlet or sides of the pond and gasp at the surface of water. Gill necrosis coupled with 
extensive discoloration and increased mucus secretion appear as early as 3 dpi. Depending on the stage 
of the infection, the skin exhibits different clinical signs, such as hyperemia, particularly at the base of 
the fins and on the abdomen; pale, irregular patches on the skin associated with mucus hypersecretion 
at the beginning of infection; peeling away of dead epithelium and lack of mucus cover in the later 
stage of infection; appearance of epidermis surface with a sandpaper-like texture; and herpetic lesions 
(Figure 4). In addition, fin erosion and bilateral enophthalmia (sunken eyes) are observed in the later 
stages of infection. Some fish show neurologic signs in the final stage of disease, when they become 
disoriented and lose equilibrium [9, 10, 58]. 
3.1.2 Histopathology 
The most important histopathological changes are observed in the gills. They involve erosion 
of primary lamellae, fusion of secondary lamellae and adhesion of gill filaments [58, 59]. Gills also 
exhibit hyperplasia, hypertrophy and/or nuclear degeneration of branchial epithelium and congestion 
of the blood vessels in the gill arch [15, 59]. Severe inflammation and gill necrosis resulting in the 
complete loss of lamellae can also be observed [31, 59]. In the kidney, the hematopoietic cells are the 
most affected ones [15]. However, a weak peritubular inflammatory infiltrate is evident in kidney as 
early as 2 dpi and increases with time. It is accompanied by blood vessel congestion and degeneration 
of the tubular epithelium in many nephrons [59]. In the spleen and liver, the most obviously infected 
cells are splenocytes and hepatocytes, respectively [15]. In the liver, mild inflammatory infiltrates are 
observed mainly in the parenchyma [59]. In the brain, focal meningeal and parameningeal 
Table 1. Organisms tested for CyHV-3 infection 
Common name (species) Detection of CyHV-3 
 
Detection of CyHV-3 
genome in naïve carp 
after cohabitation DNA Transcript Antigen 
Vertebrates     
Cyprinidae     
  Goldfish (Carassius auratus) Yes [62,68-70] Yes [68] Yes [69] Yes [68-70] 
  Ide (Leuciscus idus) Yes [62,63] NT NT NT 
  Grass carp (Ctenopharyngodon idella) Yes [62,64,70] NT NT Yes [64,70] 
  Silver carp (Hypophthalmichthys molitrix) Yes [64,70] NT NT Yes [64,70] 
  Prussian carp (Carassius gibelio) Yes [64,70]/ No 
[65] 
NT NT Yes [70]/No [65] 
  Crucian carp (Carassius carassius) Yes [64] NT NT NT 
  Tench (Tinca tinca) Yes [64,65,70] NT NT Yes [64,65,70] 
  Vimba (Vimba vimba) Yes [63,64] NT NT Yes [64] 
  Common bream (Abramis brama) Yes [64,65] NT NT Yes [64] 
  Common roach (Rutilus rutilus) Yes [64,65] NT NT Yes [64]/No [65] 
  Common dace (Leuciscus leuciscus) Yes [64,65] NT NT No [65] 
  Gudgeon (Gobio gobio) Yes [64,65] NT NT Yes [65] 
  Rudd (Scardinius erythrophthalmus) Yes [65] NT NT Yes [65] 
  European chub (Squalius cephalus) Yes[64]/No[65] NT NT NT 
  Common barbel (Barbus barbus) Yes [64] NT NT NT 
  Belica (Leucaspius delineatus) Yes [64] NT NT NT 
  Common nase (Chondrostoma nasus) Yes [64] NT NT NT 
Acipenseridae     
  Russian sturgeon (Acipenser 
gueldenstaedtii) 
Yes [66] NT NT NT 
  Atlantic sturgeon (Acipenser oxyrhynchus) Yes [66] NT NT NT 
Cobitidae     
  Spined loach (Cobitis taenia) Yes [64] NT NT NT 
Cottidae     
  European bullhead (Cottus gobio) Yes [64] NT NT NT 
Esocidae     
  Northern pike (Esox lucius) Yes [64,65] NT NT Yes [65] 
Gasterosteidae     
Three-spined stickleback (Gasterosteus 
aculeatus) 
Yes [65] NT NT No [65] 
Ictaluridae     
  Brown bullhead (Ameiurus nebulosus) Yes [65] NT NT No [65] 
Loricariidae     
  Ornamental catfish (Ancistrus sp.) Yes [62] NT NT NT 
Percidae     
  European perch (Perca fluviatilis) Yes [64,65] NT NT Yes [64]/No [65] 
  Ruffe (Gymnocephalus cernua) Yes[64]/No [65] NT NT Yes [64,65] 
Invertebrates     
  Swan mussels (Anodonta cygnea) Yes [54] NT NT NT 
  Scud (Gammarus pulex) Yes [54] NT NT NT 
NT- not tested. 
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inflammation is observed [59]. Analysis of brain from fish that showed clear neurologic signs revealed 
congestion of capillaries and small veins associated with edematous dissociation of nerve fibers in the 
valvula cerebelli and medulla oblongata [15]. In the skin, the number of goblet cells is reduced by 
50% in infected fish. Furthermore, the goblet cells appeared mostly slim and slender which suggests 
that mucus was released and had not been replenished. In addition, erosion of skin epidermis is 
frequently observed [60]. 
3.2 Host range and susceptibility 
CyHV-3 causes a symptomatic disease only in common and koi carp. Hybrids of koi × 
goldfish and koi × crucian carp are also affected by CyHV-3 disease, with mortality rate of 35% and 
91%, respectively [55]. Common carp × goldfish hybrids have also been reported to show some 
susceptibility to CyHV-3 infection; however, the mortality rate observed was rather limited (5%) [61]. 
PCR detection of CyHV-3 performed on cyprinid and non-cyprinid fish species, but also on freshwater 
mussels and crustaceans, suggested that these species could act as reservoirs of the virus (Table 1) [54, 
62-67]. Cohabitation experiments suggest that some of these fish species (goldfish, tench, vimba, 
common bream, common roach, European perch, ruffe, gudgeon, rudd, northern pike, silver carp and 
grass carp) can carry CyHV-3 asymptomatically and transmit it to naïve carp [64, 65, 68-70]. 
Consistent with this observation, in vitro studies showed that CyHV-3 can replicate and cause CPE in 
cell cultures derived not only from common and koi carp but also from silver carp and goldfish [35]. 
Recent studies provided increasing evidence that CyHV-3 can infect goldfish asymptomatically [68, 
69]. Finally, the World Organisation for Animal Health (OIE) listed four CyHV-3 susceptible species 
(Cyprinus carpio and its hybrids, goldfish, Russian sturgeon and Atlantic sturgeon) and two potential 
susceptible species (grass carp and ide) [71]. 
Carp of all ages, from juveniles upwards, are affected by CyHV-3, but younger fish (1-3 
months, 2.5-6 g) seem to be more susceptible to infection than mature fish (1 year, ≈230 g) [58]. Ito et 
al. suggested that carp larvae are not susceptible to CyHV-3 since larvae (3 days post-hatching) 
infected with virus showed no mortality whereas most of the carp juveniles (>13 days post-hatching) 
died after infection [72]. However, recent study using CyHV-3 recombinant strain expressing 
luciferase (LUC) as a reporter gene, demonstrates that carp larvae are sensitive and permissive to 
CyHV-3 infection immediately after hatching and that their sensitivity increases with the 
developmental stages [73]. 
3.3 Pathogenesis 
In early reports, it has been suggested that CyHV-3 may enter the host through infection of the 
gills based on detection of viral particles and viral genome in this organ as early as 1–2 dpi [42, 59]. 
However, more recent studies using in vivo bioluminescent imaging system demonstrated that 
Figure 5. The portal of entry of CyHV-3 in carp analysed by bioluminescence imaging. Two groups of 
fish (mean weight 10 g) were infected with a recombinant CyHV-3 strain expressing luciferase as a reporter 
gene either by bathing them in water containing the virus (Immersion, left column) or by feeding them with 
food pellets contaminated with the virus (Oral, right column). At the indicated time post-infection, six fish per 
group were analysed by bioluminescence IVIS. Each fish was analysed lying on its right and its left side. To 
analyze internal signals, fish were euthanized and dissected immediately after in vivo bioluminescence 
imaging. Dissected fish and isolated organs were analysed for ex vivo bioluminescence. The analysis of one 
fish is presented for each time point and inoculation mode. Pictures collected over the course of this 
experiment are presented with a standardized minimum and maximum threshold value for photon flux. rba, 
right branchial arches; lba, left branchial arches; ro, right operculum; lo, left operculum; p, pharynx; aw, 
abdominal wall; i, intestine. Reproduced with permission from Fournier et al. [57]. 
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according to epidemiological conditions CyHV-3 can enter carp either by skin (immersion in 
infectious water) or pharyngeal periodontal mucosa infection (ingestion of infectious materials) 
(Figure 5) [57, 74]. The epidermis of teleost fish is a living stratified squamous epithelium that is 
capable of mitotic division at all levels (even the outermost squamous layer). The scales are dermal 
structures and consequently are covered by the epidermis [74]. Removal of skin mucus and epidermal 
lesions facilitates the entry of virus into the host (Figure 6) [75]. After initial replication in the 
epidermis [74] the virus is spreading rapidly in infected fish as indicated by detection of CyHV-3 
DNA in almost all internal tissues as early as 24 h post-infection [42]. The tropism of CyHV-3 for 
white blood cells most probably explains such a rapid spread of the virus within the body [76]. Virus 
replication in organs such as the gills, skin and gut represents source of viral excretion into the water. 
Recently, pharyngeal periodontal mucosa has been shown to be the portal of entry of CyHV-3 after 
infection by the oral route using food pellets contaminated with the virus [57]. This model of 
inoculation led to the spreading of the infection to the various organs tested as well as resulted in 
clinical signs and mortality rate comparable to the infection by immersion [57]. 
All members of the family Herpesviridae exhibit 2 distinct phases in their biological cycle: 
lytic replication and latency. While lytic replication is associated with production of viral particles, 
latency consists in the maintenance of the viral genome as a nonintegrated episome and the expression 
of very few viral genes and microRNAs. Upon reactivation, latency is replaced by lytic replication. 
Even if latency has not been demonstrated conclusively in members of the Alloherpesviridae family, 
an increasing number of evidences support the existence of latent phase. These evidences related to 
CyHV-3 can be summarized as follows. (i) CyHV-3 DNA has been detected in the brain of fish that 
survived primary infection and showing no clinical signs at 64 dpi [42], and even 1 year post-infection 
[77]. (ii) CyHV-3 persisted in the wild population of common carp for at least 2 years after initial 
outbreak [46]. (iii) Finally, St-Hilaire et al. described, in fish that survived the primary infection, the 
induction of CyHV-3 reactivation by temperature stress several months after the initial exposure to the 
virus [43]. Increased level of viral DNA in gills without the appearance of disease symptoms has been 
detected after stress induced by netting fish that survived the primary infection and were kept at 20°C 
for 81 dpi [78]. Recent studies demonstrated that virus may become latent in white blood cells and 
other tissues, remains at very low copy numbers and can be reactivated by temperature stress [76, 79, 
80]. To date, the temperature-dependent reactivation of the disease which resulted in mortality of 
naïve cohabitant fish has been described after transferring the fish maintained at a low temperature to 
the higher, permissive temperature [43, 79]. These observations suggest that the temperature of the 
water could regulate the switch between latency and lytic replication and vice versa allowing the virus 
to persist in the host population throughout the seasons even when the temperature is non-permissive. 
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Figure 6. Effect of skin mucus removal on CyHV-3 binding to carp epidermal cells. Tail fin ventral lobes 
of carp were mock-treated or treated by rubbing with a soft tissue paper to remove epidermal mucus. 
Immediately after skin treatment, tail fin explants were harvested and inoculated ex vivo with a CyHV-3 
recombinant strain expressing luciferase as a reporter gene (106 PFU/mL of culture medium for 2 h). At the 
end of the 2 h inoculation period, a fragment of the fin was collected and processed for electron microscopy 
examination (EM analysis). The arrows indicate CyHV-3 particles bound to cells or cell debris. Twenty-four 
hours post-inoculation, duplicate tail explant cultures were analyzed by bioluminescence imaging (lower 
panels). Reproduced with permission from Raj et al. [75]. 
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3.4 Transmission 
To date, no evidence of CyHV-3 vertical transmission has been reported. Horizontal 
transmission of CyHV-3 occurs either by direct transmission (fish to fish) or vector based 
transmissions. Direct transmission can be by skin to skin contact of infected carp or cyprinid and 
non-cyprinid fish species that can carry CyHV-3 asymptomatically [64, 68] against naïve carp; or by 
cannibalistic and necrophagous behaviors of the carp [22, 57]. Several potential vectors could be 
involved in the vector based transmission of CyHV-3. Such vectors include fish droppings [81], 
plankton [82], aquatic invertebrates feeding by water filtration [54], piscivorous birds which could 
transfer the disease by moving sick fish from one pond to another [83], and finally the water being the 
major abiotic vector. Secretion of viral particles into the water either through shedding or together 
with sloughed epithelial cells has been documented [59]. Furthermore, the infectivity of CyHV-3 in 
water was shown to be conserved for at least 4 h [58], even if longer period could be observed 
depending on water composition (chemical and microbial) [84]. For example, the infectivity of 
CyHV-3 was drastically reduced after 3 days in environmental water, although it remained quite stable 
for more than 7 days in sterilized water [84]. 
3.5 Diagnosis 
Various CyHV-3 diagnostic methods have been developed. They are based on the detection of 
infectious particles, viral DNA, transcripts, or antigens. Virus isolation from infected fish tissues in 
cell culture was the first method developed [9, 11]. Although cell culture isolation is not as sensitive as 
PCR-based methods, it is the only technique able to detect infectious particles. Recently, Dong et al. 
isolated for the first time CyHV-3 virus from diseased koi in mainland China using a newly developed 
cell line from caudal fin of koi [34]. A complete set of molecular techniques for detection of viral 
DNA fragments has been developed, such as DNA hybridization, PCR, nested PCR, one-tube 
semi-nested PCR, semi-quantitative PCR, real-time TaqMan PCR, and loop-mediated isothermal 
amplification [22]. CyHV-3 genome can also be detected and quantified in environmental water by 
real-time TaqMan PCR after viral concentration [85]. Recently, a mRNA-specific RT-PCR assay for 
detection of replicating CyHV-3 in infected fish tissues and cell cultures has been described [86]. 
ELISA tests have been developed to detect specific anti-CyHV-3 antibodies in carp serum [22]. 
CyHV-3 has been also detected in tissues and touch imprints of organs from infected fish by 
immunohistochemistry and immunofluorescence assays, respectively [59]. Monoclonal antibodies 
against CyHV-3 ORF68 have been produced. They were proved to detect specifically CyHV-3 
without cross-reaction against CyHV-1 and CyHV-2 [87]. Finally, a CyHV-3-detection kit (The 
FASTest® Koi HV kit) that allows the detection of CyHV-3 in gill swabs in just 15 min has been 
developed [88]. 
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3.6 Vaccination 
Soon after the identification of CyHV-3 as the causative agent of koi herpesvirus disease 
(KHVD), an original protocol was developed to induce a protective adaptive immune response in carp 
[11]. This approach exploited the fact that CyHV-3 induces fatal infections only when temperature is 
between 18°C and 28°C. According to this protocol, healthy fingerlings are exposed to the virus by 
cohabitation with sick fish for 3–5 days at permissive temperature (22°C-23°C). After that the fish are 
transferred to ponds for 25–30 days at non-permissive water temperature (≈30°C). Despite its 
ingenuity, this protocol has several disadvantages. (i) Fish that are “vaccinated” with this protocol 
become latently infected by a virulent strain and are therefore likely to represent a potential source of 
CyHV-3 outbreaks if they later cohabitate with naïve carp. (ii) The increase of water temperature to 
non-permissive is costly and correlated with increasing susceptibility of the fish to secondary infection. 
(iii) Finally, after this procedure only 60% of immunized fish proved to be resistant to a CyHV-3 
challenge performed by cohabitation with infected fish [11]. 
Attenuated live vaccines appear to be the most appropriate for mass vaccination of carp. Live 
attenuated vaccine candidates have been produced by serial passages in cell culture of a pathogenic 
strain. A vaccine strain candidate was further attenuated by UV irradiation in order to increase random 
mutations throughout the genome [11, 89]. Currently, a live attenuated vaccine developed using this 
approach has been manufactured by KoVax Ltd. (Jerusalem, Israel) and is available for immersion 
vaccination of common and koi carp in Israel [90]. Protection against CyHV-3 is associated with 
elevation of specific antibodies against the virus [11, 89]. However, the duration of the protection 
conferred by the vaccine has not been established [90]. This vaccine has two major additional 
disadvantages: (i) the determinism of the attenuation is unknown; and consequently, reversions to a 
pathogenic phenotype cannot be excluded; (ii) the attenuated strain retains residual virulence that 
could be lethal for a portion of the vaccinated fish [91], particularly for small/young fish. 
An inactivated vaccine candidate was also described by Yasumoto et al. [92]. It consists of 
formalin-inactivated CyHV-3 trapped within a liposomal compartment. This vaccine can be used for 
oral immunization in fish food. Protection efficacy for carp was 70% [92]. 
4. Host-pathogen interactions 
4.1 Genetic resistance of carp strains to CyHV-3 
Genetic differences in resistance to CyHV-3 have been described among different carp strains 
and crossbreeds. Independent research groups demonstrated that resistance to CyHV-3 can be 
significantly increased by crossing of domesticated carp strains with wild carp strains. Shapira et al. 
reported that the most resistant carp crossbreed in their study (60% of survival) was that between the 
domesticated carp strain Dor-70 and the wild carp strain Sassan [93]. In comparison the survival rate 
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of domesticated carp strains Našice and Dor-70 as well as their crossbreed was much lower (8%, 27% 
and 17.7%, respectively) [93]. Recently, Piačková et al. demonstrated that most of Czech strains and 
crossbreeds which are genetically related to wild Amur carp were significantly more resistant to 
CyHV-3 infection than strains with no relation to Amur carp [94]. Carp genetic resistance to CyHV-3 
has been investigated using 96 carp families derived from diallelic crossing of two wild carp strains 
(Amur and Duna) and two domesticated Hungarian strains (Tat and HAKI 15) [95]. This study 
demonstrated that crossing with wild carp strains may result in higher resistance to CyHV-3. However, 
individual parents of the strains are also important since many of the families derived from the wild 
strains did not exhibit significantly higher resistance [95]. Recently, resistance to CyHV-3 has been 
also linked to the polymorphism of the MHC class II B genes [56] and carp IL-10 gene [96]. These 
findings support the hypothesis that the outcome of the disease can be controlled in some extent by 
genetic factors of the host, and consequently, that selection of resistant carp breeders is one of 
potential ways to reduce the negative impact of CyHV-3 on carp aquaculture. 
4.2 Immune response of carp against CyHV-3 
Knowledge on the immune mechanisms and immunological traits that can correlate with 
disease resistance in fish as well as on the immune evasion mechanisms expressed by CyHV-3, is 
essential for the development of prophylactic strategies (such as vaccination) as well as for the 
development of more resistant strains by the use of molecular marker assisted selection. The 
information related to these topics are summarized in this section. 
Perelberg et al. studied the kinetic of anti-CyHV-3 antibody expression in the serum of carp 
infected at different temperatures [91]. In fish that were infected and maintained at 24°C, antibody 
titers began to rise at 10 dpi and reached a peak around 20-40 dpi. It was shown that protection against 
CyHV-3 is proportional to the titer of specific antibodies produced during the primary infection. The 
level of antibodies decreased in the absence of antigenic re-exposure. At 280 dpi, the titer of 
anti-CyHV-3 antibodies of infected fish was only slightly higher or comparable to that of unexposed 
fish. Nevertheless, immunized fish, even those in which antibodies were no longer detectable were 
resistant to a lethal challenge; possibly because of the subsequent rapid response of B and T memory 
cells to antigen re-stimulation [91]. 
Recently, a transcriptomic study uncovered the wide array of immune-related genes involved 
in the anti-CyHV-3 immune response of carp [97]. The response of two carp lines with different 
resistance to CyHV-3 has been studied using DNA microarray and real-time PCR. Significantly higher 
expression of several immune-related genes including number of those which are involved in pathogen 
recognition, complement activation, MHC class I-restricted antigen presentation and development of 
adaptive mucosal immunity was noted in more resistant carp line. Further real-time PCR based 
analyses provided evidence for higher activation of CD8+ T cells in the more resistant carp line. Thus, 
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differences in resistance to CyHV-3 can be correlated with differentially expressed immune-related 
genes [97]. 
The anti-CyHV-3 immune response has been studied in the skin and the intestine of common 
carp [60, 98]. These studies revealed an up-regulation of pro-inflamatory cytokine IL-1β, the inducible 
nitric oxide synthase (iNOS) and activation of interferon class I pathways [60, 98]. In skin, CyHV-3 
infection leads to down-regulation of genes encoding several important components of the 
skin-mucosal barrier, including antimicrobial peptides (beta defensing 1 and 2), mucin 5B, and tight 
junction proteins (claudin 23 and 30). This probably contributes to changes in the skin bacterial flora 
and subsequent development of secondary bacterial infections [60]. Raj et al. demonstrated that skin 
mucus also acts as an innate immune barrier and inhibits CyHV-3 binding to epidermal cells at least 
partially by neutralisation of viral infectivity [75]. In vitro study demonstrated that CyHV-3 inhibits 
activity of stimulated macrophages and proliferative response of lymphocytes and that this effect is 
temperature dependent [99]. 
4.2.1 Interferon type I response 
Interferons (IFNs) are secreted mediators that play essential roles in the innate immune 
response against viruses. In vitro studies demonstrated that CyHV-3 inhibits IFN type I secretion in 
CCB cells [100]. Poly I:C stimulation of CCB cells prior to CyHV-3 infection activated the IFN type I 
response and reduced CyHV-3 spreading in the cell culture [100]. In vivo studies showed that CyHV-3 
induced a systemic IFN type I response in carp skin and intestine and that the magnitude of IFN type I 
expression is correlated with the virus load [60, 98]. 
Recently, Tomé et al. demonstrated that CyHV-3 ORF112 encodes a new Z-domain family 
protein which in vitro showed structural and functional properties similar to the poxvirus E3L inhibitor 
of interferon response [101]. This suggested that CyHV-3 may use similar mechanisms to inhibit 
interferon response as poxviruses. However, the potential function of ORF112 in virus pathogenesis in 
vivo has not been studied yet. 
4.2.2 The role of CyHV-3 IL-10 homologue 
CyHV-3 ORF134 encodes a viral homologue of cellular IL-10 [18]. Its expression product is a 
179 amino acid protein [102]. Common carp IL-10 and CyHV-3 IL-10 exhibit 26.9% identity (67.3% 
similarity) over a 156 amino acid overlap [103]. Transcriptomic analyses revealed that ORF134 is 
expressed as a spliced gene belonging to the early [37] or early-late class [31]. Proteomic analyses of 
CyHV-3 infected cell supernatant demonstrated that ORF134 expression product is one of the most 
abundant proteins of the CyHV-3 secretome [31]. In CyHV-3 infected carp, ORF134 is highly 
expressed during acute and reactivation phase, while is expressed on a low level during 
low-temperature induced persistent phase [102]. In vivo study using a zebrafish embryo model 
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suggested that CyHV-3 ORF134 encodes a functional IL-10 homologue [102]. Injection of mRNA 
encoding CyHV-3 IL-10 into zebrafish embryos increased the number of lysozyme-positive cells to a 
similar degree as observed with zebrafish IL-10 [102]. Moreover, down-regulation of the IL-10 
receptor long chain (IL-10R1) using a specific morpholino abrogated the increase of the number of 
lysozyme-positive cells after co-injection with either CyHV-3 IL-10 mRNA or zebrafish IL-10 mRNA, 
indicating that it functions via the IL-10 receptor [102]. 
Recently, a CyHV-3 strain deleted for ORF134 and a derived revertant strain were produced 
using BAC cloning technologies [31]. The recombinant ORF134 deleted strain replicated in vitro 
comparably to the parental and the revertant strains. Infection of fish by immersion in water containing 
the virus induced comparable mortality for the three virus genotypes tested (wild type, deleted and 
revertant). Quantification of viral DNA by real time TaqMan PCR and analysis of carp cytokines 
expression by RT-qPCR at different times post-infection did not reveal any significant difference 
between the groups of fish infected with the three virus genotypes. Moreover, histological examination 
of infected fish did not reveal significant differences between fish infected with the three genotypes. 
Altogether, these results demonstrated that the IL-10 homologue encoded by CyHV-3 is essential 
neither for viral replication in vitro nor for virulence in vivo [31]. 
5. Conclusions 
Since its first description in the late 1990s, CyHV-3 rapidly spread to different continents 
(Europa, Asia, North America, Africa) causing severe financial losses in the common carp and koi 
culture industries worldwide. In addition to its negative economical and societal impacts, CyHV-3 has 
also a negative environmental impact by affecting wild populations of carp. These reasons explain 
why CyHV-3 became rapidly a subject for applied science and is now listed as a notifiable disease by 
the OIE. In addition to its economic importance, recent studies demonstrated that CyHV-3 is also a 
very attractive and original subject of fundamental research: (i) it is phylogenetically distant from the 
vast majority of herpesviruses that have been studied so far (the latter belong to the family 
Herpesviridae), thereby providing an original field of research. (ii) It can be studied in laboratories by 
infection of its natural host (homologous virus-host model). (iii) The sequence of its genome published 
recently revealed a fascinating virus with unique properties in the Herpesvirales, such as an extremely 
large genome (295 Kb), a high number of genes which are not homologous to known viral sequences, 
and genes that are normally found exclusively in the Poxviridae [18]. (iv) Importantly, the CyHV-3 
genome revealed several genes encoding proteins potentially involved in immune evasion mechanisms. 
(v) Last but not least, the outcome of CyHV-3 infection is highly dependent on the temperature of the 
water in which the carp are maintained. 
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Abstract 
Many viruses have evolved strategies to deregulate the host immune system. These strategies 
include mechanisms to subvert or recruit the host cytokine network. Interleukin-10 (IL-10) is a 
pleiotropic cytokine that has both immunostimulatory and immunosuppressive properties. However, 
its key features relate mainly to its capacity to exert potent immunosuppressive effects. Several viruses 
have been shown to up regulate the expression of cellular IL-10 (cIL-10), with, in some cases, 
enhancement of infection by suppression of immune functions. Other viruses encode functional 
orthologues of cIL-10, called viral IL-10s (vIL-10s). The present review is devoted to these virokines. 
To date, vIL-10 orthologues have been reported for 12 members of the family Herpesviridae, two 
members of the family Alloherpesviridae, and seven members of the family Poxviridae. Study of vIL-
10s demonstrated several interesting aspects on the origin and the evolution of these viral genes; such 
as for example, the existence of multiple (potentially up to 9) independent gene acquisition events at 
different times during evolution, viral gene acquisition resulting from recombination with cellular 
genomic DNA or cDNA derived from cellular mRNA, and the evolution of cellular sequence in the 
viral genome to restrict the biological activities of the viral orthologues to those beneficial for the virus 
life cycle. In this review, various aspects of the vIL-10s described to date are reviewed, including their 
genetic organization, protein structure, origin, evolution, biological properties and potential in applied 
research. 
 
Key words: Cellular Interleukin-10 (cIL-10), Viral Interleukin 10 (vIL-10), IL-10 orthologues,  
Biological activities 
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1. Introduction 
For millions of years, viruses have been co-evolving with their hosts. During this process, they 
have had to deal with the most complex aspects of host physiology, often mimicking, hijacking or 
sabotaging host biological processes to their benefit. In this respect, many viruses have evolved 
strategies to deregulate the host immune response in order to avoid immune surveillance and 
elimination from the host. These strategies include mechanisms to deregulate the host cytokine 
network. 
The Interleukin (IL)-10 family of cytokines and the related Interferon (IFN) family of 
cytokines form the larger class II cytokine family (Ouyang et al., 2011). The IL-10 family of cytokines 
can be categorized into three subgroups, based primarily on biological functions: (i) IL-10 itself; (ii) 
the IL-20 subfamily cytokines composed of IL-19, IL-20, IL-22, IL-24 and IL-26; and (iii) the type III 
IFN group (also called IFN λs) (Ouyang et al., 2011; Pestka et al., 2004). 
IL-10 is a pleiotropic cytokine, with both immunostimulatory and immunosuppressive 
properties (Moore et al., 2001). However, its key features relate mainly to its capacity to exert potent 
effects in the latter category via several mechanisms. Various viruses have been shown to up-regulate 
the expression of cellular IL-10 (cIL-10), with, in some cases, an enhancement of infection by 
suppression of immune functions (Brady et al., 2003; Brockman et al., 2009; Díaz-San Segundo et al., 
2009; Yu et al., 2008). These studies suggest that cIL-10 expression during the course of infection 
might be beneficial for the pathogens concerned. 
Further supporting this conclusion, several viruses encode orthologues of cIL-10, called viral 
IL-10s (vIL-10s), that appear to have been acquired by viruses on multiple independent occasions 
from their host during evolution. This review is devoted to these virokines. Various aspects of vIL-10 
are described, including their genetic organization, protein structure, origin, evolution, biological 
properties in vitro and in vivo, and potential in applied research. 
2. Discovery of vIL-10s 
Cloning and sequencing of the human and mouse IL-10s lead to the identification of the first 
vIL-10 orthologue. It was discovered that the uncharacterized open reading frame (ORF) BCRF1 of 
Epstein-Barr virus (EBV; human herpesvirus 4) encodes a protein that exhibited high sequence 
identity (92.3%) with human IL-10 (Moore et al., 1990). Subsequently, various studies documented 
that BCRF1 possesses some of the specific biological activities of cIL-10, and it was therefore 
concluded that this ORF encodes a functional viral orthologue of human IL-10 (Hsu et al., 1990; Niiro 
et al., 1992). Ever since, the sequencing of an increasing number of viral genomes has revealed a 
growing list of vIL-10s. To date, vIL-10 orthologues have been reported for 12 members of the family 
Herpesviridae, two members of the family Alloherpesviridae, and seven members of the family 
Poxviridae (Table 1). 
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Figure 1. Schematic representation of the genomic intron/exon organization of human IL-10 (H.
sapiens, Genbank ID: NP_000563) and vIL-10s encoded by the viruses listed in Table 1. Boxes and
horizontal lines represent exons and introns, respectively. They are drawn to scale. The 5’- and 3’-UTRs of
human IL-10 are not shown. The homology existing between each human IL-10 exons and virus IL-10s were
investigated at the level of amino acid sequences using the accession numbers listed in Table 1 and the
FASTA Sequence Comparison program (http://fasta.bioch.virginia.edu/fasta_www2/index.cgi) using default
settings. Regions of vIL-10 DNA sequences encoding amino acid sequences homologous to human IL-10
protein domain encoded by each exon are drawn to scale using the following colour code: exon 1: red, exon
2: yellow exon 3: blue exon 4: green exon 5: orange Regions of vIL-10s for which no homology could be, , , .
detected are presented in grey. HCMV cmvIL-10 and LAcmvIL-10 represent transcripts of the HCMV
UL111A gene expressed during lytic and latent infections, respectively. The former retains the structure of
the gene consisting of three exons and two introns, and the latter retains only the first intron, resulting in an
in-frame stop codon 12 codons after the second exon.
Table 1. Features of vIL-10s 
Family 
Subfamily 
Genus 
Virus name Abbreviation Locus Accession 
number 
Exon 
/Intron 
Protein 
length 
(SP) 
Main host 
species 
Identity 
with host 
cIL-10 
References 
 
Herpesviridae 
Betaherpesvirinae 
Cytomegalovirus 
         
 Human cytomegalovirus HCMV UL111A/ 
cmvIL-10 
AAR31656 3/2 176 (25) Human 27.3% (Kotenko et al., 2000; 
Lockridge et al., 
2000) 
   UL111A/ 
LA cmvIL-10 
 
ACR49217 2/1 139 (24)  29.0% (Jenkins et al., 2004) 
 
 
 
 
 
Green monkey cytomegalovirus GMCMV UL111A (S) AEV80459 4/3 185 (26) Green 
monkey 
28.2% (Davison et al., 2013) 
Rhesus cytomegalovirus RhCMV U111A AAF59907 4/3 189 (31) Macaque 25.0% (Lockridge et al., 
2000) 
Baboon cytomegalovirus BaCMV vIL-10 (S) 
 
AAF63436 4/3 191 (33) Baboon 28.6% (Lockridge et al., 
2000) 
Owl monkey cytomegalovirus OMCMV UL111A (S) AEV80800 4/3 182 (21) Owl 
monkey 
30.3% (Davison et al., 2013) 
Squirrel monkey cytomegalovirus SMCMV UL111A (S) AEV80955 4/3 178 (18) Squirrel 
monkey 
31.5% (Davison et al., 2013) 
Gammaherpesvirinae 
Lymphocryptovirus 
         
 Epstein-Barr virus EBV BCRF1 CAD53385 1/0 170 (23) Human 92.3% (Arrand et al., 1981) 
Bonobo herpesvirus Bonobo-HV LOC100970108 (S) XP_003804206.1  1/0 169 (18) Bonobo 94.3%  
Rhesus lymphocryptovirus RhLCV BCRF1 (S) AAK95412 1/0 177 (29) Macaque 97.2% (Franken et al., 1996) 
Baboon lymphocryptovirus BaLCV vIL-10 (S) AAF23949 1/0 171 (24) Baboon 91.6%  
Macavirus          
 Ovine herpesvirus 2 OvHV-2 Ov2.5 AAX58040 5/4 182 (26) Sheep 49.6% (Meier-Trummer et 
al., 2009) 
Percavirus          
 Equid herpesvirus 2 EHV-2 ORF E7 (S) AAC13857 1/0 179 (18) Horse 90.4% (Telford et al., 1995) 
Alloherpesviridae 
Cyprinivirus 
         
 Cyprinid herpesvirus 3 CyHV-3 ORF134 ABG42961 2/1 179 (17) Common 
Carp 
26.9% (Aoki et al., 2007) 
 Anguillid herpesvirus 1 AngHV-1 ORF25 AFK25321 1/0 165 (19) European 
eel 
34.3% (van Beurden et al., 
2010) 
  
Table 1. Features of vIL-10s. Exon number and protein length were determined based on the sequences available in the public databases. Signal 
peptides were predicted by using SignalP 4.0 (http://www.cbs.dtu.dk/services/SignalP/). Mature proteins (excluding signal peptide sequences) 
were compared using the FASTA sequence comparison program (http://fasta.bioch.virginia.edu/fasta_www2/). Protein sequence accession 
numbers for the hosts are as follows: Homo sapiens (human; NP_000563), Macaca mulatta (rhesus macaque; NP_001038192), Papio anubis 
(baboon; XP_003893246), Pan paniscus (bonobo; XP_003822966.1), Ovis aries (sheep; emb|CAG38358), Capra hircus (goat; ABI20513), Bos 
taurus (cow; NP_776513), Equus caballus (horse; NP_001075959), Cyprinus carpio (common carp; BAC76885), Anguilla anguilla (European eel; 
AEL99923). SP: signal peptide; * no IL-10 consensus sequence is available for passeriform birds, S: Viruses for which the only available data is 
the vIL-10 sequence. 
 
 
Table 1. cont. 
Family 
Subfamily 
Genus 
Virus name Abbreviation Locus 
 
Accession 
number 
Exon 
/Intron 
Protein 
length 
(SP) 
Main host 
species 
Identity 
with host 
cIL-10 
References 
 
Poxviridae 
Chordopoxivrinae 
Parapoxvirus 
         
 Orf virus ORFV ORF127  AAR98352 1/0 184 (22) Sheep/ 
Goat 
96.6% 
/97.3% 
(Delhon et al., 2004) 
 Bovine papular stomatitis virus BPSV ORF127 (S) AAR98483 1/0 185 (23) Cattle 94.4% (Delhon et al., 2004) 
 Pseudocowpox virus PCPV ORF127 (S) ADC53770 1/0 199 (23) Cattle 87.3% (Hautaniemi et al., 
2010) 
Capripoxvirus          
 Lumpy skin disease virus LSDV LSDV005 (S) AAK84966  1/0 170 (23) Cattle 45.7% (Tulman et al., 2001) 
 Sheeppox virus SPV SPPV_03 (S) NP_659579 1/0 168 (25) Sheep 47.9% (Tulman et al., 2002) 
 Goatpox virus GPV  GTPV_gp003 (S) YP_001293197 1/0 170 (27) Goat 49.6% (Tulman et al., 2002) 
Avipoxvirus          
 Canarypox virus CNPV CNPV018 (S) NP_955041 1/0 191 (20) Passeriform 
birds 
* (Tulman et al., 2004) 
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3. Genetic structure of IL-10 orthologues 
The basic structure of the human IL-10 gene consists of five protein-coding exons (I-V) 
encoding a spliced mRNA of 1629 bp (including untranslated regions) (Figure. 1) (Moore et al., 2001; 
Sabat, 2010). The first part of exon I and the last part of exon V encode the 5’- and 3’-untranslated 
regions, respectively. The remaining parts of exons I and V, together with exons II to IV, encode a 
single protein of 178 amino acid residues. The sizes of the exons are largely conserved among animal 
species. In contrast, the sizes of the introns show greater variation, and may be up to 1 kbp in length. 
The general intron-exon structure of cIL-10 is only found in ovine herpesvirus 2 (OvHV-2) 
although the introns are considerably shorter than those of its natural host, the sheep (Jayawardane et 
al., 2008). For the other vIL-10s, variations are observed in the number and positions of introns (Table 
1 and Figure. 1) and a large proportion of vIL-10s are intronless. 
Viral capture of host genes can result either from recombination between the viral genome and 
the host genome during viral replication in the nucleus (provided that the viral genome enters the 
nucleus during replication, as it is the case for herpesviruses but not poxviruses), or from 
recombination between the viral genome and a retrotranscript (cDNA) of mRNA (Odom et al., 2009; 
Shackelton & Holmes, 2004). The latter process requires reverse transcriptase activity, most likely 
derived from retrovirus co-infection of the host cell (Brunovskis & Kung, 1995; Isfort et al., 1992). 
Direct gene capture from the host genome results in preservation of the original cellular intron-exon 
structure, as in OvHV-2 (Jayawardane et al., 2008). Subsequent selective pressure could result in 
successive shortening or even loss of one or more introns, as exemplified by the vIL-10 variants not 
containing the full subset of exons. The intronless vIL-10 genes most likely represent gene capture via 
reverse transcription of cellular mRNA, but could theoretically also represent a final stage of intron 
loss from a gene originally captured from genomic DNA. The fact that all poxvirus vIL-10 genes are 
intronless probably reflects the cytoplasmic replication cycle of poxviruses, which may exclude the 
possibility of direct capture of host genes via recombination in the nucleus (Bratke & McLysaght, 
2008). 
4. Origin and evolution of vIL-10s 
Bioinformatical analyses were performed in the context of the present review, firstly to 
identify all viral sequences encoding IL-10 orthologues that are available in the public databases, 
secondly to determine whether these sequences are true vIL-10s or orthologues of cellular genes 
related to cIL-10. Methods and sequences used for these analyses are provided as supplementary 
material (S1). The viral sequences listed in Table 1 and the 134R gene encoded by Yaba-like disease 
virus were detected as viral sequences related to cIL-10 (Lee et al., 2001). Among the sequences listed 
in Table 1, a sequence highly homologous to EBV vIL-10 was found in the bonobo genome sequence. 
We assumed that this resulted from the sequencing of a contaminating herpesvirus, hereafter called 
Figure 2. Maximum likelihood phylogenetic tree for cIL-10s, vIL-10s (listed in Table 1), the 134R protein 
encoded by Yaba-like disease virus, and selected members of the IL-20 family of cytokines. Sequences and 
methods used are described in supplementary file S1. The tree was build using MEGA (JTT+ substitution 
model) and 100 bootstrap replicates. Numbers of nodes indicate bootstrap confidence, where >70%. Cellular 
IL-10 and vIL-10s are collapsed into a single branch. Scale: substitutions per site. 
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bonobo herpesvirus (bonobo-HV) (The rational that lead to this conclusion is described in the 
supplementary material S2). Figure 2 presents the phylogenetic analysis of all the viral sequences 
detected above, together with cIL-10 orthologues and representative members of the wider IL-10 
family of cytokines. Figure 2 demonstrates that the 134R protein from Yaba-like disease virus is most 
closely related to IL-24 proteins, although its exact position in the phylogenetic tree is not well defined 
in terms of bootstrap values. Further supporting the conclusion that the 134R protein is not an IL-10 
orthologue, Barlett et al. (2004) demonstrated that it signalled via the IL-20 receptor complex. Thus, it 
is clear that the 134R protein is not a true vIL-10, and it was therefore removed from further analyses. 
 Many of the vIL-10 genes are situated in orthologous locations in viral genomes, referred to 
here as positional orthology. Given that it is unlikely that gene capture would integrate cIL-10 into the 
same viral genome location on more than one occasion, positional orthology is assumed to represent 
ancient viral capture events in ancestral viruses. Four positionally orthologous sets of vIL-10 can be 
defined in the following viral genera: Cytomegalovirus, Lymphocryptovirus, Parapoxvirus and 
Capripoxvirus. All four of these sets cluster together in the Bayesian tree vIL-10s and the cIL-10s of a 
selection of their hosts (Figure 3). Based on Figure 3, it can be concluded that the positionally 
orthologous clade of vIL-10s of the genus Lymphocryptovirus (EBV/ baboon lymphocryptovirus 
[BaLCV]/ rhesus lymphocryptovirus [RhLCV]/ bonobo-HV) is nearest neighbour to a clade 
comprising the corresponding ape cIL-10s. This capture of cIL-10 by an ancestral lymphocryptovirus 
must therefore have taken place after the divergence of Old World primates from New World primates 
42 million years ago, since marmoset IL-10 is an outlier to both members of the genus 
Lymphocryptovirus and Old World primate lineages. The minimum date for this gene capture is more 
difficult to estimate, as the resolution of the tree does not make it possible to distinguish between it 
having occurred prior to the human-gorilla divergence, at 9 million years ago, or the ape-monkey 
divergence, at 29 million years ago. In the vIL-10s of members of the genus Cytomegalovirus (HCMV 
and others in that clade), an ancient capture event can again be inferred because of positional 
orthology. This event would have to have taken place before 42 million years ago, which is when the 
Old and New World monkey lineages diverged. Apart from HCMV cmvIL-10, the vIL-10s in the 
genus Cytomegalovirus clade have the same branching pattern as IL-10s of the hosts. The best 
explanation for the anomalous position of HCMV cmvIL-10 in this clade is that there has been 
particular selective pressure on HCMV. In this context, it is notable that the nearest relative of HCMV, 
chimpanzee cytomegalovirus (CCMV), lacks a vIL-10 gene, suggesting that some evolutionary 
pressure in the common ancestor of humans and chimpanzees resulted in the loss of this gene from 
CCMV and also its extensive modification in HCMV. Concerning CCMV, as there is only one 
reported sequence, even if unlikely, one cannot exclude the possibility that this gene has been lost 
during viral replication in cell culture. For the positionally orthologous vIL-10s of members of the 
genus Parapoxvirus (orf virus [ORFV]/ bovine papular stomatitis virus [BPSV]/ pseudocowpox virus 
[PCPV]), it is apparent that the ancestor of these proteins was captured prior to divergence of the 
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sheep and goat lineages at 7.3 million years ago. However, it is more difficult to specify a maximum 
date for this gene capture event, since the relationships of parapoxvirus vIL-10s to bovine and cervine 
IL-10 are poorly resolved. 
 The Bayesian tree does not help with the assessment of the vIL-10s of the fish viruses 
anguillid herpesvirus 1 (AngHV-1) and cyprinid herpesvirus 3 (CyHV-3), nor of OvHV-2, canarypox 
virus (CNPV) or the capripoxviruses (lumpy skin disease virus [LSDV]/ sheeppox virus [SPV]/ 
goatpox virus [GPV]). However, it seems unlikely that any of these vIL-10s represents a recent 
capture from the host. The capripoxvirus vIL-10s constitute a clade, but its point of divergence from 
the host sequences cannot be pinpointed in the same way as for the parapoxviruses. The only obvious 
example of a recent gene capture event for the origin of a vIL-10 is in equid herpesvirus 2 (EHV-2). 
Overall, based on positional orthology, amino acid sequence comparisons and the presumed 
modes of gene capture, at least eight, and possibly nine (assuming that AngHV-1 and CyHV-3 vIL-
10s represent independent acquisitions), different viral cIL-10 capture events can be discriminated. 
5. Protein structure of IL-10 orthologues 
Amino acid sequence conservation is rather low among the three subgroups of the IL-10 
family of cytokines (IL-10, IL-20 subfamily cytokines and type III IFN group) (Zdanov, 2004). In 
particular, type III IFNs are closer to type I IFNs than to the IL-10. For example, the amino acid 
sequence of IFN-λ3 (which belongs to the type III IFN group) is more similar to that of type I IFNs 
(exhibits 33% of similarity) than to the IL-10 (exhibits 23% of similarity) (Gad et al., 2009). Moreover, 
induction of gene expression and biological activities of type III IFNs are more similar to those 
described for type I IFNs (Ouyang et al., 2011). However, IFN-λ3 is structurally more closely related 
to the IL-10 family of cytokines, especially IL-22 (Gad et al., 2009) and has been shown to signal 
through the same IL-10R2 chain (Ouyang et al., 2011). 
Cellular IL-10s are well conserved among species (Lockridge et al., 2000; Moore et al., 2001). 
Indeed, the high level of conservation among cIL-10s contrasts with the variable (25-97.2%), and 
frequently low levels of identity observed between vIL-10s and their respective host IL-10s (Table 1). 
However, as illustrated in Figure 1 (colour code) the percentage of conservation is not distributed 
uniformly along vIL-10s. It is generally higher for amino acid regions corresponding to the regions 
encoded by cIL-10 exons 1 (with exception of the signal peptide region), 3 and 5. 
Independent of the level of identity between vIL-10s and cIL-10s, the former share many 
features with the latter. Firstly, cIL-10s and vIL-10s are secreted proteins. They are synthesized as 
precursors expressing a 17-33 residue hydrophobic signal peptide at the N terminus (Table 1). This 
peptide is cleaved during secretion (Kotenko & Pestka, 2001). Secondly, all cIL-10s encode two 
family signature motifs: L-[FILMV]-X3-[ILV]-X3-[FILMV]-X5-C-X5-[ILMV]-[ILMV]-X(3)-L-X2-
[IV]-[FILMV] and KA-X2-E-X-D-[ILV]-[FLY]-[FILMV]-X2-[ILMV]-[EKQZ] (Pinto et al., 2007; 
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Figure 4. Structure of cIL-10s and selected vIL-10s. a) Crystal structure of human IL-10 from the IL-
10/IL-10R1 complex (PDB ID: 1j7v (Josephson et al., 2001)). IL-10 protomers are depicted with helices 
rendered as cylinders. Helices are labelled. b) Ribbon diagram of the 1:2 IL-10/sIL-10R1 complex viewed 
perpendicular to the twofold axis of IL-10 (reproduced with permission from Josephson et al., 2001). c) to f) 
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Zhang et al., 2005). These motifs, which are essential for the structure and the function of cIL-10s, are 
conserved to a large extent in vIL-10s. Thirdly, despite the variable sequence homology observed 
between cIL-10s and vIL-10s at the amino acid sequence level, their determined or predicted 
structures are highly conserved (Figure 4). The crystal structure of human IL-10 has been determined 
as free ligand (Walter & Nagabhushan, 1995; Yoon et al., 2006; Zdanov et al., 1995; Zdanov et al., 
1996) and as a binary complex bound to its soluble receptor (Josephson et al., 2001). These studies 
demonstrated that cIL-10, like all members of the IL-10 family of class II cytokines, possesses a 
characteristic α-helical fold consisting of six helices (A to F) and connecting loops (Figure 4a). It is 
secreted as a domain-swapped homodimer in which two adjacent non-covalently bounded peptides 
exchange helices E and F to form a twofold symmetric, V-shaped reciprocal dimer (Zdanov et al., 
1995). The crystal structures of EBV and HCMV cmvIL-10 have been determined (Jones et al., 2002; 
Yoon et al., 2005; Zdanov et al., 1997) (Figure 4c and d), and were proved to be similar to that of 
human IL-10 with exception that HCMV cmvIL-10 lacks helix B (Jones et al., 2002). Using the 
receptor-bound structure of human IL-10 as template (Josephson et al., 2001), the three-dimensional 
protein structures of the CyHV-3 and AngHV-1 vIL-10s and the cIL-10s of their respective host were 
predicted (van Beurden et al., 2011) (Figure 4e and f). These in silico analyses suggested that the vIL-
10s encoded by these two alloherpesviruses share the conserved structure described for cIL-10. 
6. Transcriptomic and proteomic expression of vIL-10 genes 
Expression of vIL-10 genes has been studied at the RNA and protein levels. Depending on the 
viral species, genes encoding vIL-10s have been shown to be transcribed during in vitro replication at 
early times for rhesus cytomegalovirus (RhCMV) (Lockridge et al., 2000), HCMV LAcmvIL-10 
(Jenkins et al., 2008a) and CyHV-3 (Ilouze et al., 2012), at early-late times for CyHV-3 (Ouyang et al., 
2013), or at late times for EBV (Hudson et al., 1985; Miyazaki et al., 1993; Touitou et al., 1996), 
HCMV cmvIL-10 (Chang et al., 2004) and AngHV-1 (van Beurden et al., 2013). 
The HCMV UL111A gene encodes a vIL-10 and has been shown to generate different 
transcripts during lytic and latent infections as a consequence of differential splicing (Kotenko et al., 
2000; Jenkins et al., 2004). HCMV cmvIL-10 is expressed during the productive phase of infection 
(Spencer et al., 2002; Chang et al., 2004), whereas LAcmvIL-10 has been reported to be expressed 
during both latent (Jenkins et al., 2004) and productive infections (Jenkins et al., 2008a). Both 
transcripts share the same initiation codon. However, as a result of the lack of splicing of the second 
intron, LAcmvIL-10 retains only the first two exons present in the lytic transcript (cmvIL-10), 
resulting in an in-frame stop codon 12 codons after the second exon. As a consequence, LAcmvIL-10 
encodes a truncated protein of 139 residues that shares its first 127 residues with the longer protein 
encoded by the cmvIL-10 transcript (Jenkins et al., 2004). Also, Lin et al. (2008) described five 
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cmvIL-10 isoforms resulting from alternative splicing during in vitro replication of HCMV (Lin et al., 
2008). 
EBV BCRF1 was classified as a late gene (Hudson et al., 1985), although it is expressed in B 
cells relatively early after infection (Jochum et al., 2012; Miyazaki et al., 1993). There is no evidence 
for BCRF1 transcription and protein secretion during in vitro latency. However, in in vivo studies, Xu 
et al. (2001) detected expression of BCRF1 in latently infected patients with NK/T-cell lymphoma 
(Xu et al., 2001). 
Expression of CyHV-3 ORF134, which encodes a vIL-10, has been detected in vivo during 
acute primary infection and subsequent reactivation phases. Expression during persistent infection at 
restrictive temperature was low or below the detection level (Sunarto et al., 2012). 
Secretion of vIL-10 in the extracellular compartment has been demonstrated for several 
viruses in cell culture: RhCMV (Lockridge et al., 2000), HCMV (cmvIL-10) (Chang et al., 2004), 
EBV (Touitou et al., 1996) and CyHV-3 (Ouyang et al., 2013). In vivo secretion has been 
demonstrated for RhCMV (Lockridge et al., 2000). 
The effect of vIL-10 on virus growth in vitro has been studied using recombinant strains 
containing knock-out or nonsense mutations. For all viruses tested, vIL-10 genes were shown to be 
non-essential for growth of HCMV (Dunn et al., 2003), RhCMV (Chang & Barry, 2010), EBV 
(Jochum et al., 2012), CyHV-3 (Ouyang et al., 2013) and ORFV (Fleming et al., 2007). 
7. Ligand-receptor complexes formed by IL-10 orthologues 
Cellular IL-10 acts through a specific cell surface receptor (IL-10R) complex, which is 
composed of two different class II cytokine receptor family (CRF2) subunits, IL-10R1 and IL-10R2 
(Moore et al., 2001; Zdanov, 2004). IL-10R1 is the high-affinity receptor subunit of cIL-10 and is 
expressed mainly on immune cells (Liu et al., 1994). Cellular IL-10 first binds to IL-10R1, which 
leads to changes of its conformation and subsequent association with the low-affinity receptor subunit 
IL-10R2 (Yoon et al., 2006). In contrast to IL-10R1, IL-10R2 has a broader expression pattern, being 
expressed on most immune and non-immune cells. However, IL-10R2 is unable to bind cIL-10 in the 
absence of IL-10R1 (Kotenko et al., 1997; Wolk et al., 2004). Binding of cIL-10 to the IL-10R 
complex activates a signalling pathway, which mainly acts through receptor-associated Janus kinase 1 
(Jak1, associated with IL-10R1), Tyrosine kinase 2 (Tyk2, associated with IL-10R2) and Signal 
transduction and transcription (STAT) factors, leading to initiation of transcription of the appropriate 
genes (Sabat et al., 2010). 
HCMV cmvIL-10 and EBV vIL-10 have been shown to bind to and signal through human IL-
10R1 (Jones et al., 2002; Yoon et al., 2005). The regions of the surfaces of the human IL-10 and vIL-
10 variants that make contact with the receptor are essentially the same. The binding affinity of 
HCMV cmvIL-10 (which exhibits only 27% sequence similarity with human IL-10) to soluble IL10R1 
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(sIL10 R1) is essentially similar to that of human IL-10 (Jones et al., 2002). Furthermore, HCMV 
cmvIL-10 induces phosphorylation of the transcription factor STAT3 in monocytes, indicating its 
ability to bind and signal through human IL-10R in a manner comparable to that of human IL-10 
(Jenkins et al., 2008b). The same authors blocked the ability of cmvIL-10 to down-regulate the MHC 
class II expression on monocytes by using neutralizing antibodies raised against human IL-10R 
(Jenkins et al., 2008b). None of the five cmvIL-10 isoforms resulting from alternative splicing during 
in vitro replication of HCMV induced phosphorylation of STAT 3 despite being able to bind to human 
IL-10R (Lin et al., 2008). In contrast to cmvIL-10, LAcmvIL-10 does not induce STAT3 
phosphorylation and retains the ability to reduce MHC class II expression on monocytes in the 
presence of neutralizing antibodies raised against human IL-10R (Jenkins et al., 2008b). These results 
suggest that LAcmvIL-10 does not bind to human IL-10R or acts through another receptor or binds to 
human IL-10R but in a different way as compared to cmvIL-10 and human IL-10. These variations 
most probably resulted from the fact that LAcmvIL-10 is a truncated protein that lacks C-terminal 
helices E and F. As a consequence LAcmvIL-10 lacks many of immunosuppressive functions (see 
below) that are known for cmvIL-10 (Jenkins et al., 2008b). 
The most prominent structural difference between human IL-10 and HCMV cmvIL-10 bound 
to sIL-10R1 is the ~40º interdomain angle, which forces a reorganization of the IL-10R1 subunits in 
the putative cell surface complex (Jones et al., 2002). The binding affinity of EBV vIL-10 (which has 
92% sequence identity to human IL-10) to cell surface IL-10R1 is approximately a thousand-fold 
lower than that of human IL-10 (Liu et al., 1997). This difference in receptor binding affinity is 
thought to be caused by subtle changes in the conformation and dynamics of two loop structures and 
the interdomain angle (Yoon et al., 2005), as well as by single amino acid substitutions (Ding et al., 
2000). 
Because the crystal structures of human IL-10 and EBV vIL-10 are very similar, the observed 
functional differences (described below) have been attributed to differences in binding affinity (Ding 
et al., 2001; Liu et al., 1997). Recently, the biological effect induced by CyHV-3 vIL-10 in zebrafish 
embryos was shown to be abrogated by down-regulation of IL-10R1 expression using a specific 
morpholino, suggesting that CyHV-3 vIL-10 functions also through IL-10R1 (Sunarto et al., 2012). 
8. Biological activities of IL-10 orthologues 
8.1 Biological activities of cIL-10 
Cellular IL-10 was ﬁrst described as cytokine synthesis inhibitory factor (CSIF), an immune 
mediator that is produced by Th2 cell clones and has inhibitory effects on the synthesis of IL-2 and 
IFN-γ by Th1 cell clones (Fiorentino et al., 1989). Today, it is known that many different myeloid and 
lymphoid cells have the ability to produce IL-10 (Couper et al., 2008; Mosser & Zhang, 2008; Sabat et 
al., 2010), and that infection by a single pathogen species induces secretion of cIL-10 by more than 
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one cell population, depending on the type of pathogen, the infected tissue and the time point in the 
immune response (Sabat et al., 2010). 
Cellular IL-10 is a type II pleiotropic cytokine with both immunostimulatory and 
immunosuppressive properties (Moore et al., 2001). However, the key features of this cytokine relate 
to its capacity to exert potent immunosuppressive functions on several immune cell types (Moore et al., 
1993). It shows a clear, direct immunosuppressive effect on activated monocytes/macrophages, both 
by inhibition of the release of pro-inflammatory mediators (TNF-α, IL-1β, IL-6, IL-8, granulocyte 
colony-stimulating factor [G-CSF] and granulocyte-macrophage colony-stimulating factor [GM-CSF]) 
(de Waal Malefyt et al., 1991a; Fiorentino et al., 1991) and by enhancing the release of 
anti-inflammatory mediators (such as IL-1 receptor antagonist and soluble TNF-α receptor) (Hart et al., 
1996; Jenkins et al., 1994). Additionally, cIL-10 inhibits antigen presentation by down-regulation of 
the expression of MHC class I, MHC class II and B7-1/B7-2 co-stimulatory molecules (de Waal 
Malefyt et al., 1991b; Matsuda et al., 1994; Willems et al., 1994). It also affects dendritic cells (DCs) 
by preventing their differentiation from monocyte precursors, and their maturation (Allavena et al., 
1998; Demangel et al., 2002). Furthermore, cIL-10 hampers the development of Th1 immunity, both 
indirectly by inhibiting IL-12 synthesis by antigen presenting cells (APCs) and directly by inhibiting 
IL-2 and IFN-γ production by Th1 cells (D'Andrea et al., 1993; Fiorentino et al., 1991). Moreover, 
cIL-10 acts directly on Th2 cells and inhibits IL-4 and IL-5 synthesis (Del Prete et al., 1993). Cellular 
IL-10 has also immunosuppressive effect on neutrophilic and eosinophilic granulocytes by preventing 
the synthesis of lipopolysaccaride (LPS)-induced pro-inflammatory mediators (Cassatella et al., 1993; 
Takanaski et al., 1994). Thus, cIL-10 plays a key role in the inhibition of the pro-inflammatory 
responses. It is thought that the role of this inhibition is to protect tissues from the lesions that could 
result from exaggerated inflammation (Banchereau et al., 2012). 
Notably, apart from its immunosuppressive role, cIL-10 also shows a stimulatory effect on 
several types of immune cell. It may prevent apoptosis of B cells, enhancing their activation and 
contributes to immunoglobulin class switching (Go et al., 1990; Rousset et al., 1992). Cellular IL-10 
alone or in combination with other cytokines may also have a stimulatory effect on proliferation of, 
and cytokine production by, certain subsets of cytotoxic T cells (Rowbottom et al., 1999; Santin et al., 
2000), mast cells (Thompson-Snipes et al., 1991) and NK cells (Cai et al., 1999; Carson et al., 1995). 
8.2. Biological activities of vIL-10s 
The biological activities of vIL-10s have been studied mainly in vitro using recombinant 
proteins generated from bacterial or mammalian cell expression systems, supernatants from viral 
infected cultures, or, to a lesser extent, recombinant vIL-10 knock-out viruses. Only a restricted 
number of studies have addressed the roles of vIL-10s in vivo by comparing wild type and vIL-10 
knock-out viruses. These in vitro and in vivo studies are summarized below. In vitro studies are 
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presented according to the immune process affected by vIL-10s, while in vivo studies are organized 
per virus species studied. 
8.2.1 Biological activities of vIL-10s determined in vitro 
8.2.1.1 Inhibition of cytokine synthesis and leukocyte proliferation 
The hallmark activity of cIL-10 is the inhibition of cytokine production following 
pro-inflammatory signals. In vitro studies suggest that this activity is conserved among most viral 
orthologues. The studies supporting this conclusion are summarized below. 
HCMV cmvIL-10 inhibits gene expression and secretion of pro-inflammatory cytokines by 
LPS-stimulated peripheral blood mononuclear cells (PBMCs), monocytes, monocyte-derived dendritic 
cells (MDDCs) and plasmacytoid dendritic cells (PDCs) (Avdic et al., 2013; Chang et al., 2009; 
Chang et al., 2004; Jenkins et al., 2008b; Nachtwey & Spencer, 2008; Raftery et al., 2004; Spencer, 
2007; Spencer et al., 2002). Similarly, the orthologous RhCMV vIL-10 has been shown to inhibit 
production of pro-inflammatory cytokines by LPS-stimulated PBMCs and monocytes (Logsdon et al., 
2011; Spencer et al., 2002). In addition, both HCMV cmvIL-10 and RhCMV vIL-10 reduced IFN-γ 
production by PHA-stimulated human PBMCs, as well as human and rhesus PBMC proliferation 
(Spencer et al., 2002). HCMV cmvIL-10 secreted by HCMV-infected cells can directly suppress the 
synthesis of type I IFNs by plasmacytoid dendritic cells (PDCs) (Chang et al., 2009), demonstrating 
that HCMV cmvIL-10 can act in trans, since PDCs are highly resistant to infection by HCMV 
(Slobedman et al., 2009). HCMV cmvIL-10 has a marked impact on microglial cells, which play a 
role in host defense against HCMV brain infection. Pretreatment of microglial cells with recombinant 
HCMV cmvIL-10 prior to stimulation with HCMV significantly decreased the protein level of CXC 
chemokine ligand 10 (CXCL10), which is known to be involved in the recruitment of activated T 
lymphocytes in infected tissues (Cheeran et al., 2003). Very recent studies demonstrated that cmvIL-
10 influence monocyte polarization by induction of development of M2 alternatively activated 
monocytes type c (M2c). The M2c polarization of monocytes by cmvIL-10 resulted in up-regulation 
of the anti-inflammatory enzyme heme oxygenase 1 (HO-1), and this was shown to play an important 
role in viral IL-10-mediated suppression of pro-inflammatory cytokines by M2c monocytes (Avdic et 
al., 2013). Moreover, M2c monocyte polarization by cmvIL-10 reduces the ability to stimulate CD4+ 
T cell activation and proliferation (Avdic et al., 2013). 
In contrast to cmvIL-10, LAcmvIL-10 showed no inhibitory effect on IL-1α, IL-1β, IL-6 or 
TNF-α expression by LPS-stimulated MDDCs (Jenkins et al., 2008b). However, in another study, it 
has been shown to inhibit TNF-α production by THP-1 myeloid cells stimulated with LPS (Spencer et 
al., 2008). Finally, Avdic et al. (2011) demonstrated significantly higher levels of transcription and 
secretion of cytokines associated with DC formation, as well as an increase in the proportion of 
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myeloid DCs in CD34+ primary myeloid progenitor cells latently infected with HCMV deleted for the 
UL111A gene region, compared to parental virus or mock infection (Avdic et al., 2011). 
EBV vIL-10 inhibits pro-inflammatory cytokine production by activated cells of various types 
(de Waal Malefyt et al., 1991a; Hsu et al., 1990; Jochum et al., 2012; Salek-Ardakani et al., 2002b; 
Vieira et al., 1991). In addition, it reduces both the amount of IFN-γ mRNA (Niiro et al., 1992) and 
IFN-γ secretion (Salek-Ardakani et al., 2002b) in activated human PBMCs. Jochum et al., 2012 
demonstrated that human PBMCs infected with EBV deleted for BCRF1 produced significantly higher 
levels of the pro-inflammatory cytokines IFN-γ, IL-2, IL-6 and TNF-β, whereas levels of IL-1, IL-5, 
IL-8 and TNF-α were similar to those observed with the parental wild type strain. Interestingly, these 
authors also observed an increased production of human IL-10 by PBMCs infected with the BCRF1 
deleted strain. This observation suggests that vIL-10 could regulate human IL-10 expression. However, 
the observed effect could also have been an indirect consequence of the higher level of 
pro-inflammatory cytokines resulting from infection by the EBV vIL-10-deleted recombinant (Jochum 
et al., 2012). Finally, Brodeur and Spencer (2010) demonstrated that anti-human IL-10 antibodies bind 
to and neutralize the immunosuppressive activity of EBV vIL-10 but not HCMV cmvIL-10. This 
observation is consistent with the higher homology existing between EBV vIL-10 and human IL-10 
(92.3% of identity) compared to HCMV cmvIL-10/ human IL-10 (27.3% of identity). 
The inhibition of cytokine activities were also demonstrated for two viruses infecting sheep 
(OvHV2 and ORFV) using different in vitro systems. OvHV2 vIL-10 inhibited IL-8 production by 
LPS-stimulated ovine macrophages (Jayawardane et al., 2008) whereas ORFV vIL-10 inhibited TNF-
α and IL-8 production from LPS-stimulated ovine macrophages and ionophore/PMA stimulated 
keratinocytes, as well as IFN-γ and GM-CSF production by Con-A-stimulated PBMCs (Haig et al., 
2002a, b). However, ORFV vIL-10 knock-out virus showed no effect on infected keratinocyte IL-8 
and TNF-α production (Haig et al., 2002b). ORFV vIL-10 has also been shown to inhibit expression 
and secretion of TNF-α in LPS-activated mouse peritoneal macrophages (Imlach et al., 2002), to 
inhibit TNF-α and IL-1β in the human monocyte cell line THP-1 activated by LPS (Imlach et al., 2002; 
Wise et al., 2007), and to inhibit production of IL-8, IL-1β and TNF-α in LPS-stimulated ovine 
alveolar macrophages (Fleming et al., 2000). Furthermore, inhibition of IFN-γ production in PBMCs 
by ORFV vIL-10 was demonstrated (Fleming et al., 2000). Compared to human IL-10, ORFV vIL-10 
possesses reduced ability to impair THP-1 monocyte proliferation in the presence of LPS (Wise et al., 
2007). However, it would be interesting to compare the biological activities of ORFV vIL-10 to those 
of ovine IL-10. 
8.2.1.2 Deregulation of MHC and co-stimulatory molecule expression 
Studies of the vIL-10s encoded by HCMV and EBV have demonstrated their ability to 
deregulate MHC and co-stimulatory molecule expression. HCMV cmvIL-10 and RhCMV vIL-10 
reduced cell surface expression of classical MHC class I and class II molecules (Jaworowski et al., 
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2009; Jenkins et al., 2008b; Raftery et al., 2004; Spencer et al., 2002), but also increased expression of 
the non-classical MHC molecules HLA-DM and HLA-G on LPS-stimulated human MDDCs and 
monocytes, respectively (Raftery et al., 2004; Spencer et al., 2002). These observations suggest that 
HCMV cmvIL-10 could prevent antigen presentation to T cells through MHC class I molecule down-
regulation but could simultaneously protect MHC class I-negative cells from NK cell-mediated lysis 
through up-regulation of HLA-G (Rouas-Freiss et al., 1997). Although independent studies 
demonstrated the inhibitory effect of HCMV cmvIL-10 on MHC class I expression in different LPS-
stimulated cell types, Pepperl-Klindworth et al. (2006) suggested that HCMV cmvIL-10 secreted 
during the productive phase of HCMV infection has no direct impact on MHC class I-restricted 
antigen presentation on non-infected bystander cells in the context of viral infection (Pepperl-
Klindworth et al., 2006). HCMV cmvIL-10 has also been shown to inhibit LPS-induced enhancement 
of co-stimulatory molecules (CD40, CD80, CD86, B7-H1 and B7-DC) on the surface of MDDCs 
(Jenkins et al., 2008b; Raftery et al., 2004). LAcmvIL-10 reduces the expression of MHC class II 
molecules, but, in contrast to cmvIL-10, does not down-regulate expression of MHC class I molecules 
and co-stimulatory molecules (CD40, CD80, and CD86) on LPS-stimulated MDDCs (Jenkins et al., 
2008b). The reduction of cell surface MHC class II molecule expression by LAcmvIL-10 was 
comparable to the effect of cmvIL-10 both on immature myeloid progenitor cells and human 
monocytes (Jaworowski et al., 2009; Jenkins et al., 2008b). Jenkins et al. (2008b) suggested a possible 
mechanism for the reduction of MHC class II cell surface expression at the level of the transcriptional 
activity of CIITA, a gene that encodes a protein regulating the transcription of genes involved in the 
MHC class II biosynthesis pathway. The authors demonstrated that cmvIL-10, as well as LAcmvIL-10, 
significantly inhibited transcription of CIITA, and that this resulted in down-regulation of expression 
of HLA-DR α, β and invariant chain. In addition, both cmvIL-10 and LAcmvIL-10 may inhibit MHC 
class II surface expression acting at the post-translational level by blocking transport of MHC class II 
molecules to the cell surface (Jenkins et al., 2008b). In addition to the above-mentioned functional 
studies utilizing recombinant LAcmvIL-10, Cheung et al. (2009) demonstrated that CD34+ myeloid 
progenitor cells latently infected by an HCMV strain deleted for the UL111A gene expressed a higher 
level of surface MHC class II molecules compared to cells infected with the parental strain. Cells 
infected with the knock-out strain became recognizable by allogeneic and autologous CD4+ T cells 
(Cheung et al., 2009). 
EBV vIL-10 was shown to reduce both constitutive and IFN-γ- or IL-4-induced MHC class II 
cell surface expression on monocytes and macrophages (de Waal Malefyt et al., 1991b; Salek-
Ardakani et al., 2002a, b). This resulted in a decrease of antigen presentation by monocytes, and, as a 
consequence, a reduction of T cell proliferation (de Waal Malefyt et al., 1991b). EBV vIL-10 also 
inhibited the expression of adhesion molecule ICAM-1 and co-stimulatory molecules (CD80 and 
CD86) on monocytes and macrophages when added simultaneously with IFN-γ (Salek-Ardakani et al., 
2002a). Interestingly, EBV vIL-10 inhibited IFN-γ-induced MHC class I expression on monocytes and 
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macrophages only when it was added 2 h prior to the addition of IFN-γ, suggesting that it affects an 
early step in the IFN-γ signaling pathway (Salek-Ardakani et al., 2002a). 
8.2.1.3. Inhibition of DC 
Dendritic cells play key roles in immune responses. Viral IL-10s have been shown to affect 
their maturation, functionality and survival. HCMV cmvIL-10 inhibited LPS-induced pro-
inflammatory cytokine production by immature DCs (Chang et al., 2004; Raftery et al., 2008), but was 
also shown to have pronounced long-term effects on mature DCs. Although it enhanced the migration 
of mature DCs towards peripheral lymph nodes, it also reduced their production of cytokine (Chang et 
al., 2004). In addition, the inability of mature DCs to secrete IL-12 was maintained, even when they 
were restimulated by the activated T-cell signal CD40 ligand in the absence of cmvIL-10. Finally, 
cmvIL-10 induced endogenous cIL-10 expression in DCs, further increasing its modulatory effects 
(Chang et al., 2004). 
Raftery et al. (2004) demonstrated that HCMV cmvIL-10, in contrast to EBV vIL-10, had 
additional effects on DCs that could affect negatively their roles in immunity. Firstly, it inhibited cell-
surface expression of molecules involved in antigen presentation, co-stimulation and adhesion. 
Secondly, it increased apoptosis of LPS-stimulated immature DCs by blocking expression of the anti-
apoptotic, long form cellular FLIP protein. Thirdly, it induced a strong activation of STAT3 (a key 
mediator in cIL-10 transduction signal) in immature DCs. Fourthly, it up-regulated expression of DC-
SIGN and IDO on LPS-stimulated immature DCs (Raftery et al., 2004). DC-SIGN has been shown to 
play a role in DC infection with primary HCMV isolates (Halary et al., 2002), whereas synthesis of 
IDO by human DCs caused suppression of T cell responses (Hwu et al., 2000). In contrast to HCMV 
cmvIL-10, LAcmvIL-10 showed no inhibitory effect in LPS-stimulated immature DCs on the 
expression of pro-inflammatory cytokines, co-stimulatory molecules and the maturation marker CD83 
(Jenkins et al., 2008b). However, using a recombinant virus deleted for the UL111A gene region, 
Avdic et al. (2011) demonstrated that HCMV vIL-10 expressed during latency inhibits differentiation 
of latently infected myeloid progenitor cells toward a DC phenotype, suggesting that LAcmvIL-10 
may inhibit infected myeloid progenitors to differentiate into DCs, thereby limiting the presentation of 
latency-associated viral peptides by DCs (Avdic et al., 2011). 
Immature DCs exposed simultaneously to LPS and ORFV vIL-10 showed enhanced 
ovalbumin–FITC uptake and reduced IL-12 expression, indicating inhibition of maturation of DCs. 
Furthermore, ORFV vIL-10 inhibited the up-regulation of DC cell-surface markers of activation and 
maturation such as MHC class II, CD80, CD83 and CD86, and inhibited the capacity of DCs to 
activate CD4+ T cells (Chan et al., 2006). Similarly, ORFV vIL-10 inhibited maturation and 
expression of MHC class II, CD80 and CD86 in stimulated murine bone marrow-derived dendritic 
cells (BMDCs), and reduced their ability to present antigens (Lateef et al., 2003). 
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8.2.1.4. Other immunosuppressive properties 
 In addition to the main immunosuppressive properties described above, some studies suggest 
potential additional immunosuppressive effects for some vIL-10s. HCMV cmvIL-10 decreased matrix 
metalloproteinase activity and deregulated cell-to-cell or cell-matrix interactions of infected 
cytotrophoblasts and endothelial cells (Yamamoto-Tabata et al., 2004). EBV vIL-10 has been shown 
to impair some of the defense mechanisms of activated monocytes and macrophages. It inhibited 
production of the superoxide anion by PBMCs and monocytes (Niiro et al., 1992) and PGE2 
expression by LPS-stimulated monocytes (Niiro et al., 1994). Furthermore, EBV vIL-10 inhibits 
NK/NKT cell-mediated lysis of infected B cells through a direct effect on these cytotoxic cells and 
also through an indirect inhibitory effect on the CD4+ T cells that contribute to the microenvironment 
required for NK/NKT cytotoxicity (Jochum et al., 2012). 
8.2.1.5. Immunostimulatory properties 
 In addition to their immunosuppressive effects, some vIL-10s have retained at least some of 
the immunostimulatory properties of their cellular orthologues. HCMV cmvIL-10, but not LAcmvIL-
10, showed a strong stimulatory effect on proliferation of the human B cell lymphoma Daudi cell line 
(Spencer et al., 2008) and induced the production of human IL-10 (which is a growth factor for B 
lymphocytes) (Jaworowski et al., 2009; Spencer et al., 2008). Jaworowski et al. (2009) studied the 
effect of cmvIL-10 and LAcmvIL-10 on monocytes. They demonstrated that cmvIL-10 but not 
LAcmvIL-10 increases the expression of Fcγ receptors CD32 and CD64, as well as Fcγ-receptor-
mediated phagocytosis (Jaworowski et al., 2009). RhCMV vIL-10 has been shown to stimulate 
proliferation of TF-1/IL-10R1 cells, which are human erythroleukemic cells proliferating upon 
addition of human IL-10 to the media (Logsdon et al., 2011). 
EBV vIL-10 has also been shown to stimulate proliferation and differentiation of human B 
cells as well as immunoglobulin production (Defrance et al., 1992; Rousset et al., 1992; Stuart et al., 
1995). However, EBV vIL-10 lacks several of the other immunostimulatory functions expressed by 
cIL-10, such as co-stimulation of mouse thymocyte proliferation, mast cell proliferation and up-
regulation of MHC class II expression on B cells (Vieira et al., 1991). 
 The ability of the OvHV-2 and ORFV vIL-10s to stimulate cell proliferation to levels 
comparable to those obtained with ovine IL-10 has been demonstrated by independent studies. OvHV-
2 vIL-10 induced proliferation of murine mast cell line D-36 in conjunction with IL-4 (Jayawardane et 
al., 2008). ORFV vIL-10 has been shown to induce proliferation of murine thymocytes in the presence 
of IL-2 (Fleming et al., 1997), ovine mast cells stimulated with IL-3, murine mast cell line D-36 
stimulated with IL-4 (Haig et al., 2002b) and murine MC/9 mast cells stimulated with IL-3 and IL-4 
(Imlach et al., 2002). 
 
Introduction: Viral Interleukin 10 
 55 
8.2.2 Biological activities of vIL-10s determined in vivo 
Numerous molecular and in vitro studies suggest that, following capture, there has been 
adaptive evolution of vIL-10 through positive selection to retain the properties most beneficial for the 
viral life cycle. However, very few studies have addressed the role of vIL-10 in vivo by comparison of 
a wild type strain and derived deleted and revertant strains. This approach, which is essential to 
drawing conclusions on biological relevance in vivo, has been followed for only three viruses: 
RhCMV, ORFV and CyHV-3. 
Chang and Barry (2010) demonstrated that RhCMV vIL-10 has various effects on both the 
innate and the adaptive immune responses against RhCMV in infected rhesus macaques. They 
performed comparative infections with a wild type strain and a derived recombinant strain deleted for 
UL111A. Skin biopsies from macaques infected with the deleted strain exhibited a higher level of 
cellularity at the site of infection but contained a lower frequency of CD68+ macrophages. The latter 
observation suggests that RhCMV vIL-10 could contribute to the recruitment of permissive cells on 
viral replication sites. RhCMV vIL-10 was also shown to reduce trafficking of myeloid DCs to 
draining lymph nodes and to decrease priming of naïve CD4+ T cells (Chang & Barry, 2010). 
Although RhCMV vIL-10 has no effect on IgM production, it inhibited B cell differentiation and 
antibody isotype switching, resulting in a permanent deficit of circulating anti-RhCMV IgG. In 
addition, RhCMV vIL-10 delayed antibody maturation and attenuated the magnitude of anti-viral 
antibody titre (Chang & Barry, 2010). Finally, it was also shown to reduce the frequency of RhCMV-
specific effector T helper cells secreting IFN-γ or IL-2, and T cell proliferation (Chang & Barry, 2010).  
The activity of vIL-10 encoded by ORFV in vivo has been analyzed in its natural host, the 
sheep. A preliminary study revealed that the frequency of IFN-γ mRNA-expressing cells in skin 
lesions was higher in animals infected with the vIL-10 knock-out virus than in animals infected with 
the parental wild type virus (Fleming et al., 2000). Interestingly, after primary infection, smaller, less 
severe lesions were observed in animals infected with the vIL-10 knock-out virus than those observed 
in animals infected with the wild type parental or revertant strains (Fleming et al., 2007). 
Recently, the role of CyHV-3 vIL-10 was studied in vivo using an artificial zebrafish embryo 
model (Sunarto et al., 2012). It was shown that injection of CyHV-3 ORF134 mRNA into zebrafish 
embryos increased the number of lysozyme-positive cells to a degree similar to that of zebrafish IL-10 
mRNA (Sunarto et al., 2012). However, Ouyang et al. (Ouyang et al., 2013) demonstrated that CyHV-
3 vIL-10 does not significantly affect its virulence in common carp or the host innate immune 
response. Thus, infection of carp with ORF134-deleted, ORF134-revertant or wild type strains 
induced comparable levels of CyHV-3 disease (Ouyang et al., 2013). Moreover, quantification of viral 
load and real-time PCR investigating the expression of several carp inflammatory cytokines at various 
times post-infection did not revealed any significant differences between groups of fish infected with 
the three viral genotypes (Ouyang et al., 2013). Similarly, histological examination of the gills and the 
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kidneys of infected fish revealed no significant differences between fish infected with the ORF134-
deleted virus and those infected with the control parental or revertant strains (Ouyang et al., 2013). All 
together, the results demonstrated that CyHV-3 vIL-10 is essential for neither viral replication in vitro 
nor virulence in common carp. 
9. Viral IL-10s as a topic of applied research 
In addition to their importance in fundamental research, a large number of studies demonstrate 
a role for vIL-10s in applied research. A thorough description of this abundant literature is beyond the 
scope of this review. Here, we briefly describe the two main types of applied research developed on 
vIL-10s. These studies investigate the potential of vIL-10s as candidate antigens or target genes 
(production of attenuated recombinant vaccines) for the development of anti-viral vaccine or as an 
immunosuppressor to prevent immunopathologies. 
For vIL-10s that alter innate or adaptive immunity in vivo, vaccine-mediated neutralization of 
their function could contribute to inhibition of the establishment of a persistent infection in naïve 
subjects or even interrupt a pre-existing persistent infection. This theoretical possibility could apply to 
most vIL-10s that are quite divergent in sequence from the host IL-10. To address this concept using 
the RhCMV model (Yue & Barry, 2008), inactive RhCMV vIL-10 mutants were designed as antigen 
candidates and shown to induce the production of neutralizing antibodies specific to vIL-10 (not 
cross-reacting with host IL-10) (de Lemos Rieper et al., 2011; Logsdon et al., 2011). The ability of 
such an antigen candidate to interfere with persistent RhCMV infection (establishment or maintenance) 
has not yet been tested. However, a recent study on the immunogenicity of vIL-10 in RhCMV-infected 
rhesus macaques demonstrated that the serum of persistently infected animals contains high levels of 
vIL-10-neutralizing antibodies (Eberhardt et al., 2012). This observation suggests that vIL-10-based 
vaccines may not be able to interrupt an established persistent infection. Interestingly, development of 
antibodies against RhCMV vIL-10 in uninfected rhesus macaques immunized with plasmid vectors 
encoding for engineered, nonfunctional RhCMV vIL-10 variants resulted in reduction of RhCMV 
replication at the inoculation site and RhCMV shedding in bodily fluids during subcutaneous RhCMV 
challenge (Eberhardt et al., 2013). Alternatively, for vIL-10s playing a significant role in virulence, 
deleted recombinant strains could be produced as attenuated vaccines as suggested for RhCMV 
(Chang & Barry, 2010). 
The data presented in the previous section collectively indicate that vIL-10s, compared to cIL-
10, have a restricted bioactivity profile favouring immunosuppressive activities. Based on this profile, 
several independent groups have suggested exploiting vIL-10s as potential immunosuppressive agents. 
Studies performed in laboratory animal models support this concept. Researchers have demonstrated 
the potential of some vIL-10s to induce localized immunosuppression in order to favour long-term 
engraftment of transplanted tissues (EBV vIL-10) (Nast et al., 1997; Qin et al., 1996), reduce the 
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host’s foreign body reaction against implanted biomaterials (HCMV cmvIL-10) (van Putten et al., 
2009), or treat collagen-induced arthritis (EBV vIL-10) (Keravala et al., 2006; Kim et al., 2000; 
Lechman et al., 1999; Ma et al., 1998; Whalen et al., 1999).  
10. Concluding remarks 
Most viruses have been co-evolving with their hosts for millions of years. During this process, 
viruses and hosts have been acting as strong sources of selection pressure on each other. Thus, viruses 
have been constantly selecting individuals among the host population that have the most efficient 
immune systems, while the continual improvement of the immune system has been selecting viruses 
that have evolved strategies to control the host immune response. Fundamental studies in immunology 
have demonstrated the key roles of cIL-10 in the immune system. The various independent 
acquisitions of IL-10 orthologues by viruses belonging to different viral genera, subfamilies and even 
families further support the importance of cIL-10 in the immune system. After their capture by the 
viral genome, cellular sequences evolve through positive selection to retain properties that are the 
most beneficial for the virus, and, sometimes, to acquire novel properties. The vIL-10s illustrate this 
concept. In comparison to their cellular orthologues, vIL-10s have evolved towards a more restricted 
bioactivity profile consisting mainly, but not exclusively, of immunosuppressive activities. 
Interestingly, studies on HCMV cmvIL-10 and LAcmvIL-10 demonstrate that evolution of a captured 
IL-10 gene in the viral genome has led to the expression of two different transcripts that have specific 
biological activities adapted to the replication and latent phases. 
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Table S1. Sequences used to build trees
1 
 
1 
Sequences listed in Table 1 were also used to build the trees presented in Figure 3 and Figure 4. 
2 
Accession numbers for IL-19, IL-20, IL-22, IL-22B, IL-24, IL-26 and 134R are from SwissProt. Other 
accession numbers are from GenBank. 
 
Protein Host species  Accession number
2 
Fig. 3 Fig. 4 
IL-10 Xenopus Xenopus (Silurana) tropicalis ref|NP_001165400.1 X X 
Rock dove Columba livia gb|EMC81973.1 X X 
Chicken Gallus gallus ref|NP_001004414.2 X X 
Green seaturtle Chelonia mydas gb|EMP30816.1 X X 
Tasmanian devil Sarcophilus harrisii ref|XP_003767694.1 X X 
Opossum Monodelphis domestica ref|XP_003340215.1 X X 
Cat Felis catus ref|NP_001009209.1 X X 
Walrus Odobenus rosmarus 
divergens 
ref|XP_004417638.1 X X 
Red deer Cervus elaphus sp|P51746.1|IL10_CEREL X X 
Sheep Ovis aries emb|CAG38358.1 X X 
Goat Capra hircus gb|ABI20513.1 X X 
Cattle Bos taurus ref|NP_776513.1 X X 
Chinese hamster Cricetulus griseus ref|XP_003501267.1 X X 
Mouse Mus musculus ref|NP_034678.1 X X 
Rabbit Oryctolagus cuniculus gb|ABC41664.1 X X 
Marmoset Callithrix jacchus ref|XP_002760779.1 X X 
Human Homo sapiens ref|NP_000563.1 X X 
Chimpanzee Pan troglodytes ref|NP_001129092.2 X X 
Bonobo Pan paniscus ref|XP_003822966.1 X X 
Gorilla Gorilla gorilla gorilla ref|XP_004028338.1 X X 
Baboon Papio anubis ref|XP_003893246.1 X X 
Macaque Macaca mulatta ref|NP_001038192.1 X X 
Bottlenose dolphin Tursiops truncatus ref|XP_004312277.1 X X 
Pig Sus scrofa gb|ABP68816.1 X X 
Horse Equus caballus ref|NP_001075959.1 X X 
Myotis Myotis davidii gb|ELK37201.1 X X 
African elephant Loxodonta africana ref|XP_003410325.1 X X 
Chinese treeshrew Tupaia chinensis gb|ELW47753.1 X X 
Galago Otolemur garnettii ref|XP_003792257.1 X X 
Zebrafish Danio rerio ref|NP_001018621.2 X X 
Common carp Cyprinus carpio dbj|BAC76885.1 X X 
European eel Anguilla anguilla gb|AEL99923.1 X X 
IL-19 Human Homo sapiens IL19_HUMAN X  
Mouse Mus musculus IL19_MOUSE X  
IL-20 Human Homo sapiens IL20_HUMAN X  
Mouse Mus musculus IL20_MOUSE X  
IL-22 
 
IL-22B 
Human Homo sapiens IL22_HUMAN X  
Mouse 
Mouse 
Mus musculus 
Mus musculus 
IL22_MOUSE 
IL22B_MOUSE 
X 
X 
 
IL-24 Human Homo sapiens IL24_HUMAN X  
Mouse Mus musculus IL24_MOUSE X  
Rat Rattus norvegicus IL24_RAT X  
IL-26 Human Homo sapiens IL26_HUMAN X  
Protein Virus  Accession number Fig. 3 Fig. 4 
134R Yaba-like disease 
virus 
 Q9DHH9 X  
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Supplementary material S1 
Methods and sequences used to build the trees presented in Figure 3 and Figure 4. 
Methods 
The membership of the IL-10 protein family was defined according to Pfam (Punta et al., 2012) 
(http://pfam.sanger.ac.uk/family/IL10, PF00726). As well as the “true” IL-10 proteins, this protein 
family includes the related IL-19, IL-20, IL-22, IL-24 and IL-26 proteins. Protein sequences from the 
IL-10 family were loaded into MEGA (Tamura et al., 2011) and aligned using Muscle (Edgar, 2004). 
The best-fitting substitution model was derived and found to be the Jones-Taylor-Thornton model with 
a gamma distribution of rates among sites (JTT+Γ ). A maximum likelihood phylogenetic tree was 
then built using that model. Bayesian phylogenetic trees were built using BEAST (Drummond & 
Rambaut, 2007), run on the same substitution models until convergence. The tree prior was a 
speciating Yule model, and a relaxed exponential clock was found to be the best-fitting clock model, 
by comparison of different models using Bayes factors within BEAST. 
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and maximum parsimony methods. Mol Biol Evol 28, 2731-2739. 
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Supplementary material S2 
Rational for considering the IL-10 orthologue found in the bonobo XP_003804206.1 
sequence as a sequence deriving from a contaminating bonobo herpesvirus 
 
The Pan paniscus vIL-10 sequence was found in the locus 
XP_003804206 http://www.ncbi.nlm.nih.gov/protein/397464698. A nucleotide alignment of the Pan 
paniscus unplaced genomic scaffold panpan1 scf1120388612767 (an almost 5kb DNA fragment, 
which harbours this vIL-10 gene) with the closely related Epstein-Barr virus suggesting that the whole 
scaffold is indeed viral. However, the viral sequence was too distant from EBV to represent a strain of 
this viral species. Most likely, this virus represents a bonobo lymphocryptovirus, probably the one for 
which a partial sequence of the DNA polymerase and glycoprotein B were published by Ehlers at al., 
2010. Indeed, searching of the DNA pol and gB sequence in the Pan paniscus ENA files, lead to the 
retrieve of another 4766 bp sequence (AJFE01005652.1: Pan paniscus 
cntg5853, http://www.ebi.ac.uk/ena/data/view/AJFE01005652&range=2-1842), which is 97% similar 
over >3kb to the pan paniscus lymphocryptovirus 1 described by Ehlers et al. (2010) (and ~88% to 
EBV). It is very likely that most of the sequences of this bonobo herpesvirus (with the exception of the 
vIL-10) were removed from the bonobo genome assembly, because they were mistakenly seen as a 
contamination by EBV which was used in the cell-line transformation. 
References 
Ehlers, B., Spiess, K., Leendertz, F., Peeters, M., Boesch, C., Gatherer, D. & McGeoch, D. J. 
(2010). Lymphocryptovirus phylogeny and the origins of Epstein-Barr virus. J Gen Virol 91, 
630-642. 
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Objectives 
Cyprinid herpesvirus 3 is the etiological agent of an emerging and mortal disease in common 
(Cyprinus carpio carpio) and koi (Cyprinus carpio koi) carp. Since its emergence, in the late 1990s, 
this highly contagious and dreadful disease has caused severe economic losses in both common and 
koi carp culture industries worldwide. 
In addition to its economic importance, CyHV-3 has several qualities as a fundamental model 
of infection: (i) It is phylogenically distant from the vast majority of herpesviruses that have been 
studied so far. (ii) It can be studied in laboratories by infection of its natural host (homologous 
virus-host model). (iii) The sequence of its genome published in 2007 revealed a fascinating virus with 
unique properties in the Herpesvirales, such as an extremely large genome (295 Kb), a high number of 
genes which are not homologous to known viral sequences, and genes that are normally found 
exclusively in the Poxviridae. (iv) Interestingly, the sequencing of the CyHV-3 genome revealed 
several genes potentially encoding proteins involved in immune evasion mechanisms. Among these 
genes, ORF134 encodes an orthologue of carp Interleukin 10 (IL-10). 
IL-10 is a pleiotropic cytokine that has both immunostimulatory and immunosuppressive 
properties. However, its key features relate mainly to its capacity to exert potent immunosuppressive 
properties. Many viruses exploit the immunosuppressive properties of IL-10 to evade immune 
recognition either by up-regulation of cellular IL-10 or by expressing viral orthologues of cellular 
IL-10 called viral IL-10 (vIL-10). vIL-10s have been identified in several members of the Poxviridae 
family and the Herpesvirales order. The biological activities of various vIL-10s have been studied in 
vitro by using recombinant proteins and have demonstrated their broad immunosuppressive spectrum. 
Moreover, for few viruses (RhCMV and ORFV) encoding vIL-10s, it has been shown that deletion of 
the coding gene was associated with virus attenuation in vivo. 
In the present thesis, we took profit of the identification of a vIL-10 gene in the genome of 
CyHV-3 to study the roles of such a protein in the biology of the infection of an Alloherpesviridae 
family  member both in vitro and in vivo. 
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  Preamble 
For millions of years, viruses have been co-evolving with their hosts. During this co-evolution 
process, viruses have evolved elegant mechanisms to evade detection and destruction by the host 
immune system. One of the evasion strategies that have been adopted by large DNA viruses is to 
encode homologues of cytokines, chemokines and their receptors — molecules that have a crucial role 
in control of the immune response. 
Cellular Interleukine-10 (cIL-10) is a pleiotropic cytokine, with both immunostimulating and 
immunosuppressive properties; however, the key features of this cytokine relate mainly to its capacity 
to exert potent immunosuppressive functions through various mechanisms. Many viruses exploit the 
immunosuppressive properties of IL-10 to evade immune recognition either by up-regulation of host 
IL-10 or by expression of virally encoded IL-10 homologues. 
Virally encoded IL-10 homologues have been reported in several members of the Poxviridae 
family and the Herpesvirales order. Among the Herpesvirales order, vIL-10s have been described in 
members of the Herpesviridae (e.g. human cytomegalovirus [HCMV] and Epstein-Barr virus [EBV]) 
and more recently in the family Alloherpesviridae (Anguilid herpesvirus 1 [AngHV-1] and CyHV-3). 
While the role of vIL-10s has been demonstrated in the pathogenesis of only one member of family 
Poxviridae and Herpesviridae, respectively; this has not yet been investigated in the member of family 
Alloherpesviridae.  
In the present study, we investigated the roles of CyHV-3 ORF134 in the biology of the 
infection in vitro and in vivo. In vitro studies demonstrated that ORF134 is expressed as a spliced 
early-late gene and that its expression product is the second most abundant viral protein in the 
CyHV-3 secretome. Taking advantage of the recent BAC cloning of CyHV-3 as an infectious bacterial 
artificial chromosome (BAC), a strain deleted for ORF134 and a derived revertant strain were 
produced. Comparison of these strains demonstrated that ORF134 is essential neither for CyHV-3 
replication in vitro nor for virulence in vivo. 
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Abstract
Cyprinid herpesvirus 3 (CyHV-3), a member of the family Alloherpesviridae, is the causative agent of a lethal disease
in common and koi carp. CyHV-3 ORF134 encodes an interleukin-10 (IL-10) homologue. The present study was
devoted to this ORF. Transcriptomic analyses revealed that ORF134 is expressed as a spliced gene belonging to the
early-late class. Proteomic analyses of CyHV-3 infected cell supernatant demonstrated that the ORF134 expression
product is one of the most abundant proteins of the CyHV-3 secretome. To investigate the role of ORF134 in viral
replication in vitro and in virulence in vivo, a deleted strain and a derived revertant strain were produced using BAC
cloning technologies. The recombinant ORF134 deleted strain replicated in vitro comparably to the parental and
the revertant strains. Infection of fish by immersion in water containing the virus induced comparable CyHV-3
disease for the three virus genotypes tested (wild type, deleted and revertant). Quantification of viral DNA by real
time TaqMan PCR (in the gills and the kidney) and analysis of carp cytokine expression (in the spleen) by RT-qPCR
at different times post-infection did not revealed any significant difference between the groups of fish infected with
the three virus genotypes. Similarly, histological examination of the gills and the kidney of infected fish revealed no
significant differences between fish infected with ORF134 deleted virus versus fish infected with the control
parental or revertant strains. All together, the results of the present study demonstrate that the IL-10 homologue
encoded by CyHV-3 is essential neither for viral replication in vitro nor for virulence in common carp.
Introduction
Koi herpesvirus (KHV), also known as cyprinid herpes-
virus 3 (CyHV-3; species Cyprinid herpesvirus 3, genus
Cyprinivirus, family Alloherpesviridae, order Herpesvirales),
is the etiological agent of an emerging and mortal disease in
common (Cyprinus carpio carpio) and koi (Cyprinus carpio
koi) carp [1,2]. Since its emergence, in the late 1990s, this
highly contagious and dreadful disease has caused severe
economic losses in both common and koi carp culture
industries worldwide [3-5].
The genome of CyHV-3 comprises a linear double-
stranded DNA sequence of ~295 kbp [6], similar to that of
cyprinid herpesvirus 1 and 2 (CyHV-1 and CyHV-2) [7,8],
but larger than those of other members of the order
Herpesvirales which generally range from 125 to 240 kbp.
Phylogenetic analysis of the CyHV-3 genome sequence led
to its classification in the new family Alloherpesviridae
encompassing herpesviruses of fish and amphibians [9,10].
The CyHV-3 genome contains 155 potential protein-
coding open reading frames (ORFs), some of which have
relatives in other herpesviruses, and a few of which have
relatives in poxviruses, iridoviruses and other large DNA
viruses [6,8,11]. Interestingly, CyHV-3 genome encodes
proteins potentially involved in immune evasion mecha-
nisms such as, for example, TNF receptor homologues
(encoded by ORF4 and ORF12) and an IL-10 homologue
(encoded by ORF134) [6].
Cellular IL-10 has been described in a wide range of ver-
tebrate species, including fish [12,13]. It is a pleiotropic im-
munomodulatory cytokine with both immunostimulating
and immunosuppressive properties [14]; however, IL-10 is
generally described as an immunosuppressive cytokine. It
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inhibits expression of a large number of cytokines as, for
example, TNF-α, IFN-γ, IL-1β, IL-2, IL-3, IL-6, and MHC
class II [15-17]. Many viruses exploit the immunosuppres-
sive properties of IL-10 to evade immune recognition ei-
ther by up-regulation of host IL-10 or by expression of
virally encoded IL-10 homologues (vIL-10s) [14,18,19].
Virally encoded IL-10 homologues have been reported
in members of the Poxviridae family and the Herpesvirales
order [19-21]. Among the Herpesvirales order, vIL-10s
have been described in members of the Herpesviridae (e.g.
human cytomegalovirus [HCMV] and Epstein-Barr virus
[EBV]) and more recently in the family Alloherpesviridae
(Anguilid herpesvirus 1 [AngHV-1] and CyHV-3) [22].
While the role of vIL-10s has been demonstrated in the
pathogenesis of one Poxviridae and one Herpesviridae
[23-25]; this has not yet been investigated in the family
Alloherpesviridae. However, a very recent study suggested
that the IL-10 homologue encoded by CyHV-3 ORF134
could play a role in the pathogenesis. Firstly, it has been
demonstrated that this ORF is transcribed in infected fish
maintained at permissive and even restrictive temperature
[26]. Secondly, it has been shown that injection of CyHV-3
ORF134 mRNA into zebrafish embryos increased the
number of lysozyme-positive cells to a similar degree as
zebrafish IL-10 [26]; an effect that was inhibited by down
regulation of the IL-10 receptor long chain using a specific
morpholino [26].
The present study was devoted to CyHV-3 ORF134
encoding an IL-10 homologue. In vitro studies demon-
strated that ORF134 is expressed as a spliced early-late
gene and that its expression product is the second most
abundant viral protein in the CyHV-3 secretome. Taking
advantage of the recent BAC cloning of CyHV-3 as an
infectious bacterial artificial chromosome (BAC), a strain
deleted for ORF134 and a derived revertant strain were
produced. Comparison of these strains demonstrated
that ORF134 is essential neither for CyHV-3 replication
in vitro nor for virulence in common carp.
Materials and methods
Cells and viruses
Cyprinus carpio brain cells (CCB) were cultured in mini-
mum essential medium (MEM) (Invitrogen, Merelbeke,
Belgium) containing 4.5 g/L glucose (D-glucose mono-
hydrate; Merck, Darmstadt, Germany) and 10% fetal calf
serum (FCS). Cells were cultured at 25 °C in a humid at-
mosphere containing 5% CO2. The CyHV-3 FL strain
was isolated from the kidney of a fish that died from
CyHV-3 infection (CER, Marloie, Belgium) [27].
Determination of ORF134 kinetic class of transcription
These experiments were performed as described else-
where [28]. Briefly, monolayers of CCB cells in 24-well
plates were pre-incubated for 2 h before infection with
cycloheximide (CHX) (100 μg/mL) (Sigma-Aldrich, Saint
Louis, Missouri, USA) or phosphonoacetic acid (PAA)
(300 μg/mL) (Sigma-Aldrich), the inhibitors of de novo
protein synthesis or viral DNA polymerase, respectively.
After removal of the medium, cells were infected with
CyHV-3 FL strain at a multiplicity of infection (MOI) of
0.1 plaque forming unit (PFU) per cell in presence of in-
hibitors. After an incubation of 2 h, cells were overlaid
with fresh medium containing the inhibitors. At 6, 8 and
12 h after inoculation cells were harvested and treated
for RT-PCR analysis of gene expression (see below).
CyHV-3 ORF3 (immediate early [IE]), ORF55 (early [E])
and ORF78 (late [L]) were used as reference gene of the
three kinetic classes [29,30].
Transcriptional analysis by RT-PCR
Cytoplasmic RNA was isolated from cells using the
RNeasy Mini Kit (Qiagen, Venlo, Netherlands) with on
column DNase I digestion. cDNA was synthetized from
1 μg of RNA using iScript™ cDNA Synthesis Kit (Bio-
Rad, Nazareth Eke, Belgium). Finally, PCRs were
performed with the primers listed in Table 1 (see RT-
PCR column).
Production of concentrated cell supernatant
CCB cells were infected with CyHV-3 FL strain at a
MOI of 0.05 PFU per cell using serum free culture
medium. Cell supernatants were collected 72 h post-
inoculation and then submitted to two cycles of centrifu-
gation at 4 °C (clarification at 2000 g for 15 min followed
by pelleting of viral particles at 100 000 g for 2 h
through a 30% sucrose gradient). The supernatant was
then concentrated 25-fold by centrifugation (2000 g, 75
min, 4 °C) through an Amicon Ultra-15 centrifugal filter
unit (3K NMWL; Merck Millipore, Billerica Massachu-
setts, USA) and stored at −80 °C until use.
2D-LC MS/MS proteomic approach
Proteomic analyses were performed using 2D-LC MS/MS
workflow as described previously [31]. Briefly, proteins
were reduced at 4 °C for 1 h with 10 mM DTT and
alkylated by incubation with 25 mMiodoacetamide at 4 °C
for 1 h in the dark. Proteins were recovered through acet-
one precipitation and digested with trypsin at an enzyme:
substrate ratio of 1:50 in 50 mM NH4HCO3 overnight
at 37 °C. Tryptic peptides (25 μg) were analysed by
bidimensional (SCX-RP) chromatography and online MS/
MS, as described elsewhere [32], except that only 3 suc-
cessive salt plugs of 25, 100 and 800 mM NH4Cl were
used. Peptides were analyzed using the “peptide scan” op-
tion of an HCT ultra ion Trap (Bruker, Evere, Belgium),
consisting of a full-scan mass spectrometry (MS) and MS/
MS scan spectrum acquisitions in ultrascan mode (26 000
m/z sec-1). Peptide fragment mass spectra were acquired
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Table 1 Primers and probes.
Targeted gene Primer/probe name Sequence (5’- 3’) Accession n°/ reference
Primers for PCR and RT-PCR PCR RT-PCR
CyHV-3 ORF3 ORF3InF ● TATGCCCACATGATGCTGTT DQ657948
ORF3InR ● CAGTCAGACCCTTCCTCTGC
CyHV-3 ORF55 ORF55InF ● AGCGCTACACCGAAGAGTCC
ORF55stopR ● TCACAGGATAGATATGTTACAAG
ORF55ATGF ● ATGGCTATGCTGGAACTGG
ORF55InR ● GGCGCACCCAGTAGATTATG
CyHV-3 ORF78 ORF78InF ● TGGACGACGAACACCCTTC
ORF78InR ● GGTAGAGGGTACAACCACG
CyHV-3 ORF132 ORF132InF ● GGATCCGTTTTCTGGGTCTG
ORF132InR ● CTCAATCCCTCACCGACCTC
CyHV-3 ORF133 ORF133InF ● GACGAGATCCCTATCCGCAG
ORF133InR ● GACCTCGGGTATGGTCGGTA
CyHV-3 ORF134 ORF134stopF ● TCAATGTTTGCGCTTGGTTTTC
ORF134ATGR ● ATGTTCCTTGCAGTGCTAC
ORF134InF ● GGTTTCTCTTTGTAGTTTTCCG
ORF134InR ● CACCCCAACTTTTGAGACAAC
ORF134outseqF ● GTCAACATGGACGAGCGTGA
ORF134outseqR ● GTGGGGATATCAAACACGCA
CyHV-3 ORF135 ORF135InF ● ACACCACCAACGAGACATGC
ORF135InR ● CTTTTCGGACCAGAAGACCG
Carp β-actin Actin-F ● ATGTACGTTGCCATCCAGGC M24113
Actin-R ● GCACCTGAACCTCTCATTGC
Primers for amplification of recombination cassettes
H1-galK-H2 cassette 134 galK F ATGTTCCTTGCAGTGCTACTAACCG Warming et al. [34]
CGACCATCTTCTTCGAGGCTCGGGG
CCTGTTGACAATTAATCATCGGCA
134 galK R TCAATGTTTGCGCTTGGTTTTCATG
TTCTTGACGTCTTTTGCGACCAGGA
TCAGCACTGTCCTGCTCCTT
H1-ORF134-H2 H1F GCTCATCAATCGCAGCAGCA DQ657948
cassette
H2R CAAGCCATTATCCTGTTGGG
Primers and probes for real-time TaqMan PCR quantification of CyHV-3 genome
CyHV-3 ORF89 KHV-86F GACGCCGGAGACCTTGTG AF411803
KHV-163R CGGGTTCTTATTTTTGTCCTTGTT
KHV-109P (6FAM)CTTCCTCTGCTCGGCGAGCACG(BHQ1)
Carp glucokinase CgGluc-162F ACTGCGAGTGGAGACACATGAT AF053332
CgGluc-230R TCAGGTGTGGAGCGGACAT
CgGluc-185P (6FAM)AAGCCAGTGTCAAAATGCTGCCCACT(BHQ1)
Primers for RT-qPCR analysis of carp gene expression
40S 40S-F CCGTGGGTGACATCGTTACA AB012087
40S-R TCAGGACATTGAACCTCACTGTCT
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in data-dependent AutoMS (2) mode with a scan range of
100–2,800 m/z, three averages, and 5 precursor ions se-
lected from the MS scan 300–1500 m/z. Precursors were
actively excluded within a 0.5 min window, and all singly
charged ions were excluded. Peptide peaks were detected
and deconvoluted automatically using Data Analysis 2.4
software (Bruker). Mass lists in the form of Mascot Gen-
eric Files were created automatically and used as the input
for Mascot MS/MS Ions searches of the NCBInr database
release 20120809 using an in-house Mascot 2.2 server
(Matrix Science). The default search parameters used
were: Taxonomy = Bony vertebrates or Cyprinivirus; En-
zyme = Trypsin; Maximum missed cleavages = 1; Fixed
modifications = Carbamidomethyl (C); Variable modifica-
tions = Oxidation (M); Peptide tolerance ± 1.2 Dalton
(Da); MS/MS tolerance ± 0.6 Da; Peptide charge = 2+ and
3+; Instrument = ESI-TRAP. All data were also searched
against the NCBI bony vertebrate database in order to de-
tect host proteins. Only proteins identified with p value
lower than 0.05 were considered, and single peptide iden-
tifications were systematically evaluated manually. In
addition, the emPAI [33] was calculated to estimate pro-
tein relative abundance in the culture supernatant.
Production of CyHV-3 ORF134 recombinants
CyHV-3 recombinants were produced using prokaryotic
recombination technologies (Figure 1). The FL BAC plas-
mid was used as parental plasmid [27]. In this plasmid, the
BAC cassette is inserted in ORF55 encoding thymidine
kinase (TK). ORF134 recombinant plasmids were pro-
duced using two-steps galactokinase gene (galK) positive/
negative selection in bacteria as described previously [34].
The first recombination process (galK positive selection)
consisted to replace ORF134 by galK resulting in the FL
BAC ORF134 Del galK plasmid. Recombination was
achieved using the H1-galK-H2 recombination cassette
(Figure 1b) which consisted of the galK gene flanked by
50-bp sequences homologous to CyHV-3 genome regions
flanking ORF134 deletion (Figure 1a). H1-galK-H2 recom-
bination cassette was produced by PCR (primers 134 galK
F and 134 galK R) using the pgalK vector as template.
Primer 134 galK F consisted of nucleotides 229836–
229885 (50bp) of CyHV-3 genome and 1–24 (24bp) of the
pgalK vector. Primer 134 galK R consisted of nucleotides
229262–229311 (50bp) of the CyHV-3 genome and nucle-
otides 1212–1231 (20bp) of the pgalK vector (Table 1).
The 50-bp sequences of the H1-galK-H2 corresponding to
CyHV-3 genome were used to target homologous recom-
bination in bacteria. The second recombination process
(galK negative selection) consisted to remove the galK
gene (FL BAC ORF134 Del plasmid) or to replace the galK
gene by CyHV-3 wild type ORF134 sequence (FL BAC
ORF134 Rev plasmid) (Figure 1). The FL BAC ORF134
Del plasmid was obtained by recombination with the H1-
H2 cassette (Figure 1b). This cassette was synthesized and
consisted of 200 bp of CyHV-3 genome upstream and
downstream of ORF134 deletion, respectively. The FL
BAC ORF134 Rev plasmid was produced by recombination
with the H1-ORF134-H2 cassette. This cassette was pro-
duced by PCR (primers H1F and H2R) using CyHV-3 FL
DNA as template corresponding to nucleotides 229057–
229076 and nucleotides 230056–230075 of CyHV-3 gen-
ome, respectively. To reconstitute infectious virus encoding
a wild type TK locus (removal of the BAC cassette), the
BAC plasmids (FL BAC, FL BAC ORF134 Del and FL BAC
ORF134 Rev) were co-transfected with the pGEMT-TK
plasmid (molecular ratio, 1:75) into CCB cells [27]. Plaque
negative for enhanced green fluorescent protein (EGFP)
expression (the BAC cassette encodes an EGFP expression
cassette) were picked and amplified.
Southern blotting
Southern blot analysis of recombinant viruses was
performed as described previously [27,35]. PCRs were
Table 1 Primers and probes. (Continued)
IL-1β IL-1β-F AAGGAGGCCAGTGGCTCTGT AJ245635
IL-1β-R CCTGAAGAAGAGGAGGCTGTCA
TNF-α1 and 2 TNF-α1 and 2-F GCTGTCTGCTTCACGCTCAA AJ311800
TNF-α1 and 2-R CCTTGGAAGTGACATTTGCTTTT
CXCa CXCa-F CTGGGATTCCTGACCATTGGT AJ421443
CXCa-R GTTGGCTCTCTGTTTCAATGCA
IL-10 IL-10-F CGCCAGCATAAAGAACTCGT AB110780
IL-10-R TGCCAAATACTGCTCGATGT
IFNγ-2 IFNγ-2-F TCTTGAGGAACCTGAGCAGAA AM168523
IFNγ-2-R TGTGCAAGTCTTTCCTTTGTAG
IL-6 IL-6M17-F CACATTGCTGTGAGGGTGAA AY102633
IL-6M17-R GCATCCATAGGCTTTCTGCT
Underlined: 50bp corresponding to CyHV-3 sequence.
Ouyang et al. Veterinary Research 2013, 44:53 Page 4 of 18
http://www.veterinaryresearch.org/content/44/1/53
80
_________________________________________________________________________________________________Experimental section: Chapter 1
performed to produce ORF55 probe (primers ORF55InF
and ORF55stopR) and ORF134Del probe (primers
ORF134InF and ORF134InR) using the CyHV-3 FL gen-
ome as a template (Table 1).
Multi-step growth curves
Triplicate cultures of CCB cells were infected at a MOI
of 0.5 PFU per cell. After an incubation period of 2 h,
cells were washed with phosphate-buffered saline (PBS)
and then overlaid with Dulbecco’s modified essential
medium (DMEM, Invitrogen) containing 4.5 g of glu-
cose/liter and 10% FCS. Supernatant of infected cultures
was harvested at successive intervals after infection and
stored at −80 °C. The amount of infectious virus was de-
termined by plaque assay on CCB cells as described pre-
viously [35].
Fish
Common carp (Cyprinus carpio carpio) (CEFRA, University
of Liège, Belgium), were kept in 60-liter tanks at 24 °C.
Microbiological, parasitical and clinical examinations of the
fish just before the experiments demonstrated that these
fish were fully healthy.
CyHV-3 inoculation of carp
For viral inoculation mimicking natural infection, fish
were kept for 2 h in water containing CyHV-3. At the end
of the incubation period, fish were returned to larger
tanks. In some experiments, fish that survived the primary
infection were challenged 42 days after inoculation by co-
habitation with fish that were infected by immersion in
water containing 200 PFU/mL of the FL strain just before
their release into the tank to be challenged. Two freshly
infected fish were released per tank to be challenged. The
B
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Figure 1 Schematic representation of the strategy used to produce CyHV-3 FL BAC ORF134 recombinants. (A) The region of CyHV-3
genome encoding ORF134 is illustrated for wild type (WT), ORF134 Del galK and ORF134 Del genotypes. (B) Flow chart of stages performed to
produce FL BAC ORF134 recombinant plasmids and to reconstitute virus strains.
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animal study was accredited by the local ethics committee
of the University of Liège, Belgium (Laboratory accredit-
ation N°1610008, protocol N°810).
Quantification of virus genome copies in organs by real-
time TaqMan PCR
Virus genome quantitation was performed by real-time
TaqMan PCR as described elsewhere [36]. The primers
and the probes used are presented in Table 1. Two sets
of primers were used to amplify fragments of CyHV-3
ORF89 and carp glucokinase genes. The amplicons were
cloned into the pGEM-T Easy vector and the resulting
plasmids were used to generate standard curves by run-
ning reactions with 101 to 1010 plasmid molecules. DNA
was isolated using a DNA mini kit (Qiagen) from 25 mg
of organs stored at −80 °C in RNAlater® (Invitrogen).
The reaction mix contained 1 × iQSupermix (Bio-Rad),
200 nM of each primer, 400 nM of fluorescent probe
and 250 ng of DNA. The analyses were performed using
a C1000 Touch Thermal cycler (Bio-Rad). All real-time
TaqMan PCRs for CyHV-3 DNA were run with equal
amounts of DNA estimated by the real-time TaqMan
PCR performed on carp glucokinase gene.
Quantification of carp gene expression in spleen by RT-qPCR
Total RNA was isolated from spleens stored at −80 °C in
RNALater® (Ambion®, Invitrogen, Merelbeke, Belgium)
using TRI reagent® (Ambion®, Invitrogen), including DNase
I digestion and RNA purification using RNeasyMinElute
Cleanup Kit (Qiagen). cDNA was synthetized from 1 μg of
RNA using iScriptcDNA Synthesis Kit (Bio-Rad). The
primers used for RT-qPCR were described previously [37]
and are listed in Table 1. The RT-qPCR master-mix was
prepared as follows: 1 × IQ™ SYBR® Green Supermix (Bio-
Rad), 200 nM of each primer, 5 μL of 25 × diluted cDNA
and sterile water to a final volume of 25 μL. The amplifica-
tion program included an initial denaturation at 95 °C for
10 min, followed by 40 cycles with denaturation at 95 °C
for 15 s, annealing at 58 °C for 30 s and elongation at 72 °C
for 30 s. At the end, the dissociation stage was performed
(95 °C for for 10 s) and the melt curve was obtained by in-
creasing the temperature from 60 °C to 95 °C with a rate of
0.5 °C per 5 s. Fluorescence data from RT-qPCR experi-
ments were analyzed using the CFX96 real-time system
and exported to Microsoft Excel. The threshold cycle (Ct)
was determined using the Auto method for all runs. The
expression of analyzed genes was calculated using the
2-ΔΔCt method [38]. The 40S ribosomal protein S11 was
used as a reference gene.
Histological analysis
Organs from mock-infected or infected carp were fixed
in 4% buffered formalin and embedded in paraffin
blocks. Sections of 5 μm were stained with haematoxylin
and eosin prior to microscopic analysis [39].
Statistical analyses
Multi-step growth curves data expressed as mean titer ±
standard deviation (SD) were analyzed for significance of
differences (p< 0.05) using one-way ANOVA. The differ-
ences in mortality induced by the CyHV-3 strains tested
were analyzed using Kaplan and Meier survival analysis.
Significant differences (p< 0.05) in virus load between
fish infected with the different CyHV-3 strains at each
sampling point were assessed using one-way ANOVA
followed by Holm-Sidak test when data were normally
distributed, or with the non-parametric Kruskal–Wallis
test followed by Tukey test when they were not. Signifi-
cant differences (p< 0.05) in RT-qPCR gene expression
between CyHV-3 infected and mock-infected fish, as
well as between fish infected with different CyHV-3
strains at each sampling point were assessed using one-
way ANOVA followed by Holm-Sidak test in cases
where the data were normally distributed, or with the
non-parametric Kruskal–Wallis test followed by Dunn’s
test when they were not
Results
CyHV-3 ORF134 kinetic class of expression
Two independent studies have demonstrated that
CyHV-3 ORF134 is transcribed during viral replication
in vitro thereby meeting the criteria for being a gene
[26,29]. It has been predicted to contain an 84 bp intron
flanked by 2 exons encoding a 179 amino acid product
(GenBank accession number DQ657948). Here, we used
CHX and PAA to identify the transcriptional class of
ORF134 (Figure 2). This experiment revealed that
ORF134 expression is prevented by CHX and reduced
but not prevented by PAA treatments, suggesting that
ORF134 is an E-L gene. ORF3, ORF55 and ORF78 were
used as controls in this experiment; the results presented
in Figure 2 confirmed that they are IE, E and L genes,
respectively. The absence of contaminant viral DNA in
the mRNA preparations was confirmed by the absence
of a PCR product when the reverse transcriptase was
omitted from the reactions. Furthermore, the estimated
molecular size of the major ORF134 RT-PCR product
revealed that it was derived, from the amplification of
cDNA (540 bp) rather than from the viral genome (624
bp). This observation is consistent with the earlier de-
scription of the ORF134 as a spliced gene [40,41]. How-
ever, a minor product corresponding to the unspliced
transcript of ORF134 was also observed (see the faint
624 bp band in Figure 2). The classification of ORF134
as an E-L gene is consistent with the results published
recently by Ilouze et al. who concluded that ORF134 is
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an E gene [29]. It is also consistent with the E expression
reported for other vIL-10s [40,41].
CyHV-3 secretome
While two independent studies have previously shown
that ORF134 is transcribed during viral replication
[26,29], it is still to be determined whether ORF134 en-
codes a protein secreted from infected cells. To address
this question, concentrated supernatant was produced
from CyHV-3 infected CCB cultures and analyzed by
2D-LC MS/MS. Viral and cellular proteins identified by
this approach are listed in Table 2. This list was re-
stricted to proteins identified with p value lower than
0.05 as determined by the MASCOT program. Five viral
and 46 cellular proteins were detected. CyHV-3 ORF12
and ORF134 were amongst the most abundant proteins
in the sample as revealed by their relatively high emPAI
scores (1.49 and 1.02, respectively). Only two cellular
proteins had comparable scores (Beta-2-microglobulin
and FK506 binding protein 1A, with emPAI scores of
1.79 and 1.39, respectively). ORF12 encodes a soluble TNF
receptor superfamily homologue which, like ORF134, was
expected to be secreted from infected cells. Three unique
peptides covering 16% of the ORF134 sequence were se-
quenced (Figure 3a). These peptides were distributed
throughout ORF134 sequence (Figure 3b). The divergence
existing between CyHV-3 IL-10 and carp IL-10 excludes
the hypothesis that the peptides detected could be derived
from carp IL-10 rather than from CyHV-3 ORF134. In
addition to CyHV-3 ORF12 and ORF134, three additional
viral proteins (ORF52, ORF116 and ORF119) were
detected in the CyHV-3 secretome. All three proteins are
potential membrane proteins (Table 2). The presence
of these putative membrane proteins in the CyHV-3
secretome cannot be explained by remaining viral particles
in the prepared concentrated extracellular medium, as
none of these proteins is structural [31]. It is also unlikely
that the presence of these proteins reflects cell lysis
resulting from the viral infection. Indeed, in such a case, a
higher number of viral proteins would be expected, in
CyHV - 3 infected cells
CHX PAA Untreated
6 h 8 h 12 h 6 h 8 h 12 h 6 h 8 h 12 h
- actin
RT-PCR
PCR
378 bp
ORF3
RT-PCR
PCR
ORF55
RT-PCR
PCR
ORF78
RT-PCR
PCR
ORF134
RT-PCR
PCR
226 bp
527 bp
227 bp
624 bp
540 bp
PCR
Figure 2 Determination of ORF134 kinetic class of transcription. CCB cells were infected with CyHV-3 FL strain, in absence (Untreated) or
presence of CHX or PAA as described in Materials and methods. At the indicated time post-infection, expression of IE ORF3, E ORF55, L ORF78,
ORF134 and carp β-actin was studied by a RT-PCR approach. On the left RT-PCR or PCR represent PCR products generated when the RT was
performed or omitted from the reactions, respectively. On the right, control PCR reactions were performed using genomic DNA as template
(Ctrl+) or no template (Ctrl-).
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Table 2 CyHV-3 and host proteins identified by 2D-LC MS/MS in the supernatant of CyHV-3 infected CCB cells.
Database Accession
number
Description Predicted MW
(kDa)
Mascot
score
No. of matching
spectra
emPAI
CyHV-3 proteins
Cyprinivirus gi|129560530 ORF12, TNF receptor superfamily homologue 19.2 671 14 1.49
gi|129560652 ORF134, Interleukin 10 homologue 14.8 304 6 1.02
gi|84181525 ORF116, predicted membrane glycoprotein 30.4 185 4 0.26
gi|84181523 ORF119, putative uncharacterized protein containing an
hydrophobic region
15.5 94 2 0.25
gi|129560569 ORF52, predicted membrane glycoprotein 39.2 44 1 0.10
Host proteins (species origin)
Bony
vertebrates
gi|122891218 Novel protein (zgc:103659) (Danio rerio) 51.7 410 13 0.42
gi|136429 Trypsin (Sus scrofa) 25.1 281 9 0.53
gi|297262447 Predicted keratin, type II cytoskeletal 1-like isoform 6
(Macaca mulatta)
65.3 268 3 0.12
gi|37590349 Enolase 1, alpha (D. rerio) 47.4 255 8 0.35
gi|326670662 Predicted collagen alpha-3(VI) chain-like (D. rerio) 11.3 227 8 0.17
gi|51949771 Fibronectin 1b (D. rerio) 279.3 213 8 0.08
gi|52218922 Pigment epithelium-derived factor precursor (D. rerio) 45.0 158 3 0.17
gi|416696 Beta-2-microglobulin (Cyprinus carpio) 13.5 152 8 1.79
gi|1351907 Serum albumin (Bos taurus) 71.2 149 11 0.36
gi|395744345 Predicted keratin, type II cytoskeletal 1 (Pongo abelii) 25.8 139 3 0.15
gi|229552 Albumin (B. taurus) 68.1 136 10 0.38
gi|63102189 Pgd protein (D. rerio) 53.7 134 4 0.14
gi|15718387 Gelatinase (Paralichthys olivaceus) 75.5 125 5 0.15
gi|1703244 Fructose-bisphosphate aldolase C (Carassius auratus) 39.8 124 4 0.20
gi|169154447 Fibronectin 1 (D. rerio) 275.6 117 5 0.05
gi|15149946 Procollagen type I alpha 1 chain (D. rerio) 49.4 117 5 0.34
gi|148726027 Cadherin 11, osteoblast (D. rerio) 88.9 112 5 0.13
gi|4885063 Fructose-bisphosphate aldolase C (Homo sapiens) 39.8 107 2 0.20
gi|28336 Mutant beta-actin (beta'-actin) (H. sapiens) 42.1 105 2 0.09
gi|28317 Unnamed protein product (H. sapiens) 59.7 104 3 0.13
gi|337758 Pre-serum amyloid P component (H. sapiens) 25.5 100 3 0.32
gi|223582 Histone H4 (H. sapiens) 11.2 99 5 0.84
gi|47971186 Carp C1q-like molecule (C. carpio) 20.3 98 2 0.19
gi|223061 Ubiquitin (Salmo sp.) 8.5 92 4 0.31
gi|27806751 Alpha-2-HS-glycoprotein precursor (B. taurus) 39.2 90 4 0.32
gi|47086029 Myristoylated alanine-rich C kinase substrate 2 (D. rerio) 21.0 86 2 0.18
gi|2133885 N-cadherin precursor (D. rerio) 87.4 80 3 0.09
gi|18859555 Wnt inhibitory factor 1 precursor (D. rerio) 43.2 79 3 0.09
gi|34595971 Prion-like protein 1 (C. carpio) 55.6 75 2 0.14
gi|208609649 Collagen type I alpha 3 (C. auratus) 137.7 75 1 0.03
gi|47085905 14-3-3 protein beta/alpha-B (D. rerio) 27.5 75 3 0.47
gi|6644111 Nucleoside diphosphate kinase-Z1 (D. rerio) 17.4 72 2 0.22
gi|16974825 Chain A, Solution Structure Of Calcium-Calmodulin N-
Terminal Domain (H. sapiens)
8.5 70 2 0.49
gi|41152406 FK506 binding protein 1A, 12kDa (D. rerio) 11.8 69 3 1.39
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particular the most abundant ones [31]. Several viral pro-
teins are expressed as two different forms, a membrane-
anchored form and a secreted form, the latter generated
by proteolytic cleavage of the former [42,43]. Further
experiments are required to determine whether this
phenomenon applies to the putative CyHV-3 membrane
proteins detected in the secretome.
The MS data presented above demonstrate that
CyHV-3 ORF134 encodes a protein that is abundantly
secreted in the extracellular medium by infected cells.
This observation is consistent with the hypothesis that
ORF134 may be a functional IL-10 homologue playing a
role in CyHV-3 pathogenesis [26].
Production and characterization of CyHV-3 ORF134
recombinant strains
In order to investigate subsequently the importance of
ORF134 in virus replication in vitro and pathogenesis
Table 2 CyHV-3 and host proteins identified by 2D-LC MS/MS in the supernatant of CyHV-3 infected CCB cells.
(Continued)
gi|189527793 Predicted neuroblast differentiation-associated protein
AHNAK (D. rerio)
642.1 65 2 0.01
gi|37492 Alpha-tubulin (H. sapiens) 50.8 65 2 0.07
gi|33989505 Tissue inhibitor of metalloproteinase 2b (D. rerio) 24.7 64 2 0.15
gi|8176557 Heart fatty acid binding protein (Anguilla japonica) 15.3 61 1 0.26
gi|37181 Tissue inhibitor of metalloproteinases,
Type-2 (H. sapiens)
21.4 59 2 0.18
gi|437972 Fibrillin-2 (H. sapiens) 334.8 59 1 0.01
gi|37367051 Osteopontin (D. rerio) 23.2 53 1 0.16
gi|45544646 Cold inducible RNA binding protein isoform 2 (D. rerio) 19.2 52 2 0.20
gi|51328294 Fstl1b protein (D. rerio) 39.6 50 1 0.09
gi|82245450 Triosephosphate isomerase B (D. rerio) 27.1 50 1 0.14
gi|34014734 Clusterin (D. rerio) 52.5 50 1 0.07
gi|47228578 Unnamed protein product (Tetraodon nigroviridis) 77.5 49 1 0.05
A
B
Accession 
number
Description Sequence
coverage
Peptide
sequence
Peptide
mascot score
GI 129560652 CyHV-3 ORF134 16%
SEVDEIGDNLSR 80
KSEVDEIGDNLSR 52
DSCVYLIGQTPQLLR 50
CyHV-3 ORF134
Cyprinus carpio IL-10
CyHV-3 ORF134
Cyprinus carpio IL-10
CyHV-3 ORF134
Cyprinus carpio IL-10
CyHV-3 ORF134
Cyprinus carpio IL-10
Figure 3 Identification of CyHV-3 ORF134 by 2D-LC MS/MS in the supernatant of CyHV-3 infected CCB cells. (A) Data collected on
ORF134 through 2D-LC MS/MS analysis of cell culture supernatant. (B) Sequential alignment of CyHV-3 ORF134 and Cyprinus carpio IL-10.
Sequence coverage: detected peptides are presented in rectangles.
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Figure 4 Structural analysis of the FL BAC ORF134 recombinant plasmids and derived CyHV-3 recombinant strains. The CyHV-3 FL BAC,
FL BAC ORF134 Del and FL BAC ORF134 Rev plasmids and the genome of the FL BAC revertant, FL BAC revertant ORF134 Del and FL BAC
revertant ORF134 Rev strains were analyzed by SacI restriction (left panel) and further tested by southern blotting using probes corresponding to
ORF55 (central panel) and ORF134 (right panel). White-outlined black arrowheads and white arrows indicate restriction fragments containing
ORF55 and ORF134 loci, respectively. Marker sizes (MS) are indicated on the left.
ORF134
1255bp
731bp
kb MS
1
1.5
0.8
0.6
2
FL BAC
Figure 5 PCR analysis of the FL BAC ORF134 recombinant plasmids and derived CyHV-3 recombinant strains. The CyHV-3 FL BAC, FL BAC
ORF134 Del and FL BAC ORF134 Rev plasmids and the genome of the FL BAC revertant, FL BAC revertant ORF134 Del and FL BAC revertant
ORF134 Rev strains were analyzed by PCR using the forward primer ORF134outseqF and the reverse primer ORF134outseqR (Table 1). MS are
indicated on the left.
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in vivo, a CyHV-3 strain deleted for ORF134 (FL BAC
revertant ORF134 Del strain) and a revertant strain (FL
BAC revertant ORF134 Rev strain) were produced using
BAC cloning and prokaryotic recombination technolo-
gies as described in the Materials and methods (Figure 1).
The FL BAC plasmid was used as parental plasmid. A
wild type strain (FL BAC revertant strain) was also
reconstituted from the FL BAC plasmid. The molecular
structures of the recombinant strains produced were
confirmed by a combined SacI restriction endonuclease
and Southern blot approach targeting both ORF55 (the
BAC cassette is inserted into the ORF55 locus) and
ORF134 loci (Figure 4). In the three reconstituted
strains, the ORF55 probe led to a single band
corresponding to a 5.2 kb restriction fragment, demon-
strating the reversion of ORF55 to wild type sequence
(removal of the BAC cassette) [27]. In the FL BAC re-
vertant and the FL BAC revertant ORF134 Rev, the
ORF134Del probe led to a single band corresponding to
a 6.3 kb restriction fragment consistent with the se-
quence of this region (6333kb). The absence of signal for
the FL BAC revertant ORF134 Del demonstrated the de-
letion of ORF134. The molecular structure of the
recombinants and the absence of contamination between
strains was also controlled by PCR (Figure 5) and sequen-
cing of the regions used to target recombination (data not
shown). All approaches confirmed that the resulting
recombinants have the correct molecular structure. Fi-
nally, using a RT-PCR approach, we controlled the process
so that the deletion did not markedly affect the transcrip-
tion of the ORFs located upstream and downstream of
ORF134: ORF132, ORF133 and ORF135 (Figures 1a and 6).
In these experiments, transcription of ORF55 was used as
reference. For the three recombinants tested, transcripts of
602 bp, 264 bp, 238 bp and 293 bp were observed in
infected cells for ORF55, ORF132, ORF133 and ORF135,
respectively. No transcript was detected in mock-infected
cells. When RT was omitted from the reactions, the prod-
uct seen in infected cells was not detected, indicating that
this product did not result from amplification of contami-
nant viral DNA. The three strains tested led to comparable
signals for the four ORFs. Transcription analysis of ORF134
revealed that the FL BAC revertant and the FL BAC rever-
tant ORF134 Rev expressed this ORF comparably, while no
signal was detected for the FL BAC revertant ORF134 Del.
Together, the results presented above demonstrate that the
recombinants produced have the correct molecular struc-
ture and that the deletion of ORF134 has no marked polar
effect on neighbor genes.
PCR
378 bp
624 bp
540 bp
602 bp
238 bp
293 bp
264 bp
RT-PCR
ORF55
PCR
RT-PCR
ORF132
PCR
RT-PCR
ORF133
PCR
RT-PCR
ORF134
PCR
RT-PCR
ORF135
PCR
RT-PCR
-actin
PCR
Figure 6 Transcriptional analysis of CyHV-3 ORF134 genome
region. CCB cells were infected with the indicated recombinant
strains at a MOI of 0.5 PFU/cell. Twenty-four hours post-infection,
expression of CyHV-3 ORF55, ORF132, ORF133, ORF134, ORF135 and
carp β-actin was studied by the RT-PCR approach described in the
Materials and methods. On the left RT-PCR or PCR represent PCR
products generated when the RT was performed or omitted from
the reactions, respectively. On the right, control PCR reactions were
performed using genomic DNA as template (Ctrl+) or no
template (Ctrl-).
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Figure 7 Effect of ORF134 deletion on viral growth in vitro.
Replication kinetics of CyHV-3 ORF134 recombinant strains were
compared with those of the FL BAC revertant strain using a multi-
step growth assay (see Materials and methods). The data presented
are the means ± standard errors of triplicate measurements.
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Effect of ORF134 deletion on viral growth in vitro
In order to investigate the putative effects of the recom-
bination processes on viral growth in vitro, the FL BAC
revertant, the FL BAC revertant ORF134 Del and the FL
BAC revertant ORF134 Rev were compared using a
multi-step growth assay (Figure 7). All viruses tested
exhibited similar growth curves (P ≤ 0.05), leading to the
conclusion that ORF134 deletion does not affect viral
growth in vitro (Figure 7). This observation is consistent
with what has been reported for other vIL-10s [23,25].
Taken together, these results indicate that ORF134 is not
essential for CyHV-3 replication in vitro and suggest
that ORF134 exerts its biological functions in vivo.
Effect of ORF134 deletion on CyHV-3 pathogenesis
To investigate the importance of ORF134 in the patho-
genesis of CyHV-3 disease, naïve common carp were in-
oculated by immersion in water containing the FL BAC
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Figure 8 Cumulative survival rates of common carp infected with CyHV-3 recombinant strains. On day 0, common carp (n = 30 fish per
tank), with an average weight of 3.8 g ± 1.5 g (mean ± SD), were mock-inoculated (2 tanks, panel D) or inoculated (panels A-C) by immersion for
2 h in water containing 4 PFU/mL, 40 PFU/mL or 400 PFU/mL of the indicated CyHV-3 strains. On day 42 post-infection (arrow), surviving fish
were challenged by addition of two fish infected with the parental FL strain. Percentages of surviving carp are expressed according to
days post-infection.
FL BAC revertant
1 2 31 2 3 1 2 3 1 2 3
ORF55 
ORF134 424 bp
527 bp
FL BAC revertant
ORF134 Del
FL BAC revertant
ORF134 Rev Mock-infected
Figure 9 PCR detection and characterization of CyHV-3 genomes recovered from infected carp. The analyses reported in this figure are
the follow-up of the experiment described in Figure 8. Three mock-infected carp (selected randomly before the challenge) and three dead carp
from each of the groups infected with the FL BAC Revertant, FL BAC Revertant ORF134 Del and FL BAC Revertant ORF134 Rev strains were
dissected. DNA was extracted from the kidney. PCRs were performed with the ORF55InF/ORF55stopR and ORF134InF/ORF134InR pairs of primers
(Table 1). FL strain DNA and distilled water were used as positive (Ctrl+) and negative (Ctrl-) controls, respectively.
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revertant, FL BAC revertant ORF134 Del or FL BAC re-
vertant ORF134 Rev strains (Figure 8). The three strains
induced at comparable levels all the clinical signs associ-
ated with the disease, including apathy, folding of the
dorsal fin, hyperemia, increased mucus secretions, skin
lesions, suffocation, erratic swimming, and the loss of
equilibrium. The mortality rate and the kinetics of mor-
tality observed for the three strains were not significantly
different. At necropsy, similar lesions were observed for
the three strains including the discoloration of gill fila-
ments, herpetic skin lesions, and necrotic nephritis. To
control that the infection of all groups of fish was
performed with the correct viral strain and to exclude
any possibility of wild type virus spread among tanks,
PCR assays were performed on three randomly selected
dead fish from each infected group and three mock-
infected fish randomly selected (Figure 9). The PCR
results confirmed that each tank was infected with the
correct strain and demonstrated the absence of viral
spread between tanks. Next, to determine whether the
ORF134 deletion affects the adaptive immune response
developed by fish that survived primary infection; sur-
viving fish were challenged by co-habitation with fish
inoculated with the wild type FL strain (Figure 8). Inde-
pendently of the viral strain used for the primary infec-
tion, none of the challenged fish developed CyHV-3
disease (Figure 8). In contrast, CyHV-3 disease devel-
oped in the two tanks that were initially mock-infected.
Taken together, the results presented above suggest that
ORF134 deletion does not affect CyHV-3 pathogenicity
in common carp and the protective immune response
developed by surviving fish.
To further test these hypotheses, we investigated the
effect of ORF134 deletion on viral load (Figure 10) and
on cytokine expression (Figure 11) during CyHV-3 dis-
ease. Naïve common carp were inoculated by immersion
in water containing the FL BAC revertant, FL BAC re-
vertant ORF134 Del or FL BAC revertant ORF134 Rev
strains (Figure 10). At different times after inoculation
gill, kidney and spleen were collected from randomly se-
lected fish. Viral loads were analyzed in gill and kidney
by real-time TaqMan PCR (Figure 10) while cytokine ex-
pression was studied in spleen by RT-qPCR (Figure 11).
Real-time TaqMan PCR results demonstrated that fish
infected with the three viral strains had statistically com-
parable viral loads in the gills and the kidney throughout
the course of the experiment (Figure 10). Using the
approach described in Figure 9, PCR reactions were
performed on randomly selected fish demonstrated that
each tank was infected with the correct strain and con-
firmed the absence of viral spread between tanks (data
not shown). Together, these results suggested that
ORF134 deletion has no effect on viral load during pri-
mary acute infection.
The spleen is one of the organs in which CyHV-3 is the
most abundant during the course of acute infection [36]. It
is also considered as one of the major lymphoid organ in
teleost [44]. In order to study the effect of CyHV-3
ORF134 on the carp immune response, the kinetics of gene
expression of the cytokines IFN-γ2, TNFα1, TNFα2, IL-1β,
IL-6, CXCa and IL-10 were analyzed in spleen from fish
infected with FL BAC revertant, FL BAC revertant
ORF134 deleted and FL BAC revertant ORF134 Rev strains
(Figure 11). Samples were collected over a period of 2 to 8
days post-infection and analyzed by RT-qPCR. The kinetics
of expression of studied cytokines showed similar patterns
to those observed previously [37]. Taking mock-infected
fish as a reference, expression of several cytokines (IFN-γ2,
IL-1β, IL-6, and IL-10) was up-regulated as early as day 3
post-infection. The most pronounced up-regulation was
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Figure 10 Viral load in gill and kidney. Common carp (n = 36 fish
per tank), with an average weight of 10.7 g ± 3.2 g (mean ± SD),
were inoculated by immersion for 2 h in water containing 100 PFU/
mL of the indicated CyHV-3 strains. At different times post-
inoculation, six infected fish were randomly selected per tank,
euthanized and dissected. Six mock-infected fish were used as
negative controls. Gill, kidney and spleen were harvested and stored
in RNAlaterW at −80 °C. DNA was extracted from gill (panel A) and
kidney (panel B) and analyzed by real-time TaqMan PCR for
quantification of viral genome copies. The results are expressed as
the means ± SD of the data observed for the 6 fish analyzed per
time point. Spleen were treated for quantification of carp gene
expression by RT-qPCR (see Figure 11).
Ouyang et al. Veterinary Research 2013, 44:53 Page 13 of 18
http://www.veterinaryresearch.org/content/44/1/53
89
_________________________________________________________________________________________________Experimental section: Chapter 1
observed for IL-1β and IFN-γ2. We observed a moderate
and late (day 6 and day 8 post-infection) up-regulation of
TNFα1 and TNFα2. The expression level of CXCa in
infected fish was comparable to mock-infected fish or even
down-regulated for some strains at some time points. Im-
portantly, the results presented in Figure 11 demonstrate
that there is almost no difference in the expression levels
of the cytokines studied between carp infected with three
virus strains. The only significant differences observed be-
tween virus strains were for IFN-γ2 at day 4 post-
inoculation and for IL-6 at day 8 post-inoculation. The
expression level of IFN-γ2 at day 4 post-inoculation was
significantly higher in fish infected with FL BAC revertant
ORF134 deleted as compared to FL BAC revertant and
FL BAC revertant ORF134 Rev strains. However, this
difference was rather small and was not observed for the
other sampling points, suggesting that it could reflect data
variation rather than the expression of ORF134 biological
activities. Supporting the latter hypothesis, the expression
level of IL-6 at day 8 post-inoculation was significantly
higher in the FL BAC revertant group as compared to the
FL BAC revertant ORF134 Rev group. The absence of
cross-contamination between tanks was controlled using
the approach described in Figure 9 (data not shown).
Together, these results suggested that ORF134 does not
significantly affect the carp immune response under the
experimental conditions used.
Finally, to investigate further the effect of ORF134 in
CyHV-3 pathogenesis, the lesions induced by the FL
BAC revertant, FL BAC revertant ORF134 Del and FL
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Figure 11 RT-qPCR analysis of cytokines. Kinetics of gene expression was measured in the spleen of mock-infected fish and fish infected with
CyHV-3 ORF134 recombinants (see legend of Figure 10). Gene expression was normalized relative to the expression of the S11 protein of the 40S
ribosomal subunit. Data are presented as mean ± SD (n = 6). Symbol (*) indicates statistical differences (p ≤ 0.05) observed between infected and
mock-infected fish. Symbol (a) indicates statistical differences (p ≤ 0.05) observed for a specific time point between groups of fish infected with
different CyHV-3 recombinants.
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BAC revertant ORF134 Rev strains were compared in
the gills and the kidney at various time points after in-
fection (Figures 12 and 13). Histopathological prepara-
tions were grouped according to the virus genotype used
for the infection and the time point of sampling. The
groups of slides were observed by two independent ex-
aminers using a double-blind test. The principal histo-
pathological changes were observed in gill filaments.
Gills from mock-infected fish exhibited a normal struc-
ture. However, a weak lymphocytic hyperplasia was ob-
served for the three mock-infected fish at the basis of the
secondary lamellae, leading to their fusion. Few eosino-
philic granulocytes were also observed along the primary
lamella. As early as 2 days post-infection, both examiners
were able to discriminate the three groups of infected fish
from the mock-infected group. For all three infected
groups, we observed congestion of the secondary lamellae,
infiltration of lymphocytes and histiocytes at the basis of
secondary lamellae further increasing their fusion. With
the exception of one fish from the FL BAC revertant
ORF134 Del group that exhibited weaker histopathological
changes (see Figure 12, Day 2), the two other fish from
this group expressed changes comparable to those ob-
served in the two other infected groups. The absence of
differences between the three viral groups was confirmed
at the latter time points. At day 4 post-infection, all fish
expressed comparable increased lymphocytic and
histocytic infiltrate at the basis of the secondary lamellae.
In some fish, an increase of eosinophilic granulocytes was
observed (FL BAC revertant: 2 out of 3 fish; FL BAC re-
vertant ORF134 Del: 2 out of 3 fish and FL BAC revertant
ORF134 Rev strains 1 out of 3 fish). In comparison to day
2 post-infection, the infiltrate was more pronounced and
the congestion was associated with edema of the second-
ary lamellae. The intensity of the lesions increased com-
parably in all three groups at latter time-points (Day 6 and
Day 8). The infiltrate mainly lymphocytic induced the fu-
sion of the lamellae on approximately 2/3 of their length.
The respiratory epithelium exhibited hyperplasia and ne-
crosis, associated in few cells with intranuclear inclusion
Mock-
infected
Day 2
FL BAC 
revertant
FL BAC 
revertant
ORF134 Del
FL BAC 
revertant
ORF134 Rev
Day 4 Day 6 Day 8
Figure 12 Histopathological characterization of the lesions induced by CyHV-3 ORF134 recombinants in the gills. Common carp (n = 20
fish per tank), with an average weight of 6 g ± 1.6 g (mean ± SD), were inoculated by immersion for 2 h in water containing 40 PFU/mL of the
FL BAC revertant, FL BAC revertant ORF134 Del or FL BAC revertant ORF134 Rev strains. At different times post-inoculation (2, 4, 6 and 8 days),
three infected fish were randomly selected per tank, euthanized and dissected. Three mock-infected fish were used as negative controls. Gills
(present figure) and kidney (see Figure 13) were collected and processed for histological examination. Slides corresponding to each sampling
point were grouped according to the viral strain used for the inoculation and were submitted to histopathological examinations by two
independent examiners using a double-blind test mode. The images in this figure are representative of the analysis of one selected fish per
group. Bar, 30 μm.
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bodies. Compared to day 6 post-infection, the infiltrate ob-
served on day 8 was slightly reduced while the edema and
the necrosis were increased. The lesions induced by the
three recombinant strains were also compared in the kid-
ney (Figure 13). The lesions observed in this organ were
less obvious than in the gills. On day 2 post-infection,
infected groups could not be differentiated from the
mock-infected one. The diversity and the abundance of
hematopoietic cells were normal. However, a slight in-
crease of eosinophilic cells was observed in nearly all
groups. Vacuolization of the epithelium was observed in
all preparations, and was considered to be a preparation
artifact. Starting on day 4 post-infection, both examiners
were able to discriminate the three infected groups from
the mock-infected one. However, they could not differenti-
ate the three infected groups. Comparable proliferation of
the hematopoietic cells, mainly lymphocytic and eosino-
philic, was observed in all infected groups. The prolifera-
tion increased further on day 6 and 8. Intranuclear
inclusion bodies were observed in a few hematopoietic
cells on days 6 and 8, and in few epithelial cells on day 8.
The absence of cross-contamination between tanks was
controlled using the approach described in Figure 9 (data
not shown).
Discussion
The present study was devoted to CyHV-3 ORF134,
which encodes a potential vIL-10. We confirmed that
ORF134 is transcribed as a spliced E-L gene (Figure 2).
We also demonstrated for the first time that it is one of
the most abundant proteins of the CyHV-3 secretome
(Table 1) and that ORF134 is essential neither for viral
replication in vitro nor for virulence in vivo. The latter
conclusion relied on the observations that an ORF134
deleted strain could not be differentiated from its paren-
tal and revertant strains based on induced clinical signs
and mortality rate (Figure 8), kinetic of viral load in gills
and kidney (Figure 10), kinetic of cytokine expression in
the spleen (Figure 11) and histological examination of
gill and kidney (Figure 12).
As described in the introduction, cellular IL-10 is a
pleiotropic immunomodulatory cytokine with both
immunostimulatory and immunosuppressive properties
[14]. Virally encoded IL-10 homologues have been
reported in several members of the Poxviridae family
and the Herpesvirales order [19-21]. Numerous molecu-
lar and in vitro studies suggest that there has been adap-
tive evolution of viral IL-10 following capture through
positive selection to retain properties most beneficial for
Mock-
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revertant
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revertant
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Figure 13 Histopathological characterization of the lesions induced by CyHV-3 ORF134 recombinants in the kidney. The fish infection
methods are described in the legend of Figure 12.
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the virus life cycle. However, very few studies have
addressed the role of viral IL-10 in vivo by comparison
of a wild type strain and derived deleted and revertant
strains. This approach, which is the only one that can
test the in vivo biological relevance of a gene, has been
performed for only two viruses: rhesus cytomegalovirus
(rhesus CMV) and Orf virus (ORFV) [23-25]. For both
viruses, deletion of viral IL-10 induced virus attenuation
and modulation of the host anti-viral innate immune
response.
The results of the present study demonstrate that the
IL-10 homologue encoded by CyHV-3 does not affect
significantly its virulence in common carp (Figure 8) or
the host innate immune response (Figure 11). However,
a recent study based on an in vivo artificial model sug-
gested that CyHV-3 ORF134 encodes a functional vIL-10
[26]. As IL-10 is known to induce a transient neutrophilia
and monocytosis in addition to T cell suppression [45],
these authors tested the in vivo functionality of CyHV-3
encoded IL-10 by injection of zebrafish embryos with
mRNA encoding CyHV-3 ORF134 and analysis by whole-
mount in situ hybridization (using a pan-leukocyte marker
lysozyme at 56 hours post-fertilization before development
of T cells). A slight but statistically significant increase in
the number of lysozyme positive cells was observed in em-
bryos injected with CyHV-3 ORF134 mRNA compared to
control embryos. The effect observed was inhibited by
down regulation of the IL-10 receptor long chain by a spe-
cific morpholino. These data suggested that CyHV-3
ORF134 encodes a functional vIL-10. Importantly, the
ORF134 sequence used in this study is identical to the se-
quence encoded by the CyHV-3 strain used in the present
study. Various hypotheses could explain the apparent
paradox between the functional effect reported by Sunarto
et al. and the lack of effect of deleting ORF134 described
in the present study [26].
Firstly, it is possible that the slight effect observed by
Sunarto et al. using optimal artificial conditions (over-
expression of ORF134, no inflammatory stimulation by
the viral infection, a rather immature host immune sys-
tem) has no significant biological relevance during a real
viral infection of carp. Secondly, it is possible that the role
of ORF134 is strictly restricted to latency and viral reacti-
vation. This hypothesis is inconsistent with the higher
level of ORF134 expression observed during acute infec-
tion compared to those observed during latency and re-
activation [26]. However, experiments are in progress to
determine whether ORF134 deletion affects viral load dur-
ing latency and/or the ability of the virus to reactivate and
to be excreted. Thirdly, it may be that ORF134 expression
product has a biological activity in zebrafish but not in
common carp. This hypothesis is related to the still un-
known origin of CyHV-3. Indeed, the rapid emergence of
CyHV-3 in the common and koi carp population during
the late 90s and the relatively low polymorphism existing
between CyHV-3 isolates suggest that CyHV-3 is the con-
sequence from a recent host-jump from a yet unidentified
fish species to common and koi carp. According to this
evolutionary scenario, it could be that ORF134 is func-
tional in the CyHV-3 original host species and closely re-
lated species but not in the recently colonized common
and koi carp species.
In conclusion, the present study addressed for the first
time the in vivo role of a vIL-10 encoded by a member
of the family Alloherpesviridae. It demonstrates that
CyHV-3 ORF134 does not contribute significantly to
viral growth in vitro or to virulence in vivo under the
conditions tested. However, it is possible that this pro-
tein is important under circumstances that were not re-
capitulated in the present laboratory setting.
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Preamble 
Koi herpesvirus (KHV), also known as cyprinid herpesvirus 3 (CyHV-3), is the etiological 
agent of an emerging and mortal disease in common (Cyprinus carpio carpio) and koi (Cyprinus 
carpio koi) carp. Since its emergence, in the late 1990s, this highly contagious and dreadful disease 
has caused severe economic losses in both common and koi carp culture industries worldwide [1]. 
The induction of herd immunity in fish farming is associated with key constraints. First, 
protective immunity should be induced early in life, i.e. as soon as the immune system is fully matured. 
The importance of inducing protective immunity as soon as possible in life is justified by the higher 
sensitivity of young fish to most diseases, by the aquaculture management (it is easier to vaccinate fish 
before they are distributed into nets or ponds) and by obvious economic reasons (in case of outbreak, 
the larger are the fish, the higher is the economic loss). Second, as a direct consequence of the former 
point, fish to be vaccinated are of a limited size (few centimetres) incompatible with handling and 
injection procedures. Finally, there is a strong constraint on the vaccine price that must be compatible 
with a positive “benefit – cost” balance. 
Attenuated vaccines appear to be the most appropriate for mass vaccination of carp. 
Attenuated anti-CyHV-3 vaccine candidates have been produced by serial passages in cell culture of a 
pathogenic strain. A vaccine strain candidate was further attenuated by UV irradiation in order to 
increase random mutations throughout the genome [2]. Currently, an attenuated vaccine developed 
using this approach has been manufactured by KoVax Ltd. (Jerusalem, Israel) [3]. This vaccine was 
available temporarily for immersion vaccination of common and koi carp weighing 100 g or more in 
USA (Novartis) [4]. However, after just a year, Novartis decided to stop the sale of this vaccine. This 
vaccine has two major disadvantages: (i) the determinism of the attenuation is unknown; and 
consequently, reversions to a pathogenic phenotype cannot be excluded; (ii) the attenuated strain 
retains residual virulence that could be lethal for a portion of the vaccinated fish [5], particularly for 
small/young fish. Consequently, there is still a need for a safe and efficacious attenuated vaccine 
against CyHV-3. 
The era of molecular biology is now allowing scientists to design idle attenuated replicating 
viral vaccines by targeting genes known to be involved in virulence and/or spreading and by causing 
to these genes defect that cannot be repaired by simple mutation. Recently, CyHV-3 genome has been 
cloned as an infectious bacterial artificial chromosome that can be mutated using prokaryotic 
recombination technologies [6]. While producing recombinant for ORF134, we unexpectedly obtained 
a clone deleted for ORF56 and ORF57 in addition to the expected ORF134 deletion. In comparison to 
its parental strain, this triple deleted recombinant (deleted for ORF56, 57 and 134) exhibited an 
attenuated phenotype and proved to be able to induce a protective immune response against a lethal 
challenge. Production of independent recombinants demonstrated that deletion of ORF56 and ORF57 
were responsible for the safety/efficacy profile observed for the triple deleted recombinant.  
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Abstract 
Cyprinid herpesvirus 3 is the causative agent of a lethal disease in common and koi carp. 
Since its emergence, it has caused severe economic losses worldwide creating the need for a vaccine. 
Taking advantage of the recent cloning of its genome as an infectious bacterial artificial chromosome 
(BAC), recombinant vaccine candidates were produced by deletion of a single gene. While producing 
such recombinant for open reading frame (ORF) 134, we unexpectedly obtained a clone additionally 
deleted for ORF56 and ORF57. Interestingly, this triple deleted recombinant exhibited an attenuated 
profile in vivo. To confirm that the triple deletion was indeed responsible for the phenotype observed 
and to determine the contribution of ORF134 deletion in the attenuation, a double ORF56-ORF57 
deleted recombinant and an independent triple ORF56-ORF57-ORF134 recombinant were produced 
and tested in vivo. These experiments demonstrated that ORF56-ORF57 deletion was responsible for 
the attenuation and that ORF134 deletion did neither contribute significantly to the attenuation nor 
influence the adaptive immune response induced by the infection. To further investigate the adaptive 
immune response induced by the ORF56-ORF57 deleted strain, fish previously vaccinated with this 
strain were challenged with a wild type strain expressing luciferase as a reporter gene. These results 
suggested that the vaccine strain candidate induces a protective immunity able to prevent the entry of 
the challenging virus into vaccinated fish cells. 
 
Key words: Cyprinid herpesvirus 3 (CyHV-3), attenuated vaccine, gene deletion. 
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Introduction 
In the late 1990s, a highly contagious and virulent disease began to cause important economic 
losses in both common carp (Cyprinus carpio carpio) and koi (Cyprinus carpio koi) industries 
worldwide [1]. Common carp is a freshwater fish widely cultivated for human consumption with a 
continuous increase of its world production over the last 30 years. The world production of common 
carp was estimated around 3.4 million metric tons in 2010 (Food and Agriculture Organization of the 
United Nations). The other susceptible host koi, are ornamental, colourful fish which are grown for 
personal pleasure and competitive exhibitions [7]. Initially called Koi herpesvirus (KHV) according to 
its morphological resemblance to viruses belonging to the order Herpesvirales, the agent was then 
known as carp interstitial nephritis and gill necrosis virus (CNGV) because of the associated lesions 
[8]. Finally, it was renamed CyHV-3 based on the homology of its genome with those of previously 
described cyprinid herpesviruses [9]. The rapid spread of the virus has been attributed to the 
international fish trade and koi shows that occur all around the world. 
Soon after the identification of CyHV-3 as the causative agent of the disease, an original 
protocol was developed to induce a protective adaptive immune response in carp [8]. This approach 
exploited the fact that CyHV-3 induces fatal infections only when temperature is between 18°C and 
28°C. According to this protocol, healthy fish are exposed to the virus by cohabitation with sick fish 
for 3-5 days at permissive temperature (22°C-23°C). Following this period, the fish are transferred to 
ponds for 25-30 days at non-permissive water temperature (≈30°C). Challenge performed on the 
surviving fish showed partial protection (mortality rate of 39% compared to 82% for the control 
group). Despite its ingenuity, this procedure has several disadvantages as (i) it uses a pathogenic strain 
leading to a severe risk of spreading the virus among cultivated and wild carp population during, but 
also after, the acute infection, as fish that are protected may become latently infected and exhibit 
reactivation at a later stage; (ii) it induces a loss of 40% of the fish during the procedure and protection 
is nevertheless not optimal as mentioned above; (iii) the increase of water temperature and fish losses 
are very costly for the farmers [8]. 
Vaccination is the most appropriate way to protect fish against CyHV-3. Various attempts of 
vaccination against CyHV-3 were made using both inactivated and attenuated vaccine candidates. One 
trial using oral immunization with a formalin-inactivated virus entrapped into a liposome compartment 
showed partial protection against a lethal challenge [10]. Attenuated vaccine candidates have also been 
developed by serial passages of the CyHV-3 Israeli strain in cell cultures [2,5,8]. After more than 20 
passages, the attenuated strain was cloned and several clones were subsequently tested and submitted 
to UV irradiation to increase random mutations as well as decrease the risk of reversion to a 
pathogenic virus [2,5]. Currently, a live attenuated vaccine developed using this approach (Cavoy®) 
has been manufactured by KoVax Ltd. (Jerusalem, Israel) and is available for immersion vaccination 
of common and koi carp in USA (Norvartis Animal Health). This vaccine has three major 
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Figure 1. Molecular characterization of the FL BAC revertant ORF56-57 Del pGEMT ORF134 Del 
galK strain. The indicated strains were analyzed by Sac I restriction (left panel) and by Southern blot using 
ORF55, ORF56-57 Del, ORF134 Del and pGEMT probes. Black and white arrowheads indicate fragments 
containing the ORF134 locus and ORF56-57 loci, respectively. Marker size (MS) are indicated on the left. 
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disadvantages: (i) the determinism of the attenuation is unknown, and consequently, reversions to a 
pathogenic phenotype cannot be excluded; (ii) the attenuated strain retains residual virulence that 
could be lethal for a proportion of the vaccinated fish (20-30% of mortality rate during the vaccination 
in some experiments) [5], particularly for small/young fish, what probably explains why the vaccine is 
restricted to carps weighing more than 100 g (Norvartis Animal Health); (iii) the level of protection 
against a lethal challenge does not reach 100% [5]. 
Another way to produce attenuated vaccine candidates consists to delete specific ORFs which 
may be responsible for virulence. Some trials were made using such method. Fuchs and collaborators 
(2011) generated recombinants deleted for viral enzymes involved in the metabolism of nucleotide by 
recombination using in vitro enhanced green fluorescent protein (EGFP) positive/negative selection. 
Three ORFs were targeted ORF55 (thymidine kinase; [TK]), ORF123 (deoxyuridine triphosphatase; 
dUTPase) and ORF141 (RNR subunit 1). The derived recombinants were replicating in vitro, 
demonstrating that these ORFs are non-essential, although deletion of ORF141 lead to smaller lysis 
plaques as well as a slower viral growth. Results from in vivo infection using ORF55 and ORF123 
deleted strains and their revertant strains showed inconsistent results and none deleted strain was 
simultaneously safe and efficacious [11]. In another study, Costes and collaborators (2008) produced a 
strain deleted for ORF16, encoding a potential GPCR and, by insertion and excision of the BAC 
cassette in ORF55, a TK truncated strain [6]. Both ORF55 truncated strain and ORF16 deleted strains 
showed partially attenuated phenotypes. Nevertheless, the level of attenuation was insufficient to 
propose these recombinants as vaccine candidates. 
Recently, CyHV-3 genome has been cloned as an infectious bacterial artificial chromosome 
that can be mutated using prokaryotic recombination technologies [6]. While producing recombinant 
for ORF134 using this method, we unexpectedly obtained a clone deleted for ORF56 and ORF57 in 
addition to the expected ORF134 deletion. In comparison to its parental strain, this triple deleted 
recombinant (deleted for ORF56, 57 and 134) exhibited an attenuated phenotype and proved to be able 
to induce a protective immune response against a lethal challenge. Production of independent 
recombinants demonstrated that deletion of ORF56 and ORF57 were responsible for the 
safety/efficacy profile observed for the triple deleted recombinant. 
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Results 
Molecular characterization of the FL BAC revertant ORF56-57 Del 
pGEMT ORF134 Del galK strain 
In the previous chapter, we produced a CyHV-3 recombinant strain that was deleted for 
ORF134 (encoding a viral IL-10). To reconstitute infectious viral particles, the FL BAC ORF134 Del 
galK plasmid was co-transfected with pGEMT-TK as described in the materials and methods. This 
procedure led to an abnormal restriction profile for one of the clones produced (Figure 1). Indeed, the 
fragment of 5.25 kb encompassing ORF55 (in which the BAC plasmid was inserted) was absent of the 
restriction profile. Southern Blot analysis using ORF55 probe demonstrated that the ORF55 fragment 
was shorter than expected (1.9 kb). Moreover, by using pGEMT vector as probe, we demonstrated that 
a pGEMT vector derived sequence was inserted in the genome of this strain. The sequencing of this 
region of the genome confirmed the insertion of a pGEMT vector derived sequence (2.52 kb) but also 
demonstrated that a large part of CyHV-3 genome sequence was deleted (2.75 kb) (Figure 1). The 
region deleted encompassed most of ORF56 as well as the beginning of ORF57 (Figure 2). The 
southern blot performed with the ORF56-57 Del probe confirmed the correct deletion and 
demonstrated that the deleted sequence was not translocated elsewhere in the genome (Figure 1). The 
insertion of a Sac I restriction site originating from pGEMT vector explains the restriction profile 
observed in Figure 1. The deletion of ORF134 gene can be visualized directly on the restriction profile 
and was confirmed using an ORF134 Del probe. All together, the results presented above demonstrate 
that the FL BAC revertant ORF56-57 Del pGEMT ORF134 Del galK strain is deleted for three ORFs: 
ORF56, ORF57 and ORF134. 
Safety and efficacy profiles of FL BAC revertant ORF56-57 Del pGEMT 
ORF134 Del galK strain 
The results presented above demonstrated that the FL BAC revertant ORF134 Del galK strain 
is deleted for three ORFs: ORF56, 57 and ORF134 but is still able to replicate in vitro. Next, we 
investigated whether this combination of deletion could affect the virulence of this strain in vivo. 
Groups of 20 fish (average weight 7.19 g ± 3.40 g (mean ± SD), 6 months old) were infected by 
immersion for 2 h in water containing 4, 40, and 400 pfu/ml of the FL BAC revertant ORF56-57 Del 
pGEMT ORF134 Del galK strain or the FL BAC revertant strain used as control. A third group of fish 
was composed of mock-infected fish (Figure 3). Fish infected with the FL BAC revertant strain 
exhibited all clinical signs observed during CyHV-3 disease, beginning with folding of the dorsal fin, 
apathy and loss of appetite, hyperaemia, and later, skin and fin lesions. Independent of the dose tested, 
an important mortality was observed (with survival rate between 15 and 50%). In comparison to the 
wild type strain, the FL BAC revertant ORF56-57 Del pGEMT ORF134 Del galK strain expressed an 
attenuated phenotype. Only few fish expressed mild clinical signs with the higher dose tested. These 
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Figure 3. Safety and efficacy profiles of the FL BAC revertant ORF56-57 Del pGEMT ORF134 Del galK 
strain. The safety of the FL BAC revertant ORF56-57 Del pGEMT ORF134 Del galK strain was tested on 
common carp (n=20, average weight 7.19 ±3.4 g (mean ± SD), 6 months old). The FL BAC revertant strain 
and mock-infection were used as positive and negative controls, respectively. Fish were infected by immersion 
for 2h in water containing 4, 40, 400 pfu/ml of the indicated strains. Six weeks post-infection, fish that 
survived the primary infection and mock-infected fish were challenged by cohabitation with fish infected with 
FL strain. Percentages of surviving carp are expressed according to days post primary infection. 
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signs included folding of the dorsal fin and localised hyperaemia of the skin, but most fish expressing 
the infection remained active and fed normally. These observations were later confirmed by the 
survival rate which was very high in all groups (95-100%; one fish died in the 400 pfu/ml vaccinated 
group). More importantly, fish started to recover from the infection as soon as 8 dpi corresponding to 
the peak of mortality in the group infected with the wild type parental strain. Surviving fish were 
further challenged by cohabitation with fish infected with the FL strain. While mock-infected fish 
were very sensitive to this challenge (85-100% of the fish dying from the infection within 20 days post 
challenge), fish previously infected with the FL BAC revertant ORF56-57 Del pGEMT ORF134 Del 
galK strain at the dose of 40-400 pfu/ml did not express the disease and exhibited 100% survival. Fish 
that were initially inoculated at the dose of 4 pfu/ml showed partial protection (65% of survival rate) 
(Figure 3). 
Younger (small) fish have been shown to be more sensitive to CyHV-3 than older (large) fish. 
To further investigate the safety/efficacy phenotype of FL BAC revertant ORF56-57 Del pGEMT 
ORF134 Del galK strain, the experiment described in Figure 3 was reproduced with smaller fish 
(Figure 4). At the dose of 4 and 40 pfu/ml, neither clinical signs nor dead fish was observed. At the 
dose of 400 pfu/ml, few fish had minor and transient clinical signs (mainly consisting of skin 
hyperaemia) between days 5 and 8. However, one fish died at 9 days post vaccination. Fish infected 
with FL BAC revertant ORF56-57 Del pGEMT ORF134 Del galK strain, as well as mock-infected 
fish were divided in two groups of 15 fish. One group was challenged at 3 weeks post primary 
infection, while the second group was challenged at 6 weeks post primary infection. Challenges were 
performed by cohabitation with recently infected fish as described in the Materials and Methods. The 
results obtained after challenges at 3 and 6 weeks post primary infection led to comparable results 
(Figure 4). Infection performed at the dose of 4 pfu/ml did not induce a significant protection when 
compared to the mortality observed for mock-infected groups. At the dose of 40 pfu/ml, a partial 
protection (around 80% of survival rate) was observed while the dose of 400 pfu/ml induced full 
protection (100% survival) (Figure 4). 
Production and characterization of CyHV-3 double and triple deleted 
recombinants 
The FL BAC revertant ORF56-57 Del pGEMT ORF134 Del galK strain exhibits an 
attenuated phenotype. As demonstrated above, this strain is deleted for ORF56, ORF57 and ORF134. 
Based on previous study demonstrating that ORF134 is not essential for virulence in vivo (the first 
experimental chapter of the present thesis), these data suggested that the ORF56-57 deletion is 
responsible, on its own or in combination with ORF134 deletion, for the observed attenuated 
phenotype. However, as the full length genome sequencing of the strain was not performed, we cannot 
exclude the hypothesis that the phenotype observed is the consequence of additional undetected 
mutation(s). To exclude the latter hypothesis and to determine the respective roles of the ORF56-57 
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Figure 4. Safety and efficacy profiles of the FL BAC revertant ORF56-57 Del pGEMT ORF134 Del
galK strain in small fish. The safety of the FL BAC revertant ORF56-57 Del pGEMT ORF134 Del galK
strain was tested on common carp (n=30, average weight 1.35 ± 0.5 g (mean ± SD), 15 weeks old). Mock-
infection was used as a negative control. Fish were infected by immersion for 2 h in water containing 4, 40,
400 pfu/ml. Surviving fish and mock-infected fish were challenged at 3 and 6 weeks post primary infection
by cohabitation with fish infected with the FL strain. Percentages of surviving carp are expressed according to
days post primary infection.
Experimental section: Chapter 2 
102 
 
deletion and the ORF134 deletion in the attenuation observed, two independent recombinants were 
produced: one carrying the ORF56-57 deletion (double deleted recombinant) and one carrying the 
ORF56-57 deletion and the ORF134 deletion (triple deleted recombinant). These recombinants were 
produced using the strategy described in Figure 5. FL BAC revertant as well as FL BAC excised 
infectious forms were reconstituted from the FL BAC ORF56-57 Del plasmid and the FL BAC 
ORF56-57 Del ORF134 Del plasmid. 
All strains were characterized by restriction fragment length polymorphism (RFLP) and 
southern blot analysis (Figure 6). Due to removal of the ORF56-57 Del sequence (2.75 kb), the 
ORF55 fragment was shorter (2.5 kb) as revealed by the ORF55 probe. Presence or absence of the 
BAC sequence (172 bp) allowed the discrimination between FL BAC excised and FL BAC revertant 
strains, respectively. Southern blot using ORF56-57 Del and ORF134 Del probes (corresponding to 
the deletions) demonstrated the absence of the deleted sequences in the recombinants (Figure 6). 
Finally, genome regions encompassing the mutated loci and the regions used to target recombinations 
were amplified by PCR and sequenced (data not shown). All analyses confirmed that the recombinants 
produced had the correct molecular structure. 
Safety and efficacy profile of double and triple deleted recombinants 
Groups of 30 fish were infected by immersion for 2 h in water containing 4, 40 and 400 
pfu/ml of the FL BAC revertant ORF56-57 Del strain and FL BAC revertant ORF56-57 Del ORF134 
Del strain (hereafter called double and triple deleted infected fish, respectively). A group of fish was 
infected with the FL BAC revertant strain used as a positive control for virulence (hereafter called 
wild type infected fish), while mock-infected fish were used as negative control (Figure 7A). For both 
the double and the triple deleted recombinants, the course of infection was similar to what we 
observed for the FL BAC revertant ORF56-57 Del pGEMT ORF134 Del galK strain (Figure 3 and 4). 
Survival rate observed in wild type infected fish was between 40-47% depending of the dose used. In 
contrast, nearly all fish infected with the double and the triple deleted recombinants survived the 
infection. Indeed, only a single fish infected with the higher dose of the tripe deleted recombinant died 
as a consequence of the infection. These results demonstrated the key role of the ORF56-57 deletion in 
the safety profile observed for the FL BAC revertant ORF56-57 Del pGEMT ORF134 Del galK strain. 
Fish infected with the double and the triple deleted recombinants, as well as mock-infected 
fish were divided in two groups of 15 fish. One group was challenged at 3 weeks post primary 
infection, while the second group was challenged at 6 weeks post primary infection. Challenges were 
performed by cohabitation with recently infected fish as described in the Materials and Methods. 
Results obtained after challenges at 3 and 6 weeks post primary infection led to comparable results. 
Nearly all fish vaccinated at the dose of 40 and 400 pfu/ml were protected against this lethal challenge 
(only 2 dead fish out of 119 fish challenged) whereas only 2 mock-infected fish survived out of 60 
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Figure 5. Flowchart of the stages for the production of double and triple deleted recombinants. The
region of ORF56-57, as identified in Figure 1, was replaced by a galK gene using homologous recombination
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infectious virus with a wild type TK locus (FL BAC revertant strains), the recombinant plasmid was co-
transfected in CCB cells with the pGEMT-TK plasmid. To reconstitute infectious virus with a truncated form
of TK (FL BAC excised strains), the recombinant plasmid was transfected in CCB cells expressing Cre
recombinase. The right part of the figure summarizes the genotype of the various strains produced.
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challenged fish. Protection observed for fish infected at the dose of 4 pfu/ml was partial as observed in 
previous experiments. All these experiments performed with the FL BAC revertant forms of the 
double and triple deleted recombinants were reproduced with the FL BAC excised forms. These 
experiments confirmed the results obtained (Figure 7B). 
The results of the experiments presented above demonstrated that the ORF56-57 deletion 
explains the safety/efficacy phenotype observed for the FL BAC revertant ORF56-57 Del pGEMT 
ORF134 Del galK strain. They also demonstrated that the additional deletion of ORF134 and/or 
truncation of ORF55 do not improve the safety/efficacy profile. 
Characterization of the immune protection conferred by the FL BAC 
revertant ORF56-57 Del strain using in vivo imaging system 
Most vaccines confer an immune protection able to reduce, but not to block completely, viral 
replication in the vaccinated subject. Consequently, most vaccines confer a clinical protection but do 
not confer an absolute resistance (sterile immunity). In this last section, we investigated by using in 
vivo imaging system (IVIS), the ability of the immune response induced by the FL BAC revertant 
ORF56-57 Del strain to inhibit the infection by a challenger wild type virus expressing luciferase 
under control of the HCMV IE promoter (Figure 8). Fish were infected by immersion for 2 h in water 
containing 40 and 400 pfu/ml of the FL BAC revertant ORF56-57 Del strain. Mock-infected fish were 
used as control. The course of infection was similar to what we observed before. Six weeks after the 
primary infection, fish were challenged by immersion in water containing the FL BAC revertant 136 
LUC. At different times post challenge, fish were analyzed by IVIS for detection of bioluminescence 
revealing infection (sensitivity and/or permissiveness of host cells). As early as two days post 
infection, most naïve fish (5 out of 6) that were challenged with the FL BAC revertant 136 LUC were 
detected as positive for bioluminescence revealing viral infection. On day 4 and 8 post-challenge, all 
fish tested were positive and expressed a signal increasing with time post-challenge. In contrast, fish 
immunized against the FL BAC revertant ORF56-57 Del strain prior to the challenge expressed no 
significant level of bioluminescence with exception of one fish on day 2 (immunized at the dose of 40 
pfu/ml). All together, these data suggest that the FL BAC revertant ORF56-57 Del strain has some 
potential as a vaccine strain candidate. 
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Figure 6. Molecular characterization of double and triple deleted recombinants. The indicated 
strains were analyzed by Sac I restriction (first panel) and by Southern blot using ORF55, ORF56-
57 Del and ORF134 Del probes. Black and white arrowheads indicate fragments containing 
ORF134 locus and ORF56-57 loci respectively. Marker size (MS) are indicated on the left. 
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Figure 7. Safety and efficacy of double and triple deleted recombinants. Panels A and B present the
testing of TK revertant and TK truncated recombinants, respectively. The safety of the indicated
recombinants were tested on common carp (n=30, average weight 3.77± 1.97 g (mean ± SD ), 7 months
old). The FL BAC revertant strain and mock-infection were used as positive and negative controls,
respectively. Fish were infected by immersion for 2 h in water containing 4, 40, 400 pfu/ml. Surviving fish
and mock-infected fish were challenged at 3 and 6 weeks post primary infection by cohabitation with fish
infected with the FL strain. Percentages of surviving carp are expressed according to days post primary
infection.
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Figure 7. Safety and efficacy of double and triple deleted recombinants. Panel B see legend under
Figure 7 panel A.
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Discussion 
CyHV-3 is a highly pathogenic virus causing devastating losses in cultured and wild common 
carp populations, and in ornamental koi carp. Due to the economic losses caused to aquaculture and 
the rapid spread of the virus worldwide, researches in the field were rapidly oriented to the 
development of diagnostic and prophylactic tools [1]. Vaccination is likely to be the most efficacious 
way to reduce spreading of viral infections and to protect fish from its deleterious effects. Attenuated 
vaccines seem to be particularly adapted for vaccination of carp against CyHV-3. Firstly, attenuated 
vaccines stimulate both humoral and cellular immune responses, the latter is known to be of particular 
importance for immune protection against viral diseases. Secondly, an attenuated vaccine is usually 
easy to produce, requires lower vaccine dose to induce immune protection and is frequently active 
after a single dose. These features make them well adapted for mass vaccination [12]. Thirdly, 
immunity raised by an attenuated vaccine is usually long-lasting [5]. A CyHV-3 attenuated vaccine 
was developed using attenuation through serial passages in vitro and UV irradiation to induce random 
mutations [2,5,8]. The determinism of its attenuation is unknown and consequently the risk of 
reversion cannot be evaluated or excluded. The present study was devoted to the rational development 
of a recombinant attenuated vaccine against CyHV-3. 
The publication of the CyHV-3 complete genome [13] (recently updated and compared to 
sequences of other members of the genus Cyprinivirus ; family Alloherpesviridae ; order 
Herpesvirales [14]), combined with its recent cloning as a BAC, allowed the production of 
recombinants deleted for targeted genes [6]. During the production of recombinant strain deleted for 
ORF134 encoding an IL-10 homologue [15], an additional double deletion (ORF56-57) occurred 
during the process of removal of the BAC cassette. Interestingly, this triple deleted recombinant 
(deleted for ORF56, ORF57 and ORF134 and possibly undetected mutations) replicated efficiently in 
vitro, exhibited an attenuated profile in vivo and induced an immune protection against a lethal 
challenge (Figure 3). This observation was the starting point of the present study. Based on a rational 
approach, various recombinant strains were produced to unravel the determinism of the attenuation of 
this strain. 
As the single deletion of ORF134 was shown to have no effect on the virulence of CyHV-3 in 
vivo [15], the double deletion (ORF56-57) was supposed to be responsible for the severe attenuation 
observed for the FL BAC ORF56-57 Del pGEMT ORF134 Del galK. Nevertheless, the deletion of 
ORF134 encoding an IL-10 homologue could contribute to the observed attenuated phenotype. 
Moreover, we could not exclude the unlikely hypothesis that the triple deleted recombinant encoded 
undetected additional mutations that could have been responsible for the attenuated phenotype. To 
confirm that the double ORF56-57 deletion was indeed responsible for the phenotype observed and to 
determine the contribution of ORF134 deletion in the attenuation, a double ORF56-57 deleted 
recombinant and an independent triple ORF56-57/ORF134 deleted recombinant were produced and 
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Figure 8. Immune protection conferred by the FL BAC revertant ORF56-57 Del strain as revealed by IVIS. Common carp 
(n=20, average weight 13.82 ± 5.00 g (mean ± SD), 9 months old) were infected by immersion for 2 h in water containing 40 or 
400 pfu/ml of the FL BAC revertant ORF56-57 Del strain or were mock-infected. None of the fish died from this primary 
infection. At 6 weeks post primary infection, fish were challenged by immersion for 2 h in water containing 200 pfu/ml of the FL 
BAC revertant 136 LUC strain. At the indicated time post challenge, fish (n=6) were analysed by IVIS. The upper part of the 
figure presents representative pictures obtained for each group and time point. The lower part presents the average radiance (+ 
SD) measured on the entire fish body surface per group and time point, as well as the individual measures obtained. Differences 
with p-value lower than 1 % are marked (**). 
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tested in vivo (Figures 5 to 7). These experiments revealed that ORF134 deletion did neither contribute 
significantly to the attenuation observed nor influence the adaptive immune response induced by the 
infection. Importantly, these experiments demonstrated that ORF56-57 deletion was responsible for 
the attenuation observed. Moreover, the comparison of the FL BAC excised and revertant forms 
(respectively encoding a truncated or revertant ORF55 locus) of the double and triple deleted 
recombinants also revealed that truncation of ORF55 did not improve the safety and/or efficacy of the 
strains (Figure 7, compare sections A and B). Notably, the partial attenuation due to truncation of 
ORF55 in a wild type FL background observed previously could not be reproduced in these 
experiments. This discrepancy is likely due to the fact that, in contrast to the quoted study, we used 
fish in exponential growth phase and thereby containing a large proportion of dividing cells expressing 
high level of cellular TK. Other differences in experimental procedures (we used common carps 
instead of koi carps, infection by immersion instead of infection by IP injection) [6] could also explain 
the differences observed. 
Taking into account all the recombinants deleted for ORF56-57 produced, about 420 fish with 
an average weight lower than 10 g were infected with 3 different doses (4, 40 and 400 pfu/ml by 
immersion). Out of these 420 fish, only two fish died after infection demonstrating the safety of the 
vaccine candidate (all mortalities reported). Concerning the efficacy, fish vaccinated at 40-400 pfu/ml 
and challenged with the FL strain showed very high level of protection, only 4 fish died out of 280 fish 
challenged. Experiment performed on very small fish further demonstrated the safety conferred by 
deletion of the ORF56-57 loci (Figure 4). Compared to the CyHV-3 attenuated vaccine available in 
USA (produced by KoVax Ltd, Israel), these results are very promising. Indeed, safety and efficacy of 
this vaccine are much lower than the vaccine candidate developed in the present study. Firstly, this 
vaccine has been tested at doses of 100-200 pfu/fish by IP and 10-40 pfu/ml by immersion and already 
raised safety concerns at these relatively low doses (the vaccine can be lethal for up to 30% of 
vaccinated fish weighting less than 50 g). This probably explains why this vaccine was initially 
registrated for fish weighing more than 100 g (Norvartis Animal Health). However, very recently after 
just a year on the market, Novartis decided to stop the distribution of this vaccine officially for 
marketing reasons. In addition to safety issues, this vaccine exhibited efficacy performance below 
those observed in the present work; indeed, the KoVax vaccine was never reported to confer full 
protection [2,5,8]. 
The candidate vaccine developed in the present study presents the major advantage to be the 
product of a rational genetic deletion rather than the result of random mutations. The consequences to 
precisely know the genetic origin of attenuation can be seen at several levels. The development of an 
attenuated vaccine in aquaculture is restricted by major safety concerns as these vaccines are usually 
released directly into the water [12]. Knowledge of the gene deleted and the type of mutation 
performed to invalidate the gene is crucial to estimate the risk of reversion to a pathogenic genotype. 
The vaccine candidate developed in this work fulfills this requirement. While point mutations acquired 
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by serial passages in cell cultures are likely to be reversed, reversion of the deletion performed in our 
vaccine candidate is impossible. 
 The precise knowledge of the genetic deletions present in our vaccine candidate allows the 
parallel development of diagnostic tools allowing the differentiation between infected and vaccinated 
animals based on genetic, antigenic and/or serologic assays. Another advantage of the vaccine 
candidate developed in this work, is that it has the potential to be used as vector for expression of key 
protective antigens of other pathogens. The expression cassette encoding these antigens will have to be 
inserted in place of the ORF56-57 deletion performed. As CyHV-3 has been shown to infect carp but 
also other species of cyprinid fish, it could in theory be used as an expression vector in all sensitive 
species. For example, spring viraemia of carp (SVC) is caused by a rhabdovirus responsible for 
mortalities in cyprinid species and against which no vaccine is available. As vaccination using 
glycoprotein G in delivery system such as DNA or vector based vaccine are frequent and efficacious 
in this viral family [16,17], the SVC could be a potential future candidate for vaccine development 
using CyHV-3 as a vector. 
 Orthologues of ORF57 have been reported in three viral species infecting fish (CyHV-1 and 2, 
AngHV-1) [14], two of them are responsible for severe diseases in their respective hosts. Indeed, 
CyHV-2, also known as goldfish haematopoietic necrosis virus, is responsible for a severe disease 
initially reported in goldfish (Carassius auratus auratus) [18], but recently emerging in gibel carp 
(Carassius auratus gibelio) [19]. In addition, AngHV-1 that infects European and Japanese eel 
(Anguilla anguilla and Anguilla japonica) is responsible for mortalities up to 30% in cultured and wild 
eel populations [20]. An additional homologue of ORF57 has also been described in a more distant 
viral species: the crocodilepox virus, an unclassified member of the subfamily Chordopoxvirinae of 
the family Poxviridae [21]; what suggests an ancestral origin of the gene. Consequently, putative other 
homologues of ORF57 are likely to be reported in the future. The basis of the present work identifies 
ORF57 as a first choice gene candidate to be deleted in order to produce attenuated vaccine for viruses 
encoding an ORF57 homologue. 
 In conclusion, the present work established the basis for further investigations on the use of 
ORF56-57 deleted CyHV-3 recombinants as attenuated vaccine against CyHV-3. The perspectives of 
the present study are related to both applied and fundamental sciences; they can be divided into four 
main topics: (i) to further investigate which ORF contribute to the attenuation observed: ORF56 and/ 
or ORF57? (ii) to further investigate the potential of the FL BAC revertant ORF56-57 Del strain as an 
anti-CyHV-3 vaccine candidate; (iii) to investigate the potential of this vaccine candidate as an 
expression vector for vaccination against heterologous pathogenic agents; and (ᴠ) as a subject of 
fundamental research to study the roles of ORF56 and/ or ORF57 in CyHV-3 infection. 
  
Table 1. Primers and probes 
Probe/cassette name Primer name Sequence (5’- 3’) 
Coordinates 
according to 
DQ657948 
Primers for Southern blot analysis 
CyHV-3 ORF55 ORF55InF AGCGCTACACCGAAGAGTCC 95990-96009 
ORF55stopR TCACAGGATAGATATGTTACAAG 96516-96494 
CyHV-3 ORF 56-57 Del probe ORF56-57Pr5F GGTACAAGACGGCCTGCTG 97247-97265 
ORF56-57Pr9R GCCAGCACGTAGAGCTTGTG  99686-99667 
CyHV-3 ORF134 Del probe ORF134InF GGTTTCTCTTTGTAGTTTTCCG 229362-229383 
ORF134InR CACCCCAACTTTTGAGACAAC 229795-229765 
galK probe galKF2 AGGTGAGGAACTAAACCCAG        
galKR2 GATAAAGCTGCTGCAATACG  
Primers for amplification of recombination cassettes 
ORF 134 Del galK cassette ORF134 galK F ATGTTCCTTGCAGTGCTACTAACCGCG
ACCATCTTCTTCGAGGCTCGGGG 
CCTGTTGACAATTAATCATCGGCA 
229791-229840 
ORF134 galK R TCAATGTTTGCGCTTGGTTTTCATGTTC
TTGACGTCTTTTGCGACCAGGA 
TCAGCACTGTCCTGCTCCTT 
229217-229266 
ORF 56-57 Del galK cassette ORF56-57 galK F GTCCCTCGACAGCCCCAGCCCGCACA
GCAGTCGCCACTCTTCCCTGTTGA 
TCAGCACTGTCCTGCTCCTT 
96951-97000 
ORF56-57 galK R AACCCGTACACGACGCGCTCAAGCAG
CTTGATCTTGACGACGTCGTGCAC 
CCTGTTGACAATTAATCATCGGCA 
99800-99751 
Underlined: 50bp corresponding to CyHV-3 sequence 
Italic: sequence corresponding to galK gene 
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Materials and Methods 
Cells and viruses 
Cyprinus carpio brain (CCB) cells [22] were cultured in minimum essential medium 
(Invitrogen) containing 4.5 g/liter glucose (D-glucose monohydrate; Merck) and 10% fetal calf serum. 
The cells were cultured at 25°C in a humid atmosphere containing 5% CO2. The CyHV-3 FL strain 
was isolated from the kidney of a fish that died from CyHV-3 infection (CER, Marloie, Belgium) and 
was previously used to produce the FL BAC plasmid [6]. The FL BAC revertant 136 LUC virus 
expressing luciferase as a reporter gene has been described earlier [23]. 
Fish 
Common carp (Cyprinus carpio) (CEFRA, University of Liège, Belgium), were kept in 60 L 
tanks at 24°C. Water parameters were checked weekly. Microbiological, parasitical and clinical 
examinations of the fish just before the experiments demonstrated that they were fully healthy. 
Inoculation of fish 
After a period of acclimation of 2 weeks, primary infection was done by immersion of fish in 
1-2 liters (depending on fish size) of water containing the virus (infectious doses of 4, 40 or 400 
plaque forming unit [pfu]/ml) for 2 h. At the end of the incubation period, the fish were returned to 60 
L tanks and then observed daily for clinical signs and mortality. Challenge of survival fish was 
performed at 21 days and/or 42 days post primary infection by cohabitation with infected fish. Two 
fish, freshly infected by immersion for 2 h in water containing 200 pfu/ml of the FL strain, were 
released in each tank to be challenged. The animal study was accredited by the local ethics committee 
of the University of Liège, Belgium (Laboratory accreditation N°1610008, protocol N°1059). 
Production of double and triple deleted recombinants 
Recombinants were produced using BAC cloning and prokaryotic recombination technologies. 
The different recombinant plasmids were produced using a two-step galactokinase (galK) 
positive/negative selection in bacteria as described previously [24]. The primers used are described in 
Table 1. Production of double and triple deleted recombinants encoding the accidental deletion of 
ORF56-57 observed in the FL BAC revertant ORF56-57 Del pGEMT ORF134 Del galK strain 
(Figure 2) was done by using FL BAC plasmid and FL BAC ORF134 Del plasmid as parental 
plasmids, respectively; and following the strategy described in Figure 5 [15]. The first recombination 
process consisted to replace ORF56-57 by a galK gene (positive selection) resulting in the FL BAC 
ORF56-57 Del galK and FL BAC ORF56-57 Del galK ORF134 Del plasmids. Recombination was 
performed using the ORF56-57 Del galK recombination cassette consisting of the galK gene flanked 
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by 50 base pair (bp) sequences homologous to CyHV-3 genome regions flanking ORF56-57 deletion. 
The ORF56-57 Del galK recombination cassette was produced by PCR (primers 56-57 galK F and 
56-57 galK R) using the pgalK vector as template. Primer 56-57 galK F consisted of nucleotides 
96951-97000 (50 bp) of CyHV-3 genome and nucleotides 1212-1231 (20 bp) of the pgalK vector. 
Primer 56-57 galK R consisted of nucleotides 99751-99800 (50 bp) of the CyHV-3 genome and 
nucleotides 1-24 (24 bp) of the pgalK vector. The 50 bp sequences of the ORF56-57Del galK 
corresponding to CyHV-3 genome were used to target homologous recombination in bacteria. The 
second recombination process (galK negative selection) consisted to remove the galK gene through 
recombination with the ORF56-57 Del cassette leading to the production of the FL BAC ORF56-57 
Del and the FL BAC ORF56-57 Del ORF134 Del plasmids. The ORF56-57 Del cassette consisted of 
250 bp upstream (coordinates 96751-97000) and 249 bp downstream (99751-100000 with deletion of 
base 99760) of ORF56-57 deletion. To reconstitute infectious virus, the BAC plasmids (FL BAC, FL 
BAC ORF56-57 Del, FL BAC ORF56-57 Del ORF134 Del) were co-transfected into CCB cells using 
Polyethylenimine (ratio 3 µg of Polyethylenimine for 1 µg of DNA) either with the pGEMT-TK 
plasmid or with pEFIN3 NLS Cre (Molecular ratio 1:75) [6]. Transfection with pGEMT-TK plasmid 
induced recombination upstream and downstream the BAC cassette leading to its complete removal 
and consequently reversion to a wild type TK locus (FL BAC revertant strains). Transfection with 
pEFIN3 NLS Cre induced expression of a nuclear Cre recombinase and cre-loxP-mediated excision of 
the BAC cassette. Viruses reconstituted (FL BAC excised strains) by this procedure express a 
truncated TK locus due to the BAC sequence left (172 bp) in this locus. Plaques negative for EGFP 
expression (the BAC cassette encodes an EGFP expression cassette) were picked and amplified.  
Genetic characterization of recombinants 
RFLP were performed using Sac I digestion on 2.5µg of viral DNA. Digested DNA samples 
were then submitted to migration for18 hours (50 V – 500 mA). Southern blot analyses were then 
performed as described elsewhere (Markine-Goriaynoff et al., 2004) using several probes. Viral DNA 
was also submitted to PCR analysis and sequencing of targeted regions. 
Bioluminescence imaging 
Imaging of firefly (Photinus pyralis) LUC was performed using an “in vivo imaging system” 
(IVIS) (IVIS®spectrum, Xenogen, USA) as described previously [23,25]. For in vivo analysis, fish 
were anesthetized with benzocaine (50 mg/L of water). Ten minutes before bioluminescence analysis, 
D-luciferin (150 mg/kg body weight) (Xenogen, USA) was administrated by intraperitoneal injection. 
Each fish was analyzed lying on its left and right side. All the images presented in this study were 
acquired using a field view of 15 cm, a 1 min exposure time, a binning factor of 4 and a f/stop of 1. 
Relative intensities of transmitted light from bioluminescence were represented as a pseudocolor 
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image ranging from violet (least intense) to red (most intense). Corresponding grey-scale photographs 
and color luciferase images were superimposed using the Living Image analysis software (Xenogen, 
USA).  For quantitative comparisons, the Living Image software (Caliper Life Sciences) was used to 
obtain the total flux (p.s-1) over each region of interest.  
Statistical analyses 
The differences in mortality induced by the CyHV-3 strains tested were analyzed using 
Kaplan and Meier survival analysis. Log-transformed bioluminescence data were analyzed using two-
ways analysis of variance. Fish groups, days after challenge and the interaction between these 2 
factors were tested. Results are presented as least-square means and standard errors, and p-values 
lower than 0.05 and 0.01 were reported as significant (*) and very significant (**), respectively. 
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Discussion and perspectives 
Herpesviruses are double-stranded DNA viruses identified in a wide variety of animals, 
ranging from oyster to human. They are able to establish persistent and productive infections in 
immunocompetent hosts despite provoking an efficient immune response. One of the most fascinating 
strategies is the acquisition of host immunomodulatory genes, to be used against the host during the 
course of the infection. One of the best examples of such a gene that has been acquired independently 
by several herpesvirus from their respective hosts is the pleiotropic cytokine Interleukin-10 (IL-10). 
Cyprinid herpesvirus 3 (CyHV-3), a member of the family Alloherpesviridae, is the causative 
agent of a lethal disease in common carp and koi. Because of its economic importance and its 
numerous original biological properties, CyHV-3 became rapidly a very interesting subject for applied 
and fundamental research. However, to date, there is little information on the roles of individual 
CyHV-3 genes in the biology of CyHV-3 infection or in its pathogenesis. Moreover, there is a lack of 
safe and efficacious vaccine for the control of CyHV-3 disease. 
In 2007, the whole genome of CyHV-3 has been sequenced by Aoki et al. (2007). CyHV-3 
genomes are predicted to contain 155 unique, functional protein-coding genes of which eight are 
duplicated in the terminal repeat (Aoki et al., 2007; Davison et al., 2013). This achievement was a 
major milestone towards the study of the roles of CyHV-3 genes in pathogenesis. An additional 
breakthrough was the cloning of the CyHV-3 genome as a stable and infectious bacterial artificial 
chromosome (BAC), which can be used to produce CyHV-3 recombinants (Costes et al., 2008). These 
advances provided crucial tools to study the roles of individual CyHV-3 genes. Interestingly, CyHV-3 
genome encodes several proteins that could be involved in immune evasion processes, such as, ORF4 
and ORF12, which are both predicted to encode for tumor necrosis factor receptor (TNFR) 
orthologues; ORF16, which encodes for a potential G-protein couple receptor (GPCR); and ORF134, 
which encodes for an IL-10 orthologue (Aoki et al., 2007). The initial goal of this thesis was to study 
the roles of ORF134 in the biology of CyHV-3 infection in vitro and in vivo. 
Virally encoded IL-10 orthologues have been identified in several members of the Poxviridae 
family and the Herpesvirales order (Hughes, 2002; Kotenko SV, 2001; Slobedman et al., 2009). Up to 
date, viral IL-10 orthologues (vIL-10s) have been reported for 12 members of the Herpesviridae 
family, for 2 members of the Alloherpesviridae family, and for 7 members of the Poxviridae family. 
However, the biology functional of vIL-10s have been described in vitro only in 4 members of 
Herpesviridae family (Human cytomegalovirus [HCMV], Rhesus cytomegalovirus [RhCMV], Human 
HV 4 [EBV], Ovine HV 2 [OvHV2]) and in 1 member of Poxviridae family (Orf virus [ORFV]). This 
has not yet been investigated for members of the Alloherpesviridae family. Even more restrictive, the 
role of vIL-10s has been investigated in the pathogenesis for only one member of the Herpesviridae 
family (RhCMV) and one member of the Poxviridae family (ORFV) (Chang & Barry, 2010; 
Eberhardt et al., 2012; Fleming et al., 2007). In the first experimental chapter of the present thesis, we 
Discussion and perspectives 
 
 114 
described for the first time the roles of a vIL-10 encoded by a member of Alloherpesviridae family in 
the biology of the infection in vitro and in vivo. 
In vitro, transcriptomic analysis demonstrated that CyHV-3 ORF134 is expressed as a spliced 
E-L gene. This observation is consistent with the results published by Ilouze et al. who concluded that 
ORF134 is an E gene (Ilouze et al., 2012). It is also consistent with the results reported for other 
vIL-10s which are expressed as E [HCMV (Jenkins et al., 2008; Lockridge et al., 2000); RhCMV 
(Lockridge et al., 2000)] or L [EBV (Hudson et al., 1985; Miyazaki et al., 1993; Touitou et al., 1996); 
HCMV (Chang et al., 2004); AngHV-1 (van Beurden et al., 2013)] genes. The expression product of 
ORF134 is an abundant secreted protein in the supernatant of CyHV-3 infected cells. It is synthesized 
as a precursor expressing a 17 amino acids (aa) hydrophilic signal peptide at the N-terminus (Signal 
peptide was predicted using the signalP 4.0 prediction server 
[http://www.cbs.dtu.dk/services/SignalP/]). This peptide is cleaved during secretion (Kotenko SV, 
2001). It is consistent with the results published for other secreted vIL-10s [HCMV (Chang et al., 
2004); EBV (Touitou et al., 1996)]. The expression product of ORF134 could act as a functional vIL-
10 homologue able to deregulate the immune response of the infected host. This hypothesis is further 
supported by a recent publication addressing the biological activity of CyHV-3 ORF134 in zebrafish 
using an artificial model (Sunarto et al., 2012). However, the results of the present study demonstrated 
that ORF134 is essential neither for viral replication in vitro nor for virulence in vivo. In vitro, multi-
step growth assay results revealed that ORF134 is not essential for CyHV-3 replication in vitro. This 
observation is consistent with the results published for HCMV (Dunn et al., 2003), RhCMV (Chang & 
Barry, 2010) and ORFV (Fleming et al., 1997). In vivo, we took advantage of the “CyHV-3 – carp” 
model of infection to investigate the role of ORF134 vIL-10 in the biology of CyHV-3 infection in its 
natural host. For viral inoculation, we mimicked natural infection using immersion in infectious water 
containing a broad range of virus concentration (ranging from 4 to 400 pfu/ml). Study of viral entry 
into fish demonstrated that the lowest dose tested (4 pfu/ml) is insufficient to induce an initial 
synchronous infection of all fish (Costes et al., 2009). Consequently, the infection performed with this 
lowest dose implicates the spread of the virus within the tank from primary infected fish to cohabitant 
fish that were initially not infected during inoculation. However, none of the doses tested, revealed a 
significant difference between wild type, ORF134 deleted recombinant and a derived revertant strain 
despite the different read-outs performed. 
In mammals, the biological activities of vIL-10s have been studied mainly in vitro using 
recombinant proteins generated from bacterial or mammalian cell expression systems, supernatants 
from viral infected cultures or, to a lesser extent, recombinant vIL-10 knock-out viruses (Chapter 3, 
Introduction). vIL-10s have been showed have a broad immunosuppressive  spectrum, ranging from a 
reduction of proinflammatory responses and decreased expression of MHC class I and II genes 
(Spencer et al., 2002), to inhibition of dendritic cells (DC) maturation, functionality and survival 
(Chang et al., 2009; Slobedman et al., 2009). Immunostimulatory properties also have been 
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demonstrated in some vIL-10s (Jaworowski et al., 2009; Logsdon et al., 2011; Spencer et al., 2008). 
In vivo, RhCMV vIL-10 modulated macrophage infiltration into infected tissue, altered kinetics and 
magnitude of antiviral antibody response and dampened T cell responses after stimulation with viral 
antigens (Chang & Barry, 2010). Fleming et al. observed smaller and less severe lesions in sheep after 
primary infection infected with the vIL-10 knock-out virus than those observed in sheep infected with 
the wild type parental or revertant strains (Fleming et al., 2007). 
CyHV-3 vIL-10 is the second most abundant protein secreted in the supernatant. It is essential 
neither for viral replication in vitro nor for virulence in vivo. While the present study was not able to 
incriminate a role for ORF134 neither during in vitro nor in vivo infection, it is still possible that this 
ORF plays a role that could not be revealed with the experimental setting used. Firstly, it could be 
possible that ORF134 has a role during the latent infection. However, in CyHV-3 infected carp, 
ORF134 is highly expressed during acute and reactivation phases, while it is only expressed at a low 
level during low-temperature induced persistent phase (Sunarto et al., 2012). Secondly, it could be 
possible that ORF134 has immunomodulatory functions other than those tested in the present study. 
CyHV-3 diseases outbreaks usually induced mortality rate between 60-100%. The high 
mortality induced by CyHV-3 together with its rapid spread explains why soon after its discovery it 
became an interesting subject for applied science. Many researchers tried to find a proper method to 
control this lethal disease. Based on the restriction of its replication by temperature, immunization 
against CyHV-3 was achieved by co-habitation with sick fish for 3-5 days at permissive temperature 
(22-23°C) and subsequently transferring the exposed carp to a non-permissive temperature (30°C). 
Challenge performed on the surviving fish showed partial protection (mortality rate of 39% compare 
to 82% for the control group). The disadvantages of this method have been discussed previously 
(Chapter 2, Experimental section). Vaccination is the best method to control CyHV-3 disease. 
Recently, a live attenuated vaccine developed by in vitro serial passages and treatment with UV 
irradiation has been manufactured by KoVax Ltd. (Jerusalem, Israel) and is available for immersion 
vaccination of common and koi carp in Israel (Israel:KoVax, 2012; Perelberg et al., 2005; Ronen et al., 
2003). This vaccine has several disadvantages. Firstly, the determinism of the attenuation is unknown 
and it seems insufficient for vaccination of highly sensitive small fish. This explains why the 
temporary commercialization of this vaccine in the USA was restricted to fish weighing more than 100 
g (Norvartis Animal Health). Secondly, the duration of the protection conferred by the vaccine has not 
been established. Thirdly, the protection level of this vaccine never reaches 100% (about 80%). In the 
second study, we developed a good attenuated candidate vaccine by deletion of specific ORFs. 
Since we succeeded to cloning CyHV-3 genome as an infection artificial chromosome (BAC) 
in 2008, we produced several recombinants deleted for specific ORFs. None of the selected ORFs 
induced sufficient attenuation when tested in vivo. However, during the production of a recombinant 
deleted for ORF134 (Chapter 1, Experimental section), an additional unexpected mutation was 
obtained. This strain which was deleted for ORF56-57 and ORF134 exhibited a highly attenuated 
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phenotype even when it was tested on young carp as small as 1 g. To identify the determinism of the 
attenuation of this strain, ORF56-57 double deleted recombinants and independent ORF56-57-134 
triple deleted recombinants were produced and tested in vivo. The obtained results demonstrated that 
the ORF56-57 deletion that occurred unexpectedly in the mutant strain is responsible for the highly 
attenuation observed. Moreover, we confirmed that the FL BAC ORF56-57 Del strain can induce a 
protective immune response as demonstrated by challenge with a wild type strain expressing luciferase 
as a reporter gene. All together these results demonstrated that the CyHV-3 ORF56-57 Del strain is a 
good candidate vaccine. 
In this study, the component(s) of the adaptive immune system conferring protection 
following vaccination with the FL BAC ORF56-57 Del strain was not investigated. However, previous 
work on attenuated CyHV-3 vaccine has showed good correlation between levels of protection 
induced and the level of specific antibodies against CyHV-3. Nevertheless, immunized fish, even 
those in which antibodies were no longer detectable were resistant to a lethal challenge; possibly 
because of the subsequent rapid response of B and T memory cells to antigen re-stimulation (Perelberg 
et al., 2008). Antibodies from CyHV-3 vaccinated fish also showed high neutralization against 
CyHV-3 antigens in vitro by using neutralizing assays (Perelberg et al., 2008). This study suggests 
that neutralizing antibodies are likely to play a key role in the immune protection induced by 
attenuated vaccines against CyHV-3. We observed sterile protection in the skin by using IVIS at 2-8 
days post challenge with the FL BAC revertant 136 LUC strain (Chapter 2, Experimental section). 
Components of the carp mucosal immune response, including immunoglobulins could be responsible 
for this apparent sterile protection. However, the exact immune mechanisms involved in the protection 
induced by CyHV-3 ORF56-57 Del strain still need be further investigate in the future.  
Deletion of ORF56 and ORF57 induces a strong attenuation in vivo without preventing viral 
replication in vitro. Further studies are required to determine whether deletions of ORF56 and/or 
ORF57 are responsible for the safety/efficacy profile. CyHV-3 ORF56 is a 2571 bp ORF encoding a 
856 amino acid product, while ORF57 encode a 473 amino acid product abundantly present in 
CyHV-3 virions (Michel et al., 2010). In the ORF56-57 Del strain, most of ORF56 has been deleted 
with only the last 296 bp left. Taking into account alternative ATG, the residual sequence of ORF56 
would only lead to the expression of the last 77 aa of the original protein. There is high chance that 
such a truncated protein does not yield to a functional protein. In contrast, the deletion of ORF57 was 
compatible with the expression of a truncated protein encompassing the last 333 aa of the original 
protein. To determine whether such truncated protein was expressed, CyHV-3 ORF56-57 Del virions 
were purified and analyzed by 2D-LC-MS/MS (Michel et al., 2010). pORF57 was detected in the FL 
BAC excised strain, but not in the FL BAC excised double deleted strain and FL BAC excised triple 
deleted strain (data not shown). The obtained results demonstrated that the remaining sequence of 
ORF57 does not encode a truncated protein. In order to investigate whether the ORF56-57 deletion 
affects the structure of CyHV-3 virion, semi-purified viral particles of FL BAC excised strain, FL 
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BAC excised double deleted strain, FL BAC excised triple deleted strain were submitted to electron 
microscopy examination. The double deleted, the triple deleted and the wild type virions exhibited 
structure that could not be discriminated (data not shown). 
Compared to human and domestic animals, immunization of fish against diseases still has 
limited applications. One of the reasons explaining this lacuna is the immunization method. 
Immunization of fish by injectable vaccines is effective but not yet practical on a large scale. For this 
reason many researchers concentrated on development of oral immunization. This method has been 
used against bacterial diseases such as vibriosis, columnaris, furunculosis, and red mouth (Anderson, 
1974; Romalde et al., 2004), as well as some viral diseases, such as infectious pancreatic necrosis 
virus (IPNV) (de las Heras et al., 2010). However, the administration of the antigens by the oral route 
is complicated by problems related to preparation and/or distribution.  In contrast to injection and oral 
immunization, immersion vaccination has at least two advantages: (і) it is fast, thousands of fish can 
be vaccinated in few hours; (іi) it is easy to perform, the vaccine is directly dropped into the tanks. The 
ORF56-57 Del strain that we produced in the second experimental chapter can be used to vaccinate 
fish by immersion. 
This vaccine candidate developed has several advantages. (і) It is simple to use, the fish just 
need to be immersed into the solution vaccine for two hours; (іі) it is safe, even for fish as small as 1 g 
at the dose of 400 pfu/mL (high dose); (ііі) it is efficacious, vaccination performed at 40 pfu/mL 
induced 100% survival; (iv) experiments performed by Dr M. Boutier demonstrated that the vaccine 
strain has a reduced ability to spread from vaccinated fish to naïve cohabitant (data not shown); (v) the 
determinism of the attenuation is known and the risk of reversion can be excluded. 
To determine precisely which ORF contribute to the attenuation of ORF56-57 Del strain. 
Deletion of ORF56 or ORF57 will be produced by using BAC cloning technologies. To exclude the 
potential polar effect of the deletion, we will also produce antibodies against ORF56 and ORF57 by 
using DNA immunization as described elsewhere (Lemaire et al., 2011). In order to study the 
properties of the vaccine candidate to replicate into vaccinated fish, we plan to produce a FL BAC 
revertant ORF56-57 Del strain expressing LUC gene as a reporter. By using IVIS analysis, this strain 
will allow us to study the tropism of the vaccine strain compared to a wild type strain (also encoding a 
LUC cassette). Moreover, it will also allow us to study the portal of entry of the vaccine and its 
putative spreading to naïve cohabitant fish. Once the vaccine candidate will be fully characterized, we 
plan to test its potential as an expression vector by developing recombinant derived strain expressing 
glycoprotein G of spring viraemia of carp (SVC) as a transgene. 
The perspectives of the present work are also fundamental. We plan to unravel the roles of 
ORF56 and/ or ORF57 in the biology of CyHV-3 infection both in vitro and in vivo. When studying 
the structural proteome of the ORF56-57 double deleted strain (data not shown), we discovered an 
interesting link between ORF57 and ORF34. Indeed, the absence of pORF57 in the structural 
proteome systematically led to the absence of pORF34. This ORF encodes an unclassified structural 
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protein (Michel et al., 2010), without any predicted transmembrane domain but with a predicted signal 
peptide (Davison et al., 2013). The study of the interaction between pORF57 and pORF34, as well as 
potential additional modifications in the structural proteome, could reveal interesting clues about the 
role of pORF57 in the viral morphogenesis, and perhaps an unexpected role of pORF34 in the 
observed attenuated phenotype. 
In conclusion, in the present thesis we addressed for the first time the role of a viral IL-10 
encoded by a member of the Alloherpesviridae family both in vitro and in vivo. During the course of 
this first study, an unexpected event was discovered and became the beginning of the work for the 
second experimental chapter. The characterization of a triple deleted recombinant obtained by chance 
lead to the identification of the ORF56-57 loci as perfect candidate loci for production of attenuated 
recombinant CyHV-3 vaccines. This thesis illustrates the fact that while science must always be 
rational and critical, part of its progress relies on chance. 
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Summary 
The common carp is one of the most important freshwater fish species in aquaculture, and its 
colourful subspecies koi is grown for personal pleasure and competitive exhibitions. Both two 
subspecies are economically important. In the late 1990s, a highly contagious and lethal pathogen 
called koi herpesvirus (KHV) or cyprinid herpesvirus 3 (CyHV-3) began to cause severe financial 
losses in these two carp industries worldwide. In 2005, CyHV-3 has been classified in the 
Alloherpesviridae family of the order Herpesvirales. Because of its economic importance and its 
numerous original biological properties, CyHV-3 became rapidly an attractive subject for applied and 
fundamental research. However, to date, there is a little information on the roles of individual CyHV-3 
genes in the biology of CyHV-3 infection or its pathogenesis. Moreover, there is a lack of safe and 
efficacious vaccine for the control of CyHV-3 disease. The goal of this thesis was to study the roles of 
CyHV-3 ORF134 encoding an IL-10 homologue in the biology of the infection. 
CyHV-3 ORF134 has been predicted to contain an 84 bp intron flanked by 2 exons encoding 
together a 179 amino acid product. Transcriptomic analyses reveal that ORF134 is expressed as a 
spliced early-late gene. The identification of the CyHV-3 secretome was achieved using 2D-LC 
MS/MS proteomic approach. This method led to the identification of 5 viral and 46 cellular proteins in 
concentrated infected cell culture supernatant. CyHV-3 ORF12 and ORF134 were amongst the most 
abundant proteins detected. To investigate the roles of ORF134 in the biological of the infection, a 
strain deleted for ORF134 and a derived revertant strain were produced by using BAC cloning and 
prokaryotic recombination technologies. Comparison of these strains demonstrated that CyHV-3 
ORF134 does not contribute significantly to viral growth in vitro or to virulence in vivo in the present 
laboratory setting. The present study addressed for the first time the in vivo role of a vIL-10 encoded 
by a member of the family Alloherpesviridae. This study has been published in Veterinary Research. 
During the course of the first study, we obtained an unexpected recombination event while we 
were reconstituting infectious virus from mutated BAC plasmids. To generate a revertant ORF134 Del 
galK strain, CCB cells were co-transfected with the FL BAC ORF134 Del galK plasmid and the 
pGEMT-TK vector to remove the BAC cassette inserted in the ORF55 locus (encoding thymidine 
kinase). One of the clones obtained had an unexpected recombination leading to the deletion of 
ORF56 and ORF57 in addition to the expected deletion of ORF134. Unexpectedly, this triple deleted 
strain replicated efficiently in vitro, exhibited an attenuated phenotype in vivo and was proved to 
confer in a dose dependent manner an immune protection against a lethal challenge. The goal of the 
second experimental chapter was to investigate the role of the ORF56-57 and ORF134 deletions in the 
observed safety/efficacy profile of the triple deleted recombinant. To reach this goal, a collection of 
recombinant strains were produced using BAC cloning technologies, characterized and tested in vivo 
for their safety/efficacy profile. The results obtained demonstrated that the ORF56-57 deletion is 
responsible for the phenotype observed and that ORF134 deletion does not contribute to this 
Summary 
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phenotype significantly. Finally, the immune protection conferred by ORF56-57 deleted recombinant 
was investigated by challenging immunized fish with a wild type strain expressing luciferase as a 
reporter gene. In vivo imaging system (IVIS) analyses of immunized and challenged fish demonstrated 
that the immune response induced by the ORF56-57 deleted strain was able to prevent subclinical 
infection of the challenge strain. 
In conclusion, the present thesis addressed both fundamental and applied aspects of CyHV-3. 
For the first time, it investigated in vivo the roles of a viral IL-10 homologue encoded by a member of 
the family Alloherpesviridae. Importantly, it identified the ORF56-57 loci as target for production of 
safe and efficacious attenuated recombinant vaccines. 
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